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The importance of the gut microbiome in human health and disease has 
become apparent in recent years. The bacterial component is well characterised in 
comparison to the viral fraction, that is predominantly composed of bacteria infecting 
viruses called bacteriophages (phages). Phages are largely understudied in the context 
of the human gut despite their potential as driving forces of microbiome composition 
and function. Changes in the composition of the microbiome have been linked to 
disease states such as IBD, colorectal cancer and diabetes. However, the root causes 
of these changes remain to be elucidated. While gradual improvements in virome 
metagenomic analyses have provided us with important insights, we are only just 
beginning to understand the complex roles of gut phages. If we are to truly understand 
how phages may shape our microbiome and influence our health, it will be necessary 
to determine the mechanisms behind phage-bacterium host interactions as well as how 
phages affect the human host such as through interactions with the immune system. 
As metagenomics provides little insight into the biological properties of phages, the 
isolation of novel phage-host pairs from the human gut is required in conjunction with 
characterisation using in vitro, ex vivo and in vivo models with naturally relevant 
conditions. However, this is not without challenges. 
To gain some scope into the human gut phageome, this thesis focuses on one 
of the most interesting and abundant phages identified within the “dark matter” of viral 
sequences, crAssphage. This phage was predicted to infect hosts of the Bacteroidales 
order, one of the most important bacterial groups in the healthy human gut. We 
performed bioinformatic analyses of crAss-like phage relatives using faecal phageome 
datasets originating from multiple human cohorts. This led to the de novo assembly of 
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244 novel crAss-like phages and their taxonomic classification at the genus-level. We 
demonstrated the first evidence of ex vivo crAss-like phage propagation and generated 
preliminary electron micrographs using faeces from a crAss-rich donor, confirming a 
podovirus morphology. 
Following this, the objective was to isolate members of the crAss-like phage 
family in vitro using a targeted screening approach. Both phage and host enrichments 
were performed from the same crAssphage-rich faeces which was aided by the use of 
antibiotics to selectively promote the growth of Bacteroidales with the parallel 
expansion of associated crAss-like phages. This led the isolation of a novel member 
of the crAss-like family in pure culture, ΦcrAss002, the characterisation of which 
provided interesting insights into gut phage-host dynamics. 
A similar methodology was applied with the goal of isolating further 
Bacteroidales associated phages, however, a more traditional screening approach was 
implemented. This resulted in the isolation and first detailed characterisation of a 
virulent Parabacteroides distasonis phage to be reported as of 2020. Given that no 
other virulent phages targeting this important bacterial genus are deposited on NCBI 
Taxonomy, the need for in vitro isolation of further phage-host pairs is emphasised. 
These novel gut phages show that virulent phages do not necessarily present 
with traditional biological properties such as plaque formation or complete lysing of 
host cultures. Interestingly, both phage isolates were able to co-exist with their host 
over time. This is consistent with the observed persistence of virulent phages in the 
human gut over extensive periods of time.  Consequently, our view of phage-host 
interactions in the human gut is likely to change and expand in years to come. This 
will be necessary if we are to fully understand the extent to which these bacteria 
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infecting viruses shape the microbiome and mediate homeostasis of the gut. This will 
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The human gut is a complex environment that contains a multitude of 
microorganisms that are collectively termed the microbiome. Multiple factors have a 
role to play in driving the composition of human gut bacterial communities either 
towards homeostasis or the instability that is associated with many disease states. One 
of the most important forces are likely to be bacteriophages, bacteria infecting viruses 
that constitute by far the largest portion of the human gut virome. Despite this, 
bacteriophages (phages) are the one of the least studied residents of the gut. This is 
largely due to the challenges associated with studying these difficult to culture entities. 
Modern sequencing technologies have played an important role in improving our 
understanding of the human gut phageome but much of the generated sequencing data 
remains uncharacterised. Overcoming this requires database-independent 
bioinformatic pipelines and even those phages that are successfully characterised, 
limited insight into associated biological properties is provided, and thus the majority 
of viral sequences exist only in silico as “dark matter”. Fundamental to understanding 
the role of phages in shaping the human gut microbiome, and in turn perhaps 
influencing human health, is how they interact with their bacterial hosts. An essential 
aspect is the isolation of novel phage-bacterium host pairs by direct isolation through 
various screening methods, which can transform in silico phages into a biological 
reality. However, this is also beset with multiple challenges including culturing 
difficulties and the use of traditional methods, such a plaquing, which may bias the 
phage-host pairs that can be successfully isolated. Phage-bacterium interactions may 
be influenced by many aspects of complex human gut biology which can be difficult 
to reproduce under laboratory conditions. Here we discuss some of the main findings 
associated with the human gut phageome to date including composition, our 
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understanding of phage-host interactions, particularly the observed persistence of 
virulent phages and their hosts, as well as factors that may influence these highly 
intricate relationships, and current methodologies and bottlenecks hindering 
progression in this field. We also discuss potential steps that may be useful in 




The human microbiome is collectively comprised of trillions of microbial cells 
originating from all domains of cellular life (Bacteria, Archaea, Eukarya) as well as 
viruses (Ursell et al., 2012). The human microbiome has received significant attention 
in the past two decades, and can even be considered as an organ in its own right due 
to its important role in multiple aspects of human health (O’Hara and Shanahan, 2006; 
Baquero and Nombela, 2012; Lloyd-Price et al., 2016). Microbial numbers equate to 
~1014 cells which is comparable to the total number of human cells (Sender et al., 2016; 
Cani, 2018). The vast majority of these microorganisms reside in various locations 
within the human gastrointestinal tract (GIT) where they partake in essential metabolic 
and physiological processes that impact human biology (Turnbaugh et al., 2007; 
Sender et al., 2016). Thus, the GIT forms a complex ecosystem where biotic factors 
and abiotic factors, such as immune components and physiochemical parameters, are 
intertwined (Mirzaei and Maurice, 2017; Shkoporov and Hill, 2019). Bacteria 
constitute the majority of biomass in the GIT where they have key roles in maintaining 
human homeostasis, immunity, and health (O’Hara and Shanahan, 2006; Qin et al., 
2010; Yatsunenko et al., 2012; Belkaid and Hand, 2014; Sender et al., 2016). A healthy 
human gut, with no obvious signs of disease, is populated by more than 1000 bacterial 
species with greater than 90% resolving into two phyla, the Firmicutes and 
Bacteroidetes (Turnbaugh et al., 2007; Lozupone et al., 2012). In the healthy human 
gut, these bacterial species will be generally stable over years and perhaps even 
decades (Faith et al., 2013). Perturbations and shifts in the composition, abundance, 
and diversity, of bacterial communities has been associated with multiple disease 
states (Lozupone et al., 2012). These include inflammatory bowel disease, obesity, 
diabetes, eczema, cancer and neurological disorders (Karlsson et al., 2011; Giongo et 
15 
 
al., 2011; Gkouskou et al., 2014; Goodrich et al., 2014; Halfvarson et al., 2017; Casén 
et al., 2015; Hartstra et al., 2015; Vogt et al., 2017; Helmink et al., 2019). The driving 
forces that cause these shifts in the gut bacterial community remain a vital question in 
the field of human gut microbiome research. One of the most understudied aspects of 
the microbiome are viruses of bacteria, bacteriophages (phages). It is well known that 
phages have an important role as drivers in shaping bacterial communities in different 
environments both by predation or horizontal gene transfer by transduction and can be 
regarded as powerful evolutionary forces (Koskella and Meaden, 2013). To date, the 
phageome has been largely studied in the context of ecosystems such as the marine 
environment (Rodriguez-Brito et al., 2010; Hurwitz et al., 2014). However, in recent 
years, it has become apparent that phages are also highly abundant in the human gut. 
Together bacteria and their viruses are the most abundant components of the 
human gut (Cani, 2018). Despite this, and their role in influencing bacterial 
communities in the GIT ecosystem, the viral fraction remains one of the least 
understood components of the human gut microbiome. The virome includes both 
bacteriophages and eukaryotic viruses; however, phages (phageome) are significantly 
more abundant (Gregory et al., 2019). Furthermore, recent studies have shown that 
microbiome composition is driven by phages and not by the eukaryotic viruses which 
are generally not associated with health (Moreno-Gallego et al., 2019). Despite being 
independently discovered over a century ago by Twort and d’Herelle, it is only in the 
past decade that the potential role of phages in the gut microbiome has been considered 
(Twort, 1915; d’Hérelle, 1917). Phage-driven alterations of bacterial composition by 
direct interactions or potentially via the human immune system and changes in the gut 
phageome composition itself have been linked to a number of disease states including 
inflammatory bowel disease (IBD), diabetes, malnutrition, Parkinson’s disease 
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(Norman et al., 2015; Reyes et al., 2015; Manrique et al., 2016; Nguyen et al., 2017; 
Zhao et al., 2017; Belleghem et al., 2017; Ma et al., 2018; Kieser et al., 2018; Tetz et 
al., 2018; Gogokhia et al., 2019; Zuo et al., 2019; Clooney et al., 2019). Faecal filtrate 
transfer (FFT) studies further indicate that the phageome has the potential to shape the 
microbiome. For example, the administration of a bacterial cell-free faecal filtrate 
from healthy donors to patients with Clostridioides difficile infection (CDI) was 
demonstrated to prevent disease recurrence (Ott et al., 2017). The engraftment of the 
donor phageome has also been observed in another study involving faecal microbiota 
transplantation (FMT) in CDI patients (Draper et al., 2018). Furthermore, some 
abundant gut phages, such as the crAss-like phages, appear to interact with their 
bacterial hosts in dynamics that have not been typically observed in other ecosystems. 
They have been found to persist in the gut over extensive periods of time without 
major impacts on their bacterial hosts (Maura et al., 2012a; Guerin et al., 2018; 
Shkoporov et al., 2018a). These intriguing interactions merit further investigation. 
Findings to date highlight the importance and significance of the human gut phageome 
but the factors and mechanisms by which phages impact on bacterial communities and 
overall microbiome homeostasis or instability are still unclear. Key to understanding 
this is gaining insight into how phages interact with their bacterial host in the human 
gut. 
Despite a resurgence in interest in gut phages, current methodologies are 
limited and require improvements. Modern sequencing technology has been essential 
in providing insights that would have not been possible with culture-based methods 
(Shkoporov et al., 2019). However, this methodology is also limited as a consequence 
of the fact that most viral sequences lack homology with known phages in current 
databases, with up to 86-99% of reads remaining uncharacterised, sometimes referred 
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to as viral “dark matter” (Aggarwala et al., 2017). Many bioinformatic pipelines are 
database-dependent and only focus on the characterizable fraction. This results in the 
exclusion of the majority of viral sequences and skewed overall findings (Clooney et 
al., 2019; Sutton and Hill, 2019; Gregory et al., 2019). Furthermore, novel phages 
identified through viral metagenomics often only exist in silico and it can be difficult 
to predict potential bacterial hosts at a species or strain level (de Jonge et al., 2019a). 
Overall, current pipelines can result in incomplete and skewed analyses. 
In terms of laboratory-based research there are also multiple challenges to 
overcome. Many gut bacteria are difficult to culture, thus making isolation of their 
associated phages extremely difficult (Browne et al., 2016). Furthermore, many 
phages are strain specific, mimicking gut conditions is problematic, and host factors 
such as phase variable expression of phage receptors add another level of difficulty 
(Porter et al., 2020). Many current studies only look at the phage host-pair under 
reductionist in vitro conditions. Although laboratory characterisation is essential and 
provides important insights, analysis of novel phage-host pairs should also be coupled 
where possible with examination under more complex, realistic conditions such as 
fermenter systems or mouse models. Mouse models also provide insight into the radial 
and distal variability along the GIT (Zhao et al., 2019; Lourenço et al., 2019). The 
importance of coupling in vitro work with other models was highlighted in a study 
which found that a single point mutation in the tail fibre gene of an E. coli infecting 
phage was sufficient to allow the phage to “jump” host at a strain level when faced 
with resistance. However, this phenomenon was overlooked under in vitro conditions 
and only detected in a conventional mouse model (De Sordi et al., 2017). 
This review will discuss the current understandings of the human gut phageome and 
phage-host interactions. We will also discuss the importance of isolating and 
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characterising novel phage-host pairs from the gut to attain news insights and improve 
our knowledge on phage-bacteria dynamics. We will review the current 
methodologies implemented in the laboratory and in bioinformatics, and the 
challenges associated with each that need to be overcome if both in silico and in 
vitro/in vivo findings are to provide a better understanding of the reality of the gut 
phageome. The ultimate goal is to fully understand how phages shape the microbiome 
and thus how this can impact on human health and disease. 
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1. The human gut phageome 
The human gut is a densely populated ecosystem with significant variability in 
physical conditions as well as abiotic and biotic factors including pH, oxygen, nutrient 
and water availability, immunoregulators and bile acids (Mirzaei and Maurice, 2017). 
This creates a gradient of conditions ranging from the mouth to the stomach and to the 
small and large intestine, which results in niche specificity of the microbial residents 
of the gut (Pereira and Berry, 2017; Bauer et al., 2018). In addition to longitudinal 
variation, there is radial variation along the GIT due to features such as mucosa, villi 
and crypts (Donaldson et al., 2016; Zhao et al., 2019). Within this complex ecosystem 
bacteriophages, although structurally simple, can partake in intricate dynamics with 
bacteria and can influence microbiome homeostasis. 
 
1.1 Phage lifecycles 
Traditionally, phages have been classified as lytic/virulent or 
lysogenic/temperate based on the method of infection they employ when targeting a 
permissive host (Hobbs and Abedon, 2016). Both life cycles initiate with adsorption 
of the phage to its specific bacterial host where binding occurs between the phage 
receptor binding protein and a host cell surface feature which acts as the corresponding 
receptor. Following this, the phage injects its genetic material, which can be either 
single-stranded (ss) or double-stranded (ds) DNA or RNA, from its capsid into the 
host cell. It is at this point that the life cycles diverge. Lytic phages hijack host 
replication machinery to replicate their genomes, assemble phage components and 
produce progeny (Figure 1A). This ultimately ends in lysis of the host cell and release 
of progeny phages to commence subsequent rounds of host infection. In contrast, 
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lysogenic phages can integrate into the host chromosome forming a prophage and 
replicates in tandem with the bacterial genome (Figure 1B). In the case of 
pseudolysogeny, the genetic material persists in the host cytoplasm as an episome 
independent of the host genome (Figure 1C). In both cases, the phage genome 
replicates with the host and is carried in daughter cells without leading to lysis. The 
direct integration of a temperate phage into the bacterial genome, or the horizontal 
gene transfer that they are capable of mediating by transduction, can confer the host 
with beneficial genes and functions including virulence factors and stress tolerance. 
This is reviewed in detail by Obeng and colleagues (Obeng et al., 2016). Certain 
stimuli can cause the induction and excision of prophages which revert to a lytic 
lifestyle. These stimuli can include multiple intrinsic and extrinsic factors, including 
antibiotics and inflammation of the gut (Goerke et al., 2006; Nanda et al., 2015; 
Howard-Varona et al., 2017; Clooney et al., 2019). Pseudolysogeny is associated with 
conditions of stress such as host cell starvation and allows the phage to avoid 
resistance strategies. Thus, it is thought to provide phages with a means of survival. 
Depending on the favourability of conditions, pseudolysogenic phages can then 
commit to a lysogenic or lytic infection cycle (Łoś and Węgrzyn, 2012). A carrier state 
life cycle has been described for Campylobacter jejuni phages (Figure 1D). This 
alternative life cycle is pseudolysogenic-like in that the phage can enter an episome 
state in a permissive host, but it can also remain “carried” on the surface of non-
permissive host cells without replication. The phage will then commit to lysis when it 
comes in contact with a sensitive host and conditions are favourable for progeny 
production. This is largely dictated by whether the host is phage permissive, thus 
creating an equilibrium that is favourable to both phage and host survival (Siringan et 
al., 2014). Chronic phage infections can be likened to the lytic cycle in that new 
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progeny is produced by hijacking the host, but newly produced virions are exported 
by alternative mechanisms without lysis thus the host cell is maintained intact (Figure 
1E). This method of replication has been associated with filamentous phages such as 
M13 and CTXΦ (Hobbs and Abedon, 2016; Smeal et al., 2017a, 2017b).  Although 
pseudolysogeny, the carrier state lifestyle and chronic phage infections are less 
characterised in comparison to the lytic and lysogenic lifecycles, the prevalence of 
each of the lifecycles is poorly understood in the context of the human gut. To avoid 
ambiguity, when discussing the phageome we generally refer to phages present within 
bacterial genomes as temperate, while free phage virions are referred to as virulent 
phages or virus-like particles (VLPs). 
 
1.2 Taxonomy 
 The International Committee on Taxonomy of Viruses (ICTV) is responsible 
for the taxonomic classification of prokaryotic viruses which has been traditionally 
based on virion morphology (Lefkowitz et al., 2018). The best characterised of the 
phage families are the Siphoviridae, Podoviridae and Myoviridae that make up the 
Caudovirales order, all of which are tailed with dsDNA genomes. Members of these 
phage families have distinct head and tail morphologies: Siphoviridae have long non-
contractile tails, Podoviridae have short non-contractile tails and Myoviridae have 
long contractile tails (Ackermann, 1998). Electron microscopy (EM) of human faecal 
filtrates shows a dominance of these phage morphologies (Hoyles et al., 2014). 
However, many studies focused solely on VLPs and observations can be skewed due 
to the ease at which phages of the Caudovirales order can be recognised. An interesting 
argument was put forward by Sutton and Hill regarding the current discrepancies in 
phage taxonomy, where two phages that shared similar genomic and functional 
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characteristics were classified into different phage families solely based on virion 
morphology (Sutton and Hill, 2019). This highlights the need for a move towards the 
use of sequenced-based taxonomic classification. Currently, efforts are being made to 
develop a genome-based taxonomic scheme (Bolduc et al., 2017; Eloe-Fadrosh, 2019; 
Jang et al., 2019). This will be important for future virome studies and for the 
classification of novel phages. However, this is not without difficulties and will require 
integration with the current taxonomic scheme.  
 
1.3 Composition and structure 
In the human gut, phages are estimated at ~1010 g-1 while the bacteria they 
infect equate to ~1011 g-1 (Shkoporov and Hill, 2019). It has been long postulated that 
phages greatly outnumber their bacterial hosts at 10:1 virus-to-microbe ratio (VMR) 
(Bergh et al., 1989; Wommack and Colwell, 2000; Chibani-Chennoufi et al., 2004) 
VMR has been associated with influencing lifestyle switches of phages (Howard-
Varona et al., 2017). With shifts to a high VMR (high phage to low host densities), it 
was thought that phages would enter into a lysogenic life cycle to ensure persistence 
in the community. However, more recently it has been proposed that with increased 
bacterial abundances, phages will transition from lysis to lysogeny allowing them to 
take advantage of the success of their host in “Piggy-Back-The-Winner” dynamics 
(Knowles et al., 2016). It is important to note however, that this is largely based on 
marine and aquatic environments and may not necessarily be representative of the 
human gut. The VMR in the human gut is significantly lower compared to other 
ecosystems, estimated at ~0.1:1 (Shkoporov and Hill, 2019). 
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The ratio of virulent and temperate phages in the healthy human gut has been a 
question of interest. In recent years, the main consensus based on both microscopic 
and sequenced-based virome studies is that the human gut is dominated by temperate 
dsDNA phages of the Caudovirales order and ssDNA phages of the Microviridae 
family (Reyes et al., 2010; Kim et al., 2011; Minot et al., 2011; Hoyles et al., 2014; 
Moreno-Gallego et al., 2019).  These phages, in particular Caudovirales, have been 
described as the core of a healthy human adult phageome with a high occurrence of 
prototypical crAssphage and related crAss-like phages (Dutilh et al., 2014; Manrique 
et al., 2016; Moreno-Gallego et al., 2019). In addition, this core was found to be highly 
stable over time which is consistent with reports on crAss-like phages and the slow 
evolution rates associated with temperate phages compared to virulent phages (Minot 
et al., 2011; Dutilh et al., 2014; Shkoporov et al., 2018a; Guerin et al., 2018; 
Shkoporov et al., 2019). Studies have found that 95% of viral genotypes are 
maintained after one year and 80% after two years (Reyes et al., 2010; Minot et al., 
2013). This was linked to the dominance of temperate phages which have low 
mutation rates compared to virulent phages, such as Microviridae, which have 
mutation rates as high as 10-5 substitutions per day (Minot et al., 2013). Changes in 
the composition and the richness of the temperate core have also been associated with 
diseases states such as IBD (Norman et al., 2015). However, the existence of this 
phage core in the human gut shared across individuals has also been disputed (Gregory 
et al., 2019). There have also been suggestions of a healthy “core microbiota” in 
relation to bacterial communities in the gut and that deviations from this core are 
associated with disease. For defining this, it was found that specifying the core was 
most appropriate based on shared functionalities as opposed to taxonomy (Turnbaugh 
et al., 2009). 
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A key issue with many virome studies is that the analytical pipelines focus 
solely on the known, annotated component (~1-14% of sequences generated) and 
exclude viral dark matter which currently constitutes most of the sequences in viral 
datasets (Aggarwala et al., 2017). If only a fraction of the reads are examined, this 
obviously leads to an incomplete and potentially biased analysis. More recent studies 
have attempted to take this into account by implementing stricter criteria and limiting 
the use of database-dependent methods. 
A study examining the correlation between virome and microbiome similarity 
among 21 adult monozygotic twin pairs with concordant or discordant microbiomes 
confirmed that phages indeed drive microbiome diversity (Moreno-Gallego et al., 
2019). This fits well with observations made for FMT recipients whose phage and 
bacterial profiles reflected that of the donor (Draper et al., 2018). In addition, 18 
contigs were found to be shared across all individuals tested, the majority of which 
were crAss-like phage family associated (Moreno-Gallego et al., 2019). These 
findings support the presence of a potential core virome; however, additional 
longitudinal studies of healthy and disease cohorts are necessary to examine the 
stability, composition and inter-personal variation of this supposed core over time. 
A longitudinal study of the healthy human gut virome of ten individuals over 
a one-year period, which implemented a database-independent approach, identified a 
personal persistent virome  (PPV) (Shkoporov et al., 2019) (Figure 2A). A total of 22 
abundant and temporally stable phage clusters were identified; however, none of these 
were present in all individuals at one time and the presence and abundance of each 
cluster was individual specific. These 22 clusters were classified as virulent crAss-like 
phages, other virulent Caudovirales, and Microviridae with only three being identified 
as temperate. A transiently detected virome (TDV) was also observed but in contrast 
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to the PPV, it was less abundant and less stable but surprisingly more shared among 
individuals. The TDV is comprised of Siphoviridae and phages such as Inoviridae 
(Figure 2B). Interestingly, CRISPR-spacer analyses found that the PPV was associated 
with abundant and stable bacterial genera specifically adapted to a healthy gut 
environment, whereas more transient genera such as Escherichia and Streptococci 
were associated with the TDV (Shkoporov et al., 2019). Overall this study clarifies 
multiple discrepancies in virome studies and is in agreement with a previous study that 
was unable to support the idea that a defined set of specific phages are shared among 
all individual (Gregory et al., 2019). These findings also show that the gut is dominated 
by virulent phages as opposed to temperate phages which only form a subset of the 
virome (Reyes et al., 2010; Minot et al., 2011; Moreno-Gallego et al., 2019). In 
summary, there is a predominantly virulent core of phages clusters in healthy 
individuals that forms an individual specific PPV that results in high inter-personal 
variation across phageomes. The gut is indeed dominated by dsDNA Caudovirales and 
ssDNA Microviridae, but the most abundant phages are virulent. If temperate phages 
are not dominant as previously thought, this begs the question of how virulent phages, 
such as crAss-like phages, maintain themselves in the human gut at high levels over 
extensive periods of time? In vitro studies of ΦcrAss001 in serial co-culture with 
Bacteroides intestinalis 919/174 showed that despite propagation at high titres, both 
phage and host were able to co-exist over 23 days (Shkoporov et al., 2018a). Chapter 
3 of this thesis also demonstrates similar dynamics and co-existence for ΦcrAss002 
and Bacteroides xylanisolvens APCS1/XY. These findings are consistent with the 
observed ability of lytic phages to propagate on their hosts for multiple weeks in the 
murine intestine with minimal impact on host counts (Weiss et al., 2009; Maura et al., 
2012a). The co-existence of virulent phages and their bacterial hosts was recently 
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examined in a murine model with a defined community. Findings suggests that the 
spatial variation in the GIT allows co-existence in that phage propagation occurs in 
the lumen while a subset of the target host population remains in the mucosa or crypts 
where they are inaccessible to the phage (Lourenço et al., 2019). 
With high inter-individual variation across viromes, the identification of viral 
signals or biomarkers that could differentiate and group individuals based on disease 
states is a challenge. Clooney et al. examined the potential of the virome to distinguish 
cohorts using a combination of a previously published and an in-house dataset of 
healthy and IBD viromes (Norman et al., 2015; Clooney et al., 2019). This was 
performed using a database-independent method based on the whole virome, i.e. both 
the known viral sequences and dark matter were examined. Protein-based clustering 
was performed to identify compositional patterns that potentially separated the two 
cohorts using vConTACT2, a protein clustering program and the same pipeline 
implemented by Shkoporov et al. (Jang et al., 2019; Shkoporov et al., 2019). 
Interestingly, this protocol also revealed a person-specific virulent core of crAss-like 
phages and Microviridae in health which was absent in IBD patients. IBD viromes 
were found to have an increased abundance of induced temperate phages and this was 
reflected by a reduction in bacterial alpha-diversity (Clooney et al., 2019). The 
characteristic inflammation of this disease may be due to the induction of a 
proinflammatory immune response as a result of increased bacterial lysis. These 
findings support the observed expansion of specific phage populations in other IBD 
virome studies (Norman et al., 2015; Duerkop et al., 2018). Duerkop and colleagues 
proposed that members of the Spounaviridae subfamily could serve a biomarker of 
colitis (Duerkop et al., 2018). Clooney et al. observed an expansion of temperate 
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Myoviridae, as well as Siphoviridae (Clooney et al., 2019). As Spounaviridae resolve 
into the Myoviridae family, further investigation of this biomarker is merited. 
In summary, this work shows that loss of, or deviation from, the healthy 
virulent core to a virome with increased temperate phage induction is indicative of 
IBD. It would be worthwhile expanding on the findings in these studies to identify 
genus- or species-specific changes and apply the same experimental protocol to other 
disease states of the GIT to examine if similar disease-specific shifts occur. 
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2. Phage-host interactions 
The maintenance of a phage in an ecosystem is dependent on its ability to infect 
a suitable bacterial host. However, bacterial hosts can employ an arsenal of defence 
mechanisms. This leads to antagonism between the two populations, as phages have 
also evolved strategies to counter bacterial resistance mechanisms. If selective 
pressures occur, co-evolution can result in genotypic variants due to mutations at 
specific sites within both entities, such as phage tail fibres and bacterial surface 
receptors. These complex interactions are believed to be an important shaping force 
of multiple ecosystems. Several ecological models have been developed in attempt to 
explain these interactions. In recent years, a number of interesting mechanisms have 
been observed in this relationship of resistance and counter-resistance. To add another 
level of complexity, phages are also thought to interact with the mammalian host, both 
directly and indirectly, via the immune system. For clarity, when discussing phage-
host interactions, this refers solely to the bacterial host unless stated otherwise. 
 
2.1 Host defense mechanisms and phage counter defense strategies 
Both bacterial defence and phage counter-defence strategies have been 
reviewed extensively (Labrie et al., 2010; Samson et al., 2013; Seed, 2015; Rostøl and 
Marraffini, 2019). Here we will summarise the key features and significance of these 
antagonistic interactions (Figure 3A). Bacteria can employ an array of defence 
mechanisms when faced with phage predation. These include preventing phage entry, 
blocking injection of or elimination of nucleic acids, inhibiting the hijacking of 
replication machinery and programmed cell death. Bacteria can prevent phage 
adsorption by modifying, masking or differentially expressing surface features such 
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as lipopolysaccharide and polysaccharide capsules (Bertozzi Silva et al., 2016). Some 
bacteria produce outer membrane vesicles (OMVs) that extend from the cell surface, 
irreversibly bind phage and pinch off thus acting as a decoy (Manning and Kuehn, 
2011; Schwechheimer and Kuehn, 2015). Interestingly, OMVs were also shown to 
transfer phage receptors to resistant host cells making them transiently susceptible to 
phage infection (Tzipilevich et al., 2017). How bacteria use cell surface features to 
control phage interactions will be discussed in more detail later. 
Should the phage overcome these initial barriers the host can employ other 
forms of defence to interfere with other stages of the phage infection cycle. Bacteria 
can inhibit the injection of phage genetic material in multiple ways, some of which are 
mediated by altering the conformation of the injection site or the inner membrane (Lu 
et al., 1993; Cumby et al., 2015).  If the phage nucleic acids enter the cytoplasm, they 
can be eliminated by restriction modifications systems which cut the invading phage 
DNA (Roberts et al., 2003; Tock and Dryden, 2005). CRISPR-Cas systems provide 
bacteria with a means to form an adaptive immunity against phage infection, by 
cleaving a 20 – 40bp segment of the phage genome and incorporating it into the 
bacterial genome. This short segment is called a CRISPR-spacer and allows rapid 
elimination on repeated infection by the same phage by spacer sequence directed 
cleavage of phage DNA (Horvath and Barrangou, 2010; Wiedenheft et al., 2012). 
Some bacteria encode phage-inducible chromosomal islands that are excised on phage 
infection. These interfere with the progeny assembly stage of the infection cycle and 
can act by interfering with DNA packing for example. Ultimately, this leads to cell 
death but limits phage dissemination to neighbouring cells (Ram et al., 2012; Seed, 
2015). Bacteria can also possess toxin-antitoxin systems which can interfere with 
different levels of the phage infection cycle. These systems are thought to have 
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multiple roles in addition to phage resistance (Rostøl and Marraffini, 2019). Three 
novel anti-phage defence systems, the BREX (bacteriophage exclusion) system,  the 
DISARM system and the cyclic-oligonucleotide-based antiphage signalling system 
(CBASS), were detected only recently in 2015, 2018 and 2019 respectively (Goldfarb 
et al., 2015; Ofir et al., 2018; Cohen et al., 2019). BREX inhibits DNA replication and 
DISARM is a restriction modification type system (Goldfarb et al., 2015; Ofir et al., 
2018). CBASS, analogous to the mammalian cGAS-STING innate immune response, 
is a signalling pathway activated on phage detection that leads to cyclic GMP-AMP 
production and effector activation resulting in cell death prior to phage progeny release 
(Cohen et al., 2019).  These findings suggest that many novel systems have yet to be 
discovered. The final resort for a bacterial cell is abortive infection in which the cell 
shuts itself down to prevent phage replication and release of progeny. This protects 
sister cells from a similar fate (Dy et al., 2014). Although bacteria have been reported 
to possess multiple defence mechanisms, none have been reported to possess all 
possible options, probably due to the associated fitness costs (Bernheim and Sorek, 
2019; De Sordi et al., 2019). Indeed, a “pan-immune system” model has been 
presented suggesting that bacteria can “pick and choose” defence systems from related 
strains by horizontal gene transfer to overcome the fitness burden of possessing 
specific defences (Bernheim and Sorek, 2019).When a prophage has integrated and 
overcome host defences it confers the lysogen with resistance to further phage 
infection. This phenomenon is called superinfection exclusion (Cumby et al., 2012). 
However, poly-lysogeny is also possible in which the bacterial genome carries several 




Despite the efforts of bacteria to ward off phage attack, their predators employ 
mechanisms to fight back. In the case of masked receptors, phages can encode 
enzymes which degrade capsular polysaccharides (Cornelissen et al., 2012; Leiman et 
al., 2007). Phages can modify their genomes to avoid restriction modification systems 
or they can encode anti-CRISPR proteins (Samson et al., 2013; Wiedenheft, 2013). 
Phages can also mimic host antitoxins to neutralise host produced toxins in host toxin-
antitoxin defences allowing the phage to proceed with propagation (Blower et al., 
2012). Interestingly, phage encoded CRISPR-Cas systems have also been detected 
which allow the phage to hijack host defences (Seed et al., 2013). When presented 
with a resistant host with modified receptors, phages can modify their receptor binding 
protein (RBP) to continued replication on the same host. For example, lambda phage 
originally absorbed to its host, Escherichia coli B, at cognate receptor LamB but with 
the introduction of four point mutations into the gene encoding its RBP, the phage was 
able to bind at a new host receptor, OmpF, while maintaining its ability to bind at the 
original receptor (Chatterjee and Rothenberg, 2012; Meyer et al., 2012). This bacterial 
adaptation during resistance and phage counter resistance has given rise to co-
evolution which in turn has led to diversity and expansion of host range and strain 
diversity in ecosystems. Phages are also capable of switching hosts at the strain level 
and in rarer cases they can infect across species. It is proposed that this may occur 
when a host becomes spatially inaccessible or reduced in abundance. This was 
identified in a conventional murine model in which it was discovered that a single 
point mutation in the tail fibre gene of an E. coli LF82 infecting phage, P10, was 
sufficient to allow the phage to “jump host”. Subsequently, the phage could infect an 
originally non-permissive strain, E. coli MG1655, in the presence of an intermediate 
host within the murine microbiome. (De Sordi et al., 2017). 
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It has been proposed that antagonistic co-evolution plays an important role in 
the diversification of bacteria and phages in the human gut and merits further 
investigation. However, this is challenging due to the complexity of this ecosystem 
and the multiple influencing factors to consider (De Sordi et al., 2019). Longitudinal 
studies have provided some insight into the genetic variation among phages in the 
human gut. In the previously discussed longitudinal study performed by Shkoporov et 
al., the accumulation of single nucleotide polymorphisms (SNPs) was monitored over 
a one-year time period. It was found that novel genotypes replaced the original phage 
strain in some cases while in other instances multiple genotypes of the same phage co-
existed for some time (Shkoporov et al., 2019). These findings are indeed suggestive 
of arm-race dynamics; however, findings in vivo suggest that these dynamics may not 
be as prevalent in the GIT as previously thought, in particular for persistent virulent 
phages. It is proposed that the spatial spread of virulent phages and bacterial hosts in 
the GIT limits the need for selective pressures and allows co-existence without 
significant emergence of resistant variants (Lourenço et al., 2019). This is indicated 
by the low emergence of resistant bacterial clones after phage exposure in a murine 
model and maintenance of phage populations. These findings support observations 
that have been made in previous studies, including work on crAss-like phages (Weiss 
et al., 2009; Maura et al., 2012a; Shkoporov et al., 2018a). Conversely, a number of 
studies have detected the emergence of phage-resistant clones at high levels (Hsu et 
al., 2019). Although, the percentage of resistant mutants selected may be influenced 
by a specific phage-host pair or environmental conditions. Significant variation in 
phage-host dynamics have been observed. For example, T7 phage was found to select 
for only 20% resistant E. coli clones versus 68% resistant E. faecalis clones selected 
for in the presence of VD13 phage in vivo (Weiss et al., 2009; Hsu et al., 2019).  
33 
 
2.2 Ecological models and the GIT 
A number of ecological models have been developed that describe phage-host 
interactions in various ecosystems. One of the earliest defined ecological models 
describing these interactions is the classical kill-the winner model which is derived 
from the Lotka-Volterra equation (Thingstad, 2000). This model describes the 
predation of the most abundant bacteria in an ecosystem by their associated phages in 
a manner that leads to an abrupt reduction in their population. This in turn results in 
the expansion of another “winner” and a subsequent round of predation leading to 
fluctuations of the dominant phages and bacteria in an ecosystem (Maslov and 
Sneppen, 2017). This pattern of predator-prey dynamics is generally not associated 
with the GIT, at least not at the genus or species level (Reyes et al., 2010; Minot et al., 
2011; Shkoporov et al., 2019). Furthermore, it doesn’t take lysogenic conversion into 
account. This is considered in the piggyback-the-winner model which was previously 
discussed in relation to VMR. Traditionally, this model proposed the lysogenic 
conversion of phages in a high VMR (high phage: low bacterial densities) to ensure 
survival until conditions favoured reversion to lysis. However, more recently 
lysogenic conversion was also described in the case of a low VMR (low phage: high 
bacterial densities) in which phages take advantage of and “piggyback” on host 
prosperity (Knowles et al., 2016; Silveira and Rohwer, 2016). 
In relation to the preceding discussion, the constant antagonistic battle that 
leads to the co-evolution of phages and their hosts has been described as the arms-race 
dynamics. This describes the constant cycling between infection, resistance, 
adaptation and counter resistance in phage-host interactions that is responsible for 
evolutionary pressures (Hall et al., 2011). It has also been proposed that these 
dynamics can shift towards what is referred to as the fluctuating selection dynamics 
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model (Gandon et al., 2008). In the context of phages, this model considers the fitness 
cost that comes with selection for genetic resistance. For example, when a phage 
initially infects its host they successfully propagate, but with time they select for 
resistance mutants. This reduces the number of infectible hosts, and in turn phage 
numbers will decrease which allows sensitive host populations to recover. (Hall et al., 
2011; Scanlan et al., 2015). 
It is important to consider that these ecological models have been largely 
discussed in the context of environmental ecosystems such as oceans and may not be 
directly applicable to the human gut ecosystem. A recently proposed ecological model, 
although discussed in the context of the marine environment, fits well with our current 
understanding of virulent phage-host interactions in the human gut. These interactions 
occur between a stable and persistence dominant core of lytic phages that can co-exist 
with their hosts. The “royal family” model proposes that kill-the-winner dynamics 
occur at a host strain or sub-strain level, which is below detectable levels of techniques 
such as 16S rRNA gene sequencing, and as a result population dynamics appear stable 
at both the genus and species level over time (Gandon et al., 2008; Breitbart et al., 
2018). This is also supported by the phenomenon of “host jumping” which occurs at 
the strain level (De Sordi et al., 2017). Quorum sensing has also been proposed as a 
factor that allows phage-host co-existence (Høyland-Kroghsbo et al., 2013).  
The ability to come into contact in the gut is also thought to influence phage-
host interactions; for example, motility and diffusion can be affected due to variations 
in mucus concentrations. A “continuous time random walk” model was developed to 
describe how this can influence the rate at which phage-host interact (Joiner et al., 
2019). Further supporting this and the role of spatial heterogeneity in the co-existence 
and maintenance of virulent phages with their hosts, is the source-sink dynamic model. 
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This accounts for the radial variation of the gut due to anatomical features and the 
influence that this has on the spatial dissemination of phages and their hosts (Figure 
3B). The mucosa is described as the source, a phage inaccessible refuge for bacteria 
that can gradually disseminate into the lumen. The lumen acts as the sink where phage 
propagation occurs on permissive hosts (Holt, 1985; Lourenço et al., 2019). As a 
result, this creates a gradient of low virulent phage density in mucosal crypts which 
increases towards the lumen. Interestingly, this is consistent with the idea that 
populations of intestinal bacteria, particularly commensals, reside in microhabitats 
such as crypts (Figure 3B). This allows them to form reservoirs and manage the 
population by re-seeding of the lumen after perturbations (Donaldson et al., 2016). A 
number of prior studies support the idea of spatial refuges for bacteria to avoid phage 
predation (Schrag and Mittler, 1996; Bruttin et al., 1997; Weiss et al., 2009). If virulent 
phage-host interactions do indeed occur in the lumen, stability may result here due to 
the constant “arms-race” of resistance and counter-resistance between the two 
antagonistic populations at the strain (De Sordi et al., 2019). This may also account 
for the genotypic heterogeneity that can develop among certain virulent phages in the 
personal persistent virome over time (Shkoporov et al., 2019).  However, it has also 
been suggested that “arms-race” dynamics and extension of host range do not have a 
role in this persistence (Lourenço et al., 2019). 
 
2.3 Other influencing factors and alternative interactions 
The ability of a phage to infect its host is not solely dependent on resistance 
and counter resistance. The lifestyle and physiological state of the target host is 
thought to be a significant influencing factor on the success of a phage infection. The 
environmental conditions of the GIT have an important role in this due to the impact 
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they can have on the metabolic state and stress levels in bacteria (Figure 3B, 3C). 
These conditions include the physical and anatomical variation along radial and 
longitudinal axes of the GIT, mucous, bile acids, pH, oxygen, water levels, nutrient 
levels, peristalsis and dietary components (Koziolek et al., 2015; Vandeputte et al., 
2016; Shkoporov and Hill, 2019; Zhao et al., 2019). Furthermore, in vitro and in vivo 
laboratory conditions can also influence physiology which may have an important role 
in experimental outcomes. The role of host physiology in phage-host interactions has 
been comprehensively reviewed by Lourenço et al. (Lourenço et al., 2018). 
The physiological state of a bacterial host can influence whether it is phage 
permissive. This can also generate phenotypic heterogeneity within an isogenic 
population with part phage sensitive and others resistant (Bull et al., 2014) (Figure 
3C). A phenomenon called phase variation (PV) is thought to be an important mediator 
of transient resistance that results in phenotypic variation in response to environmental 
conditions. The effects of PV in terms of phage-host interactions were first described 
in detail in Haemophilus influenzae (Zaleski et al., 2005). Recently, the significance 
of PV in dictating phage-host interactions in the gut has become of interest (Jiang et 
al., 2019; Turkington et al., 2019; Porter et al., 2020). PV is a mechanism by which 
bacteria undergo transient phenotypic switching. This occurs by variable expression 
of gene loci switches due to hypermutation or methylation. This results in genes being 
reversibly switched “on or off” (Bayliss, 2009). This switching is often mediated by 
recombinases, integrases or invertases. These enzymes act on invertible regions 
containing promotors of gene loci often associated with expression of surface features 
such as Sus-like systems, capsule polysaccharides, S-layer and Ton-dependent 
transporters, which can act as phage receptors, outer membrane vesicles, flagella or 
restriction modification systems (Zaleski et al., 2005; Coward et al., 2006; Nakayama-
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Imaohji et al., 2009; Zitomersky et al., 2011; Nakayama-Imaohji et al., 2016; Porter 
et al., 2020). These phenotypic switches allow the host to adapt to environmental 
stresses, which are abundant in the human gut, while minimising the fitness impact on 
the total population (Moxon et al., 1994). A recent study demonstrated that phase 
variable invertons are more dominant in the human gut compared to other 
environments, particularly among Bacteroidetes (Jiang et al., 2019). This indicates the 
importance of this phenomenon in the survival of bacteria in the human gut. An 
interesting example of how hosts can mediate phage interactions through phenotypic 
modifications was observed in Campylobacter jejuni. It is thought that PV is the most 
common phage resistance mechanism used by these bacteria (Gencay et al., 2018). 
Although not a native of the human gut, it was observed that C. jejuni was able to co-
exist in equilibrium with its infecting phage. Electron microscopy revealed attachment 
of phage to host cells, noted as flagella absent, without infection resulting in a carrier 
state. A sub-population of cells with functional flagella were phage permissive and 
able to support phage replication thus resulting in phage titre remaining almost equal 
to host counts (Siringan et al., 2014; Brathwaite et al., 2015).  Recently, the role of PV 
and its influence on capsular polysaccharide expression in the evasion of phage 
predation was effectively demonstrated in Bacteroides thetaiotaomicron (Porter et al., 
2020). This study identified as many as nineteen host cellular functions could dictate 
the ability of the phage to infect its host. The phenotypic heterogeneity that PV 
generates is believed to act as a form of herd immunity equivalent to that seen in 
human disease immunity. By limiting the viral load, the impact on sensitive variants 
is reduced thus preventing a drastic reduction in the overall population (Turkington et 
al., 2019). The use of herd immunity style dynamics to limit phage predation was 
further supported by the persistent propagation of virulent phages on a microcolony 
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without its elimination (Eriksen et al., 2018). The variability of conditions in the GIT 
likely generates significant PV mediated heterogeneity within bacterial niches. With 
the presence of spatially distributed phage-permissive and non-permissive hosts 
variants in parallel, it is possible to stably maintain both virulent phages and their 
associated hosts. Incorporation of transcriptomic profiling into experimental design 
may provide further insight into the role of PV in phage-host interactions and its 
implications for phage therapy. 
Interestingly, temperate phages can hijack host quorum sensing to monitor 
metabolic conditions and population densities, thus granting them the ability to make 
informed lytic-lysogenic switch decision (Laganenka et al., 2019). For example, this 
was observed to occur for E. coli phage T1 which encodes a transcriptional regulator, 
Pir. In the maintenance of lysogeny, pir expression is inhibited by host produced 
cAMP-CRP. In conditions of efficient host metabolism, repression of pir is lifted by 
increased influx of sugar levels. If cell densities are sufficient, indicated by high levels 
of autoinducer, the phage commits to lysis as conditions are optimal for progeny 
production (Laganenka et al., 2019). 
Quorum sensing (QS) is a phenomenon employed by bacteria that allows 
controlled expression of specific genes for processes such as virulence and biofilm 
formation. This occurs through cell-cell communication mediated by bacterial 
produced extracellular signalling molecules, autoinducers. These molecules allow 
bacteria to monitor population density and make an informed collective decision on 
whether expression of specific genes is a fitness cost or beneficial to the overall 
population (Whitehead et al., 2001; Turovskiy et al., 2007; Ng and Bassler, 2009; 
Papenfort and Bassler, 2016). Bacteria can use QS to assess the risk of phage predation 
and act accordingly. For example, E. coli can reduce expression of λ phage receptors 
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in response to an autoinducer thus limiting phage adsorption and as a result limits the 
effect on population levels (Høyland-Kroghsbo et al., 2013). However, QS homologs 
have also been identified in phage genomes deposited in NCBI databases. The 
presence of a QS cassette has been reported in a temperate Clostridium difficile 
infecting phage, phiCDHM1 (Hargreaves et al., 2014). More recently, it was shown 
that Vibrio cholerae infecting phage VP882 encodes a QS receptor (VqmAPhage) 
homologous to that of the host allowing it to “listen in” on its host via host produced 
autoinducer (DPO). In turn, the phage can monitor population densities thus allowing 
an informed lytic/lysogenic lifestyle switch. In high host cell density, lysis occurs 
resulting in optimal propagation (Silpe and Bassler, 2019). Interference with QS 
regulation of virulence factors in P. aeruginosa have been shown to cause repression 
of CRISPR-Cas defences. This in turn makes the host more susceptible to phage attack 
and may have useful application in phage therapy (Høyland-Kroghsbo et al., 2017). 
Phages are believed to interfere with host QS to their advantage. Indeed, this was 
recently shown to be true for the lytic Pseudomonas phage LUZ19 (Hendrix et al., 
2019). 
The above demonstrates that there are a multitude of factors that influence the 
interactions and dynamics between phages and their bacterial hosts. These factors are 
important for the success of both in the complex gut environment and are summarised 







2.4 Interactions with the mammalian host 
In addition to phage-bacterium interactions, phages have also be demonstrated 
to interact with their mammalian host adding another level of complexity when 
studying the human gut phageome. 
Ig-like domains have been identified in certain phages which help them to 
reside in the outer mucosal layer in the GIT. This led to the proposition of the 
“bacteriophage adherence to mucus” (BAM) model which describes the idea that such 
phages protect the mammalian host from bacterial infections (Barr et al., 2013). 
However, it has also been demonstrated, in vitro, that phages can migrate across the 
mucus layer, cross the gut epithelial barrier or enter systemic circulation either by 
transcytosis or by peptide-guided transport and subsequently interact directly with 
cells of both the innate and adaptive immune system (Belleghem et al., 2017; Duerr et 
al., 2004; Moustafa et al., 2017; Nguyen et al., 2017; Van Belleghem et al., 2019). 
This was further supported by in vivo studies in a germ-free murine model that 
examined the use of endotoxin-free lytic phages in the alleviation of bacterial driven 
colon cancer. The administered phages, specifically Caudovirales phage with DNA 
and not empty capsids, interacted directly with the murine immune system. This was 
indicated by interferon production (virus-specific immunity) which led to the 
exacerbation of colon inflammation (Gogokhia et al., 2019). Although it has been 
shown that phages can induce an inflammatory response, it is thought that their 
interactions with the immune system are generally anti-inflammatory; however, this 
is still debated (Van Belleghem et al., 2017; Zhang et al., 2018b; Van Belleghem et 
al., 2019). These interesting tripartite interactions were extensively reviewed by Van 
Belleghem et al. (Van Belleghem et al., 2019). Findings thus far suggests that phages 
can directly influence mammalian health and indirectly shape the gut microbiome via 
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interactions with immune system; however, we still have little understanding of the 
mechanistic details and further in vivo studies are required. Considering the various 
phage interactions above, there are multiple layers of conditions and factors to take 




3. Current methodologies, challenges and potential solutions 
In the past decade there have been many significant advances in our 
understanding of the human gut virome. Findings to date show that the healthy gut 
virome is individual specific and temporally stable with a lytic core that is personal 
specific persistent and dominated by crAss-like phages, other Caudovirales and 
Microviridae, but which are not shared among all individuals. However, many 
important questions remain unanswered and our overall understanding of this elusive 
component of our gut microbiome still remains poor in comparison to our 
understanding of the bacterial fraction. This is largely due to challenges with in silico, 
in vitro and in vivo methodologies. Efforts are being made to highlight current 
shortcomings, to develop and standardise protocols, and improve overall 
reproducibility and comparability. This is essential to truly understand the importance 
of the phageome in health and disease and to take advantage of phages for therapeutic 
applications. 
 
3.1 Viral metagenomics, sequencing and in silico methods 
Next generation sequencing technologies, bioinformatic tools and 
metagenomic studies have provided important insights into the human gut phageome 
such as profiling of community composition and in silico identification of novel 
phages. However, the protocols implemented in these studies are often not optimised 
and don’t lead to a true representation of the phageome. The majority of these studies 
have used faeces as the sample source of phage genetic material due to the practical 
difficulties with using other sampling sites of the GIT (Reyes et al., 2010; Minot et al., 
2011; Dutilh et al., 2014; Norman et al., 2015; Guerin et al., 2018; Devoto et al., 2019; 
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Shkoporov et al., 2019; Clooney et al., 2019). In brief, the key protocol steps involved 
in the majority of viral metagenomics studies includes VLP enrichment, nucleic acid 
extraction, sequencing library preparation, followed by in silico characterisation and 
annotation of generated viral sequences using bioinformatic pipelines. However, due 
to the lack of universally reproducible methods being implemented in this field, cross-
study comparisons of findings are difficult, and disparities can occur between different 
studies. 
The first step in viral metagenomic studies is the removal of non-target 
contaminants from faeces (or other biological samples) and the enrichment of VLPs 
to ensure optimal yield and quality of nucleic acids for library preparations (Kleiner 
et al., 2015). This involves the elimination of prokaryotic and eukaryotic DNA and 
RNA as well as cellular and dietary debris using physical and chemical process such 
as homogenisation, filtration, chloroform treatment and enzymatic action (Conceição-
Neto et al., 2015). There are multiple phage nucleic acid isolation protocols described 
and while CsCl gradient centrifugation can yield highly purified samples, this protocol 
is time consuming, laborious and can introduce bias (Castro-Mejía et al., 2015; Kleiner 
et al., 2015). It is important to consider that the phageome is comprised of virulent and 
temperate phages that vary in nucleic acid content (ssDNA, dsDNA, ssRNA, and 
dsRNA). The challenge in developing a protocol to consider all these components is 
difficult and can affect our overall picture of human gut phage profile. Due to the 
shared physio-chemical properties among temperate and virulent Caudovirales 
phages, many techniques have been developed to allow their co-purification. 
However, it is important to note that using the incorrect protocol can lead to the 
generation of a biased virome composition (Gregory et al., 2019). The majority of 
metagenomic studies have focused on enrichment of VLPs followed by extraction of 
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nucleic acids, although many of the protocols promote a biased focus on free-phage 
and the enrichment of DNA phages (Kleiner et al., 2015). Whole community 
metagenomic sequencing is thought to be more informative in providing data with into 
phage-host interactions in the gut than that derived from VLP metagenomics which 
may exclude certain phage types including RNA phages and integrated phages (Ma et 
al., 2018). 
Protocols may also generate low nucleic acid yields and to overcome this, 
amplification methods are performed such as multiple-displacement amplification 
(MDA) (Kim et al., 2011; Marine et al., 2014). However, this leads to the biased 
amplification of ssDNA viruses such as Microviridae by as much as 10-fold, which in 
turn, skews phage community composition and is thought to be the confounding factor 
behind why certain viral datasets have an extremely high relative abundances of 
Microviridae (Kim et al., 2011; Roux et al., 2016; McCann et al., 2018; Garmaeva et 
al., 2019; Shkoporov and Hill, 2019; Gregory et al., 2019; d’Humières et al., 2019). 
Many virome studies interpret findings based on relative abundance and thus results 
may be skewed where MDA has been implemented (Sutton and Hill, 2019). MDA has 
also been shown to affect phage diversity and method reproducibility (d’Humières et 
al., 2019). MDA can introduce GC bias and coverage extremes which can have 
implications for de novo genome assemblies (Chen et al., 2013; Sutton et al., 2019). 
Having identified the effects of amplification on viral nucleic acids, there is a call to 
eliminate this step from metagenomics protocols. However, this is challenging due to 
the variable concentration yields of phage genetic material that can be acquired from 
samples due to the differences in the viral loads of samples and the strict input 
requirements for sequencing library preparation (Shkoporov and Hill, 2019). For 
example, one study found that DNA yields, despite enrichment, could range from 4 – 
45 
 
500 ng of DNA per gram of faeces (Shkoporov et al., 2018b). Attempts have been 
made to improve current sequencing library preparations, such as the adaptase-linker 
amplification method, by excluding the need for MDA with the goal of eliminating 
downstream issues and providing a more accurate representation of phage composition 
in a community (Roux et al., 2016). 
The elimination of bacterial contamination has also been a challenge both in 
terms of viral nucleic acid extraction and for in silico analyses. Although it is difficult 
to completely avoid, efforts should be made to limit levels as it is thought to impact 
on the validity of viral sequences deposited in database (Roux et al., 2013). In the 
enrichment of VLPs and extraction of viral nucleic acids, the choice of filter pore size 
is important to avoid contaminants. The use of a larger pore size filter such as 0.8 μm 
is less biased as it allows larger viruses to be retained but this also leads to high levels 
of bacterial contamination. Studies indicate that a pore size of 0.45 is optimum 
(Conceição-Neto et al., 2015; Shkoporov et al., 2018b). How bacterial contamination 
among viral sequences can impact on conclusions drawn from findings was 
highlighted in a study that demonstrated the over-representation of antibiotic resistant 
genes of bacterial origin among phage genomes (Enault et al., 2017). The issue of 
contamination was further highlight by Zolfo and colleagues who examined 
metagenomic virome sequences from 35 studies and detected an abundance of 
bacterial, archaeal and fungal contaminants irrespective of VLP enrichment technique 
(Zolfo et al., 2019). Bioinformatic pipeline development and standardisation of criteria 
for the detection of bacterial contamination among viral sequences is important in 
ensuring the quality of viral databases and the de novo detection of phages. Shkoporov 
et al., recently developed an effective pipeline to eliminate bacterial contamination by 
aligning reads against a database of the conserved bacterial genes, cpn60 and setting 
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strict cut-offs to identify true viral contigs (Shkoporov et al., 2018b). ViromeQC also 
has significant potential in aiding the detection of contaminants. This pipeline was 
developed to allow stringent quality control of viral sequences using 31 universal 
bacterial genes in addition to the 16S/18S rRNA genes and 23S/28S rRNA genes 
(Zolfo et al., 2019). In addition to contamination, Shkoporov et al., also considered 
the effects of sample storage conditions and operator bias in virome analyses and has 
proposed the use of an exogenous phage standard to spike faecal samples to allow 
absolute quantification of total viral loads across samples (Shkoporov et al., 2018b). 
The disparity between relative and absolute quantification in microbiome profiling can 
be significant (Stämmler et al., 2016; Vandeputte et al., 2017). This issue was recently 
highlight by Shanahan and Hill. They discussed the issue of microbiome 
misrepresentation due to relative abundance and how it can mask variations between 
microbiomes that would be highlighted by absolute abundances (Shanahan and Hill, 
2019). Thus, the inclusion of a standard to allow absolute quantification of sequences 
and viral load should form part of future virome studies to give a more accurate 
representation of composition. It has also suggested that viral load may have potential 
as a biomarker (Sutton and Hill, 2019). 
Many protocols in phageome studies have been developed with a particular 
focus on DNA phages. This results in RNA phages being underrepresented in viral 
databases and highlights the need for developing of protocols specific to the isolation 
of these phages (Callanan et al., 2018). This will not be without difficulties due to the 
sensitive nature of RNA. The potential array of human gut RNA phages was recently 
highlighted with the in silico discovery of over one thousand near complete RNA 
phage genomes and over fifteen thousand non-redundant genomes by screening 82 
publicly available metatranscriptomic datasets, generated from activated sludge and 
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aquatic environments studies, using profile hidden Markov models to detect conserved 
proteins. Overall this represents a 60-fold increase in identified ssRNA phages 
(Callanan et al., 2020). 
The choice of sequencing platform for virome analysis can influence the read 
length output. Following quality control, reads are assembled into contigs generally 
by referenced-based or de novo assembly methods (Garmaeva et al., 2019). The 
challenges associated with former method will be discussed below. Short read 
platforms allow deep sequencing with low error rates and require low DNA 
concentrations. However, de novo assembly of short reads is testing due to the modular 
nature of phage genomes, strain heterogeneity, high incidences of hypervariable and 
repeat regions and MDA influenced variations in coverage and GC content (Lima-
Mendez et al., 2011; Minot et al., 2012, 2013; Chen et al., 2013; Sutton et al., 2019). 
This leads to fragmented assemblies and hampers downstream in silico analyses 
(Sutton et al., 2019). It has been suggested that the use of long-read sequencing 
platforms, such as Oxford Nanopore, which can generate reads that are representative 
of near complete genomes may overcome the issues associated with short-read 
sequencing (Somerville et al., 2019; Warwick-Dugdale et al., 2019). The major 
drawback with this method is that high DNA concentrations are required which, as 
discussed previously, can be difficult to attain. Therefore, when performing 
assemblies from short reads, the choice of assembly software and stringent criteria to 
recruit true viral sequences is essential (Roux et al., 2017; Sutton et al., 2019). 
In recent years, sequence-based methods have played an important role in 
providing insights into the poorly understood human gut phageome. Nevertheless, 
there is a pressing challenge for metagenomics and in silico analyses in current phage 
research. This is the dependency on insufficiently developed viral databases. The 
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majority of phage sequences in these databases are not annotated due to the lack of 
homology with known phages. When newly generated sequence reads are aligned to 
these databases as much as 99% of the reads from a dataset can fail to align to known 
phage genomes or homologs and thus these reads remain as dark matter (Aggarwala 
et al., 2017). As a consequence, multiple studies have based their findings solely on 
the identifiable fraction of reads and have excluded the abundant unexplored dark 
matter. Although these studies have identified cohort variation, it is unknown how the 
inclusion of viral dark matter would influence and validate the overall findings 
(Norman et al., 2015; Lim et al., 2015; Monaco et al., 2016; Zuo et al., 2019). To 
overcome this issue, there has been a move towards the use of database- independent 
methods such as open-reference and clustering approaches to include both the 
identifiable and unknown fraction of reads in a dataset (Shkoporov et al., 2018b; 
Clooney et al., 2019; Moreno-Gallego et al., 2019; Shkoporov et al., 2019). Protein-
clustering programs, such as vContact2, offer an effective solution and allow the 
implementation of a whole virome analysis (Bolduc et al., 2017). These work by 
building a gene-sharing network based on shared protein families across genomes, an 
approach similar to that employed in the development of the crAss-like phage family 
taxonomy (Yutin et al., 2018; Guerin et al., 2018; Jang et al., 2019). In addition, this 
approach overcomes the challenge of detecting cohort variation within datasets due to 
the high inter-individual variation associated with the human gut phageome (Clooney 
et al., 2019; Shkoporov et al., 2019; Sutton and Hill, 2019). The power of this 
approach, in the context of the human gut, was recently demonstrated in a study by 
Shkoporov et al. This study discovered a predominantly lytic core in healthy adults 
that is persistent, temporally stable and individual specific (Shkoporov et al., 2019). 
This is contradictory to the temperate core identified in other studies (Reyes et al., 
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2010; Minot et al., 2011; Moreno-Gallego et al., 2019). These findings were further 
supported in a study examining the IBD virome by Clooney et al., which implemented 
the same database-independent methodology. A healthy lytic core was once again 
identified that was absent in IBD patients whose viromes were dominated by induced 
temperate phages (Clooney et al., 2019). This analysis included both an in-house and 
a previously published IBD dataset that was analysed using database-dependent 
methodology (Norman et al., 2015). The whole virome analysis applied in the replicate 
study identified a number of findings that were contradictory in relation to the initial 
study (Clooney et al., 2019). This highlights the importance of looking at the virome 
as a whole. The use of these methods will also gradually lead to more complete viral 
databases and reduce the incidence of incomplete analyses. Also, where annotation is 
possible, it is important to consider that some phages use alternative genetic codes 
such as Lak phages and crAss-like phages of specific candidate genera (Guerin et al., 
2018; Devoto et al., 2019). 
Although the number of phage genomes being generated is increasing rapidly 
due to sequencing technology and in silico tools, many fail to be taxonomically 
assigned (Korf et al., 2019). Many of the newly deposited phages are de novo 
assembled without in vitro characterisation and therefore do not necessarily slot into 
a morphology based taxonomic scheme (Ackermann, 2012). As a result, there is a 
significant push towards a genome-based taxonomic classification to allow universal 
and accurate taxonomic assignment of phages that have not yet been culture in vitro 
(Meier-Kolthoff and Göker, 2017; Simmonds et al., 2017; Aiewsakun et al., 2018; 
Eloe-Fadrosh, 2019). This is not without challenges due to the current incompleteness 
of viral databases, the mosaic structure of phages and the lack of a universal taxonomic 
marker shared across phages (Lima-Mendez et al., 2011; Shapiro and Putonti, 2018). 
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The application of gene-sharing networks, protein clustering, and whole virome 
analysis provides possible methodologies to aid the development of such a scheme 
(Clooney et al., 2019; Jang et al., 2019). This can provide insights into evolution and 
shared functions across phages (Shkoporov and Hill, 2019). In summary, the above 
highlights the need for the development, optimisation and standardisation of protocols 
in many aspects of viral metagenomics and in silico tools. CRISPR-spacer analysis of 
phages identified in silico allows for host predictions (Zhang et al., 2018a). For 
example, prototypical crAssphage host predictions were done in this manner in 
conjunction with BACON domain analysis (Dutilh et al., 2014). These predictions 
were later confirmed with the isolation of ΦcrAss001 and its associated host, 
Bacteroides intestinalis (Shkoporov et al., 2018a). However, without in vitro isolation 
of these in silico phages, insights into biological characteristics remain limited. 
CRISPR-spacer analyses can aid the phage-host pair screening process, by predicting 
associated hosts at a species level (Paez-Espino et al., 2019). With time, it is hoped 
that strain level predictions will be possible that will greatly aid in vitro and in vivo 
studies. 
Sequence-based analyses have provided significant insights into the 
composition of the human phageome which would not be possible in vitro. Despite 
this, in silico analysis alone can provide little insights into phage-host interactions and 
biological properties of de novo phages as is possible with in vitro and in vivo methods. 
However, both methodologies in unison will be essential in fully understanding the 
interactions between phages and the microbiome in the gut and how these relationships 




3.2 In vitro, ex vivo and in vivo methods 
With recent findings, a number of questions have arisen regarding the human 
gut phageome. The observed ability of virulent phages to stably co-exist with their 
host over time remains poorly understood and requires further investigation 
(Shkoporov et al., 2018a, 2019). The isolation of dominant gut phages and their hosts, 
such as the crAss-like phages and Microviridae which form the virulent core of the 
phageome in healthy individuals, would provide insights into the mechanisms behind 
these interactions. Isolation of transient gut phages may also help us understand why 
certain phages are not persistent. CRISPR-spacer analyses have provided some 
directions for targeting potential hosts (Shkoporov et al., 2019). One of the main 
challenges with the isolation of novel phage-host pairs, their biological 
characterisation, and examining their interactions under laboratory conditions, is the 
ability to mimic the complex conditions of the GIT from where they originate. 
Many gut bacteria are difficult to culture as they are often strict anaerobes and 
the conditions necessary for their growth in vivo is unknown. Metagenomic studies 
have demonstrated the diversity of bacterial species in the human gut, however, this 
provides limited value when an isolate is required in vitro (Gill et al., 2006; Turnbaugh 
et al., 2007; Huttenhower et al., 2012). Until recently, as many as ~80% of the bacteria 
identified by these studies were uncultured or unculturable (Eckburg et al., 2005). 
Nevertheless, significant efforts are being made to culture the “unculturable”. As a 
result, there has been a push towards the isolation and culturing of bacteria using novel 
techniques with the complement of genome sequencing. Culturing of GIT bacteria is 
not only necessary to improve our understanding of their role in the microbiome, it is 




An example of recent advancements is The Human Gastrointestinal Bacteria 
Culture Collection which was compiled with cultured human GIT isolates and their 
sequences with the goal of improving the accuracy of metagenomic analyses and 
archiving novel isolates (Forster et al., 2019). Improvements in culturing methods has 
played an important role in cultivating bacterial species of the human gut. Media 
developments have aided the isolation of novel obligate anaerobes from human faeces. 
For example, yeast extract, casitone and fatty acid (YCFA) medium has been shown 
to support the growth of these bacteria to high levels and can be modified with 
antibiotics, carbohydrates or other components to select for less abundant species or 
phenotypes of interest (Duncan et al., 2002; Browne et al., 2016; Das et al., 2018; 
Forster et al., 2019). YCFA modified with carbohydrates and antibiotics was applied 
in the successful isolation of bacterial hosts in Chapters 3 and 4 of this thesis.  
Culturomics has also proved to be an important tool in expanding the repertoire 
of bacterial species isolated from the human gut (Bilen et al., 2018). This involves 
coupling high-throughput culture-dependent and culture-independent methods. 
Samples from which bacteria are to be isolated from are tested in multiple optimised 
culture conditions and rapid identification of isolates is performed using MALDI-TOF 
MS or 16S rRNA gene sequencing (Lagier et al., 2012, 2016). In the context of the 
human gut, culturomics has been successfully applied in the isolation of bacteria from 
faeces, small intestine and colonic samples (Lagier et al., 2016). The potential of this 
method was reviewed by Lagier and colleagues (Lagier et al., 2018). It is also 
important to consider screening conditions in relation to phenotypic features 
associated with intestinal bacteria. For example, the human gut contains a significant 
population of spore-forming bacterial species which are troublesome to culture 
(Abecasis et al., 2013; Rajilić-Stojanović and de Vos, 2014; Browne et al., 2016). 
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Browne and colleagues successfully cultured an array of spore-formers from faecal 
samples using ethanol shock enrichment to distinguish them from vegetative cells 
(Riley et al., 1987; Browne et al., 2016). This led to the isolation of 137 bacterial 
species from six healthy individual, 90 of which were on the Human Microbiome 
Project’s “most wanted” list of species that had yet to be cultured and sequenced 
(Browne et al., 2016).  This emphasises that even the most stubborn gut residents can 
be cultured in vitro when the correct conditions are applied; however, identifying these 
conditions can be fastidious. 
In silico analyses, such a co-occurrence networking of metagenomic data, can 
also help guide the identification of suitable combinations of bacterial species in co-
culture (Das et al., 2018). This is an important consideration to limit significant 
antagonisms between bacteria when examining phages in a defined microbial 
community and may have implications for the validity of findings. 
Faecal samples have been widely used when screening for novel gut phages. 
Traditional methods of plaque and spot assays are still widely used in this process. 
This involves screening a phage rich suspension, such as faecal filtrate, from which 
bacteria and debris have been removed, against a lawn of pure bacterial culture in 
overlay agar. A successful phage-host pair is indicated by host lysis through spot or 
plaque formation, which are picked, enriched, and purified on the specific host (Furuse 
et al., 1978; Kai et al., 1985). Due to the variable abundance of different phages in 
faecal samples, enrichment is often performed to allow phage-host interactions 
establish and increase titres to detectable levels which is often indicated by clearing of 
culture (Salem et al., 2015). This is generally followed by sequencing of the phage 
genome. Isolating phages on a single strain has been the general practice, although it 
has been shown that enriching phages on strain variants of a specific host can increase 
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host range of a phage which may have useful applications in phage therapy (Hyman, 
2019). Plaque assays may fail to detect temperate phages unless an induction 
treatment, such as mitomycin C, is performed to induce the phage to a lytic state 
(Castellazzi et al., 1972). It has also become apparent that not all lytic phages form 
clear plaques or spots on a suitable host nor clear liquid cultures (Porter et al., 2020) 
(Chapters 3 and 4 of this thesis). This can be due to phenotypic heterogeneity within 
an isogenic population, resulting in both phage permissive and non-phage permissive 
variants within a single culture. This can be mediated by phenomena such a phase 
variation which was discussed above. This is an important consideration when 
screening for phage-host pairs and highlights the need to avoid focusing on traditional 
signs of phage-host pairing such a plaque assays, zones of clearing and culture lysis. 
Enrichment of phages on intestinal bacteria, either acquired from culture 
collection or through selective enrichment from faeces, followed by shotgun 
sequencing is a useful approach for screening of novel gut phages. This approach led 
to the isolation of ΦcrAss001, the first member of the elusive crAss-like phage family 
to be isolated in pure culture with its host Bacteroides intestinalis (Shkoporov et al., 
2018a). To achieve this, 20 healthy faecal donors were recruited, faecal filtrates were 
prepared, pooled and screened against 53 bacterial strains in modified YCFA broth 
under anaerobic conditions over three days, with each filtered lysate used to inoculate 
the subsequent round of enrichment. The enriched lysates were then sequenced to 
identify expansion on a specific host (Shkoporov et al., 2018a).  
Chemostats are convenient for phage-host enrichment from faeces. They allow 
more controlled conditions than can be provided in vitro and are useful for examining 
phage-host interactions (Santiago-Rodriguez et al., 2015a). Chapters 3 and 4 discuss 
the use of antibiotics to selectively promote the growth of Bacteroidales ex vivo. This 
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was performed in a chemostat using frozen standard inoculum prepared from faeces 
(O’Donnell et al., 2016). This in turn allowed the forced expansion of Bacteroidales 
and associated phages and the generation of a phage-rich fermentate. The fermentate 
was then screened against individual bacterial species by serial co-culture followed by 
plaque assay attempts and sequencing. The bacterial species that were tested were 
selectively enriched in vitro from the same faecal sample used to prepare the 
fermentate, in the presence of the same antibiotics. This ultimately led to the isolation 
of two novel phage-host pairs, ΦcrAss002 that infects Bacteroides xylanisolvens and 
ΦPDS1 that infects Parabacteroides distasonis. A similar protocol could be applied 
in the isolation of further novel phage-host pairs from the GIT. 
Culture-independent methodologies have also been applied in the isolation of 
novel phage-host pairs. Within samples used for screening there are constantly a 
percentage of bacterial cells that either have free virions attached to their surface or 
contain phages internally either due to replication or as prophages. A number of 
protocols take advantage of this to match phages and their hosts. 
Viral tagging (VT) has proved to be a useful tool in linking phages to their 
host. This method was originally used to examine marine viruses. A sample of interest 
is obtained, and virions are randomly tagged with a generic fluorescent marker that 
binds to nucleic acids. The tagged phages are then applied to potential bacterial hosts. 
If interactions occur, fluorescence-activated cell sorting (FACS) can isolate and 
discriminate between tagged phage-host pairs and free virions. The isolated phage can 
then be sequenced. This methodology can also provide insights into phage-host 
interactions (Deng et al., 2012, 2014). Single bacterial cells can be isolated from 
samples using FACS. This allows complete sequencing of the bacterial genome to be 
performed and in parallel can also capture the genomes of phages which were infecting 
56 
 
or attached to the cell. This method of identifying phage-host pairs is called single 
amplified genomes (SAGs) (Swan et al., 2013; Labonté et al., 2015). It is also possible 
to directly isolated single uncultured viruses from environmental samples using flow 
cytometry. This allows for single viral genomics (SVGs) which involves sequencing 
isolated viruses individually which overcomes certain assembly limitations associated 
with metagenomics and provided insights into strain variation and genetic diversity 
(Allen et al., 2011; Martinez-Hernandez et al., 2017). In one case, this method allowed 
the recovery of genetic information from 5,000 individual viruses sorted from a marine 
sample (Martínez et al., 2014). SVGs, however, excludes the host so provides little 
insight into phage-host pairs or interactions. FACs, although very useful in its 
applications, is biased toward the isolation of more abundant viruses (Martinez-
Hernandez et al., 2017; Lawrence et al., 2019).  
VT proves to be a particularly powerful tool for examining phage-host 
interaction. It has been largely applied with known panels of bacteria but could have 
potential in identifying pairing between both unknown bacteria and novel phages from 
a specific sample. A workflow incorporating single-cell VT in parallel with 
metagenomics and SAGs has been developed using human faecal samples. This led to 
the identification of 363 novel phage-host pairs (Džunková et al., 2019). Isolating a 
large panel of phage-host pair in this manner highlights the current advancements in 
this field. However, once isolated, it is still necessary to carry out characterisation of 
biological properties and mechanisms involved in the phage-host pairing. 
 As mentioned previously, many studies use faeces as the sampling source for 
examining the virome due sampling difficulties associated with other sites of the GIT. 
It has been shown that consistency and transit time of faeces can influence bacterial 
composition and in turn influence variation in clinical studies, suggesting that the 
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importance of recording this information (Vandeputte et al., 2016). This can also have 
a knock-on effect for virome studies. Faeces is the most easily accessible and ethical 
sample source for examining the GIT; however, it is important to consider that phage-
host interactions vary radially and longitudinally along the GIT (Maura et al., 2012b; 
Galtier et al., 2017). Biogeographical sectioning of the microbiota was extensively 
reviewed by Donaldson and colleagues. The importance of bacterial microhabitats, 
such as in crypts, along the GIT is thought to play an important role in providing 
bacterial reservoirs which maintain homeostasis and allow rapid recovery of bacterial 
populations after perturbations (Donaldson et al., 2016). (Figure 3B). This is likely to 
have an important impact on phage-host interactions and co-existence dynamics. 
Martinez-Guryn and colleagues also described region to region variation of the GIT, 
from oral cavity to distal colon, physical, chemical and biological factors such as cell 
type and surface variation, mucus composition, pH, oxygen, bile acids and immune 
factors. This creates functional heterogeneity within the GIT and influences the 
regional variation in bacterial composition (Martinez-Guryn et al., 2019) (Figure 3B, 
3C). This heterogeneity along with bacterial microhabitats plays an important role in 
influencing phage composition and interactions along the GIT. A recent study 
examined the virome along different sites of the GIT in nonhuman primates. The 
virome of the large intestine and rectum were found to be similar but distinct from the 
ileum. These findings indicate that faeces provide a good representation of the colon 
specifically rather than the GIT as a whole (Zhao et al., 2019). Microbial signatures 
associated with Crohn’s disease (CD) were examined in CD children and were 
observed in mucosa; however, these signatures went undetected during the assessment 
of stool samples (Gevers et al., 2014). Therefore, focusing solely on stool samples 
would have had significant implications for the findings of this study. Faeces doesn’t 
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necessarily represent the virome of each region of the GIT, but it is a useful proxy for 
providing insights into the gut phageome. However, considering the above, future 
studies will need to extend beyond the scope of stool samples if we are to truly 
understand the human gut phageome. Naturally this is not without challenges and 
highlights the need for developing in vivo models. 
The examination of phages at multiple experimental levels (in vitro to ex vivo 
to in vivo), the importance of incorporating relevant conditions to experimental models 
and considering the influence of host metabolic state in phage-host interactions was 
recently discussed by Lourenço and colleagues (Lourenço et al., 2018). These are 
important factors in developing an experimental pipeline. The advantages and 
disadvantages of using defined bacterial communities in in vitro and in vivo models 
for studies of the human gut was recently reviewed by Elzinga and colleagues (Elzinga 
et al., 2019). Several studies have demonstrated the usefulness of in vivo models in 
gaining insights into phage-host interactions (Maura et al., 2012a, 2012b; Reyes et al., 
2013; De Sordi et al., 2017; Galtier et al., 2017; Hsu et al., 2019). While in vitro studies 
can be of great importance, they are not necessarily always good representatives of 
realistic conditions. Here, we will discuss two examples where in vivo models proved 
particularly useful compared to in vitro analyses. De Sordi et al. examined the 
phenomenon of phage host strain jumping in vitro and in vivo in a conventional murine 
model; however, host jumping was only detected under the latter conditions (De Sordi 
et al., 2017). This emphasizes the important of testing under multiple experimental 
conditions. In another study, a gnotobiotic mouse was colonized with ten human 
intestinal strains followed by introduction of four lytic phages. The phages were 
shown to knock down levels of their target hosts but without complete elimination 
resulting in co-existence of virulent phages and their hosts. In parallel, a knock-on 
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effect on non-target community members was observed which in turn has an influence 
on the gut metabolome and mammalian host (Hsu et al., 2019). However, 
perturbations of off-target bacterial communities have not been observed in other 
murine studies (Galtier et al., 2016; Cieplak et al., 2018; Lourenço et al., 2019). 
Therefore, this topic requires further investigation. Murine models also overcome the 
issue of acquiring samples that would be ethically difficult to access in the case of 
humans, such as mucosa or biopsies, and they also allow spatial heterogeneity in the 
GIT to be examined (De Sordi et al., 2019). Interestingly, recent work found that the 
phageome in healthy and colitis murine models shared some overlap with the 
phageome of healthy and IBD human patients. This suggests that the murine model is 
conducive to human-like GIT conditions making it suitable for studying phage-host 
interactions and the virome in diseases such as colitis (Duerkop et al., 2018).  
There are a number of other techniques that can be incorporated into human 
gut phageome studies. Transcriptome profiling and metatranscriptomics can provide 
insights into gene expression during individual or community phage-host interactions. 
Few studies have examined this in the context of the human gut. Transcriptome 
profiling of phage communities in the oral cavity was recently carried out to compare 
gene expression in health versus periodontal disease (Santiago-Rodriguez et al., 
2015b). Such studies should also be performed to compare gene expression of phages 
in a healthy compared to diseased gut. This technique is also useful for examining 
changes in bacterial host gene expression in the presence of a phage. Transcriptomics 
recently demonstrated the significance of phase variation in B. thetaiotaomicron 
during phage infection (Porter et al., 2020). It can also determine the effect of an 
experimental model on bacterial host gene expression (Denou et al., 2007). This can 
aid the development of experimental pipelines and avoid inaccurate conclusions. 
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Bioelectronics has provided many useful biological and biomedical 
applications in recent years (Strakosas et al., 2015; Pitsalidis et al., 2018). With this, 
it is possible to mimic bacterial and mammalian membranes, called supported lipid 
bilayers, using bioelectronic tools and membrane biosensors which can detect specific 
interactions. For example, this method was used to examine membrane interactions 
with antibiotics to determine antibiotic targets that were discriminatory between 
bacterial and mammalian membranes (Su et al., 2019). Similar tools were used to 
monitor Salmonella typhimurium infection of epithelial cells (Tria et al., 2014). 
Bioelectronics could also have useful applications for detailed examination of phage-
host interactions. 
In summary, it is necessary to make improvements to bioinformatic pipelines 
and experimental protocols so that there is greater reproducibility allowing more 
accurate cross-study comparisons. Methodology can have a greater influence on the 
virome than the examined disease state (Gregory et al., 2019). The influence virome 
analysis protocols have on findings and the pros and cons of specific techniques used 
in analyses have been highlighted (Sutton and Hill, 2019). It is also important to use 
relevant conditions when examining phage-host interactions. Transcriptomic profiling 
should also be incorporated into studies of the human gut phageome. Overall, the 
progression in metagenomics is more rapid than in the isolation and characterisation 
of novel phage-host pairs from the human gut. Using a top-down approach that links 
metagenomic findings to the screening protocol may allow a more targeted approach. 
For example, metagenomics can aid the primer development for qPCR detection and 
monitoring of phage propagation in vitro or in vivo. Novel phages that have been 
identified in silico need to be isolated and characterised in vitro and in vivo to 
understand the mechanisms they employ when interacting with their host, and the 
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health and disease implications that this may have for the human host. Experimental 
pipelines that bring the above together will be key to this progress (Figure 4). 
Furthermore, we need to consider the most recent findings with regard to the human 
phageome, in particular the individual-specific healthy core phageome. This needs to 
be further elucidated and it will also be necessary to reconsider our current application 
of ecological models to the human gut. As many of these models were developed in 
the context of other ecosystems, it may be necessary to develop new models to explain 
the low VMR, the temporal stability, and the persistence of virulent phages and their 
bacterial hosts that is observed in the human gut. 
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3.3 Case Study: The crAssphage family story: from de novo assembly and in 
silico characterisation to an in vitro reality 
CrAssphage provides an important example of novel phage discovery in silico 
using methods that overcame the limits of database-dependency. For years, following 
this discovery, crAssphages largely existed only in silico due to the challenges faced 
in achieving isolation on a suitable host. Here, we will discuss the crAssphage timeline 
from an in silico discovery to an in vitro reality, and highlight the role that this phage 
family has played in pushing human gut phage research towards looking beyond the 
known (Figure 5). 
 
3.3.1 Discovery and importance  
Despite over one hundred years of phage research, the most abundant phage in 
the human gut remained undetected until 2014. The database independent approach 
implemented proved essential to its discovery among the viral dark matter. Prior to 
this, the phage remained undetected due the majority of its encoded proteins having 
no homology with phage proteins in public viral databases (Dutilh et al., 2014). In this 
sense, crAssphage is an ideal example of the current status of human gut phage 
research in that it highlights key bottlenecks and ways in which these can be overcome. 
In the few years since its discovery, this phage has also played an important role in 
providing essential insights into the human gut phageome. 
For clarity, the initial crAssphage detected in 2014, will be referred to as 
prototypical-crAssphage (p-crAssphage). P-crAssphage was discovered through 
mining of a previously published human metagenomic dataset (Reyes et al., 2010). 
This dataset comprised of viromes sequenced from the faeces of 12 human subjects, 
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of which included 4 pairs of monozygotic twins and their mothers. The metagenomes 
were analyzed for co-occurring contigs with similar depth-profiles thus ensuring the 
contigs originated from the same individual phage genome. Using this information, 
the p-crAssphage genome was de novo assembled (Dutilh et al., 2014). This was 
performed using Cross-Assembly (crAss) software, a reference-independent tool, 
from where the phage received its name (Dutilh et al., 2012). The novel dsDNA phage 
was found to have a circular genome ~97 kbp in size. The genome was further 
analyzed against public metagenomes sequenced from human faeces in Europe, Korea 
and the USA. P-crAssphage was detected in 73% of the faecal metagenomes 
examined, contributed to as much as 90% of faecal VLP-derived sequencing reads and 
as much as 30% of whole metagenome reads. This analysis indicated that the phage 
was present in ~50% of human populations (Dutilh et al., 2014). To highlight the 
significance of this discovery, p-crAssphage was found to be six times more abundant 
in public metagenomes than all other known phages combined, and it showed little to 
no homology with any of these known phages (Dutilh et al., 2014). Despite the 
abundance it which this phage occurs, it remained undetected prior to 2014, due to the 
database-dependency of many bioinformatic pipelines. This emphasizes the potential 
for novel phage discovery within the viral dark matter. 
 
3.3.2 Taxonomic classification and identification of an expansive family 
When originally discovered, p-crAssphage was considered as a single entity. 
Variants were detected in a Chinese dataset indicated by complete deletion of an open 
reading frame (orf00039) and low similarity of DNA polymerase to the equivalent 
gene in p-crAssphage (Liang et al., 2016). Other studies also saw indication of 
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crAssphage variants (Manrique et al., 2016; García-Aljaro et al., 2017). This was 
further developed in 2018 by Yutin and colleagues by performing the first detailed 
sequence-based analysis of the proteins encoded by p-crAssphage. This work was the 
first to propose p-crAssphage as the original member of an expansive family, the 
crAss-like phage family, which includes the IAS-virus (Oude Munnink et al., 2014; 
Yutin et al., 2018). These phages were predicted to have a podovirus-like morphology, 
resolve into the Caudovirales order, and were initially predicted to be predominately 
temperate (Yutin et al., 2018). They were identified from reads generated from sources 
including the human gut, termite gut, animals, marine, and soil samples, thus 
indicating their presence in an array of environments. Due the ubiquitous nature of 
these phages among humans, qPCR assays have been developed to implement them 
as markers in faecal source tracking and tracing the origin of antibiotic resistance 
genes released into the environment due to human faecal pollution (Stachler et al., 
2017; Karkman et al., 2019). A number of qPCR assays have either detected p-
crAssphage at low levels or not at all in non-human mammals, among other 
environmental sources, but not at the same abundance as seen among humans (García-
Aljaro et al., 2017; Stachler et al., 2017; Ahmed et al., 2018, 2019; Karkman et al., 
2019; Ahmed et al., 2019). Hidden Markov model (HMM) analysis was also applied 
to crAss-like phages against public virome database and all sequences detected were 
human faecal virome associated (Moreno-Gallego et al., 2019).  This indicates these 
phages are particularly abundant and specific to the human gut. 
In 2018, Guerin et al., proposed a taxonomic classification scheme for crAss-
like phages of human gut origin, with four sub-families (Alphacrassvirinae, 
Betacrassvirinae, Gammacrassvirinae and Deltacrassvirinae) and ten candidate 
genera. This was developed using 249 gut associated crAss-like phages, 244 of which 
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were de novo assembled in this study (Guerin et al., 2018). Members of the same 
subfamily shared 20-40% similarity between orthologous proteins and crAss-like 
phages that clustered into each genus shared >40% protein similarity. This was 
performed using a protein clustering approach that allowed similarity to be identified 
across the phages despite sharing little to no similarity at the nucleotide level. This 
was further supported by phylogenetic analyses of four conserved genes (capsid, 
primase, portal protein and terminase) which is consistent with earlier studies (Yutin 
et al., 2018; Guerin et al., 2018). This work also presented the ex vivo propagation of 
crAss-like phages from five candidate genera including p-crAssphage, but without 
host identification. Electron micrographs generated from crAssphage-rich faecal 
filtrate also supported previous predictions that these phages have a podovirus-like 
morphology (Guerin et al., 2018). 
 
3.3.3 CrAssphage host predictions and in vitro isolation  
Through CRISPR-spacer profiling and bacterial co-abundance analysis, it was 
predicted that this phage infects bacteria of the Bacteroides genus or other members 
of the Bacteroidetes phylum. Further supporting this, Bacteroidetes-associated 
carbohydrate-binding (BACON) domains were identified within the p-crAssphage 
genome (Dutilh et al., 2014). It is likely that this interaction is evolutionary ancient, 
based on the conservation of a DNA primase among crAss-like phages that is 
homologous to the primase genes of Bacteroidetes. This is one of the few highly 
conserved crAss-like phage family replication genes that is linked to Bacteroidetes 
(Yutin et al., 2018). Despite these in silico analyses, without a phage-host pair isolated 
in vitro we would gain little insight into the biological properties of this phage. 
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Due to the difficulty in isolating crAss-like phages and their associated hosts, 
little biological characterizations have been performed until recently. In 2018, the first 
crAssphage-host pair was isolated in pure culture using a phage enrichment protocol 
from a pool of human faeces from 20 individuals against a panel of 53 strains, which 
included 18 members of the Bacteroidales order (Shkoporov et al., 2018a). The 
isolated IAS-like crAssphage, ΦcrAss001, of candidate genus VI, sub-family 
Betacrassvirinae, was found to infect Bacteroides intestinalis thus confirming in silico 
predictions. Electron micrographs also confirmed the podovirus-like morphology 
predicted for these phages. Intriguingly, the phage was found to co-exist with its host 
in co-culture over 3 weeks without significant impact on host growth despite efficient 
propagation. The phage genome was also absent of lysogeny genes (Shkoporov et al., 
2018a). Similarly, ΦcrAss002, was found to stably co-exist with its host B. 
xylanisolvens (Chapter 3 of this thesis). This is consistent with the observed 
persistence and stability of these phages in metagenomics datasets over time (Guerin 
et al., 2018; Edwards et al., 2019; Shkoporov et al., 2019). This was further supported 
by the stable engraftment of these phages in certain individuals for up to a year 
following FMT (Draper et al., 2018; Siranosian et al., 2020). More recently, the 
isolation of two crAss-like phages which infect Bacteroides thetaiotaomicron and are 
closely related to ΦcrAss001 have been reported, DAC15 and DAC17 (Hryckowian 
et al., 2020). Detailed biological characterization of these phage has yet to be 






3.3.4 Our current understanding of crAss-like phages 
Thus far we know that crAss-like phages are generally absent from the neonate 
gut but are acquired in infanthood, however, the influence of birth mode on the 
transmission of these phages has been debated (McCann et al., 2018; Siranosian et al., 
2020). It was initially thought that crAss-like phages were absent from the infant gut, 
however, now we know that these phages can be vertically transferred from mother to 
infant (Lim et al., 2015; Siranosian et al., 2020). The early colonization of crAss-like 
phages and their universal ubiquity is not surprising considering the predominance of 
Bacteroidetes in the healthy human gut from infancy (Rodríguez et al., 2015). These 
phages have also been detected in the elderly virome (Stockdale et al., 2018). With 
crAss-like phage variants detected in non-human primate faecal metagenomes, it is 
likely that this phage family has coevolved with humans over millions of years 
(Edwards et al., 2019). CrAss-BACONs have also provided insights into the evolution 
and diversity of this phage family and allowed the detection of two novel lineages (de 
Jonge et al., 2019b). Furthermore, the crAssphage family is globally distributed, with 
one or more types being detected in 77% of individuals with geographic variability of 
strains and genera (Cinek et al., 2018; Guerin et al., 2018; Edwards et al., 2019). For 
example, p-crAssphage (candidate genus I), is largely absent from the gut of hunter-
gatherer populations and is more abundant among industrialized populations (Honap 
et al., 2020). CrAss-like phages of candidate genus I are predominant in Western 
infants, among other less abundant genera, compared to malnourished and healthy 
Malawian infants which are dominated by crAss-like phages of the candidate genera 
VI, VIII, and IX (Guerin et al., 2018). CrAss-like phages have not been linked to 
factors such as disease, age, gender, or body mass index, but a weak link to diet has 
been detected as well as potential links to ethnicity and geography (Guerin et al., 2018; 
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Edwards et al., 2019; Honap et al., 2020). Diet may be one factor driving the 
crAssphage family variation observed between Western and more rural non-
industrialized populations. The Western diet generally drives a microbiota dominated 
in Bacteroides/Clostridia, whereas a non-Western fibre rich diet is associated with 
high Prevotella/low Bacteroides. Therefore, this diet driven variation in dominant 
bacterial species in the gut may also influence crAss-like phage composition 
(Gorvitovskaia et al., 2016; Guerin et al., 2018). Despite the genetic divergence, the 
organisation of crAss-like phage genomes are colinear in humans and primates thus 
suggesting the genome structure of these phages has been conserved throughout 
evolution due to the stability of the gut ecosystem (Edwards et al., 2019). 
One of the most intriguing characteristics of these phages is their ability to 
persist in the human gut. Following in silico and in vitro analysis, it was observed that 
these phages have the remarkable ability to maintain themselves in the gut and engage 
in an unusual interaction with their host that allows co-existence of two antagonistic 
populations over extensive periods of time (Guerin et al., 2018; Shkoporov et al., 
2018a). The concept of a stable healthy core gut phageome that is dominated by 
temperate phages and abundant in crAss-like phages has been debated (Manrique et 
al., 2016; Moreno-Gallego et al., 2019). This was further expanded on by Shkoporov 
and colleagues in a longitudinal study that monitored the gut virome of ten healthy 
individuals over a one-year period. This study identified a small but abundant, 
predominately virulent core virome of 22 phage clusters using a database-independent 
clustering approach. CrAss-like phages represented approximately one third of these 
clusters. This confirmed that temperate phages are not as dominant in the healthy 
human gut as previously thought. Therefore, mechanisms other than lysogeny must be 
a play to maintain virulent crAss-like phages in the human gut over time (Shkoporov 
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et al., 2019). This is supported by the absence of a lysogeny gene module in 
ΦcrAss001 and crAss-like prophages going undetected in Bacteroidales genomes 
deposited in databases such as NCBI RefSeq (Shkoporov et al., 2018a). Transient 
phenotypic resistance mediated by phase variable expression of host encoded phage 
receptors, such as capsular polysaccharide, is thought to play an important role in the 
persistence of virulent phages and their hosts. This phenomenon creates heterogeneity 
within an isogenic population with sub-populations oscillating between phage-
susceptible and phage-resistant phenotypes. As a result, the phage can efficiently 
propagate but viral load is limited by the co-occurrence of a phage-resistant sub-
population which continues to grow, thus creating a form of herd immunity that 
protects sensitive variants by limiting phage accessibility (Turkington et al., 2019). 
The importance of phase variation among Bacteroidales has been recently highlighted 
(Jiang et al., 2019; Porter et al., 2020). The influence of this phenomenon on crAss-
like phage-host interactions has been indicated by the inability of  ΦcrAss001 to clear 
liquid cultures of its host at high titres and the isolation of ~46% resistant clones and 
~54% completely or partially phage-susceptible clones following co-culture 
experiments (Shkoporov et al., 2018a). ΦcrAss002 was also unable to clear liquid 
cultures of B. xylanisolvens despite achieving high titres. On initial exposure the phage 
selects for resistant host variants followed by a greater selection for phage-susceptible 
variants (Chapter 3 of this thesis). The inability of a virulent phage to clear liquid 
culture of B. theataiotaomicron was also observed due to population heterogeneity 
mediated by phase variable expression of CPS (Porter et al., 2020). In the case of 
ΦcrAss002, it appears that the presence of the phage ultimately leads to the selection 
of phage-susceptible variants (Chapter 3). This may suggest that co-existing with these 
phages confers the host with some benefit. However, most examples of phage 
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conferred benefit identified to date have been observed among temperate phages 
(Obeng et al., 2016). Transcriptomic profiling may shine light on this and will be 
necessary to confirm the role of phase variation in phage-host interactions. 
“Royal-family” model dynamics may also provide an explanation for the 
observed stability. If kill-the-winner dynamics occur at a strain or sub-strain level, 
stability is maintained at the species or genus levels over time (Breitbart et al., 2018). 
The spatial heterogeneity of the GIT could provide bacterial hosts with phage-
inaccessible reservoirs in microhabitats, such as crypts and mucosa, creating source-
sink dynamics with predation predominating in the lumen thus allowing maintenance 
of both phage and host (Lourenço et al., 2019). Overall, it is likely that the persistence 
of crAss-like phages in the human gut and the co-existence with their host is due to an 
inter-play of multiple mechanisms. 
The isolation of further representatives from the crAss-like phage family from 
different genera will be necessary to identify shared and unique biological properties. 
The precise mechanisms mediating the stable and persistent colonization of these 
virulent phages at high levels needs to be further examined. Ideally, future studies 
should examine these phages in in vivo models that simulate realistic conditions as 
best as possible. This will provide important insights in the healthy gut phageome. The 
ultimate goal of this will be to understand how these phages shape our microbiome 
and influence health. Although we still have a lot to learn about these enigmatic 
phages, they have played a significant role in highlighting the potential of viral dark 
matter and in improving our understanding of the human gut phageome both in terms 
of composition and interactions (Figure 5).  
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4. The merits of studying bacteriophages and future prospects 
Despite the hurdles that need be overcome in phage research and the challenges 
faced in studying the human gut phageome, phages have many applications which 
could be potentially of benefit to humans, in addition to forming an important 
component and driving force of the microbiome. 
Interest in phages has resurged in recent years due to current and projected 
severity of the antibiotic resistance crises. It is estimated that the inability to treat 
bacterial diseases due to multi-drug resistance may lead to 10 million additional deaths 
globally per annum by 2050 (Sugden et al., 2016). Phage therapy is being examined 
as an alternative or as an aid to antibiotic treatment; however, this is not without 
difficulties due to possible undesirable immune responses, host resistance 
development, identifying suitable phage(s), and regulations (Oechslin, 2018; 
Brüssow, 2019). Several human diseases, such as IBD, have a bacterial component 
that worsens disease status due to over-stimulation of the immune system (Gevers et 
al., 2014). Phage-driven selective elimination of pathogens from the gut to shape 
microbiome composition towards homeostasis is also being examined. The ability of 
phages to shape the microbiome is supported by outcomes of FFT/FMT studies (Ott 
et al., 2017; Draper et al., 2018). Phages produce lytic enzymes, endolysins, which 
degrade the cell wall of their associated bacterial host, and also have therapeutic 
potential as alternatives to antibiotics (Love et al., 2018). While phage therapy is not 
within the scope of this review, we will mention a few cases of its application. The 
current status of phage therapy has been extensively reviewed and assessed 
(Czaplewski et al., 2016; Cisek et al., 2017; Lin et al., 2017; Lourenço et al., 2018; 
Hyman, 2019; Brüssow, 2019). Phages have also been proposed as a means of 
reducing the use of preservatives or antibiotics in food production (O’Sullivan et al., 
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2019; Lewis and Hill, 2020). However, here we will focus on therapeutic applications. 
We have seen the antimicrobial capacity of phages in selectively eradicating infection 
and alleviating diseases with a microbial component. Recently, phages were 
successfully administered in eliminating cytolytic E. faecalis in humanized mice, a 
pathogen responsible for increased disease severity and mortality in patients with 
alcoholic hepatitis (Duan et al., 2019). Phage-guided nanoparticles were used in the 
eradication of pro-tumoral Fusobacterium nucleatum and allowed the site-specific 
delivery of chemotherapeutic drugs in parallel. This resulted in colorectal cancer 
tumour reduction in a mouse model with limited impact on healthy tissue (Zheng et 
al., 2019). This technology was also applied in a piglet model without induction of the 
immune system or adverse effects (Zheng et al., 2019). However, in another study, 
phage treatment of carcinogenic bacteria to alleviate colorectal cancer led to immune 
activation and exacerbation of colitis in a murine model, despite reducing the target 
bacteria in the mouse intestine (Gogokhia et al., 2019). This study also showed that 
high levels of Caudovirales phages in IBD patients can dictate the efficacy of FMT in 
treating the disease (Gogokhia et al., 2019). Phage therapy has also led to the 
eradication of multi-drug resistant Klebsiella pneumoniae by oral and rectal 
administration of one lytic phage in a human patient without any adverse effects 
(Corbellino et al., 2019). One report showed that phages can act in synergy with innate 
immune cells to eliminated pathogens. This was observed in a murine lung model of 
drug resistant Pseudomonas aeruginosa in which phages could only eradicate the 
pneumonia-causing pathogen in synergy with neutrophils which aided the elimination 
of resistance clones that emerge on phage exposure (Roach et al., 2017). The above 
highlights the potential of phage therapy in selectively eliminating pathogens, but also 
the need to fully decipher phage gut dynamics with both the bacterial and human host, 
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before we apply phages for therapeutic use. Considering the impending outcome of 
the antibiotic resistance crisis and the importance of microbiome homeostasis, we need 
to expand our knowledge rapidly. 
As we begin to understand phage-host dynamics and how they drive the 
microbiome, specific phages or phage compositions may be identified as biomarkers 
of disease or health. Database-independent methods and examination of the virome as 
a whole will be essential for discovering disease-specific alterations. For example, 
whole virome analysis of the IBD and healthy virome identified a shift from a lytic 
core of a few but abundant clusters of Microviridae and crAss-like phages in health to 
a virome with increased induction of temperate phages such as Myoviridae and 
Siphoviridae in the disease state (Clooney et al., 2019). Further development of these 
findings and the identification of compositional patterns in the context of other 
diseases states may lead to the use of virome biomarkers in the future. 
The recognition of a temporally stable, personal persistent virulent core in 
healthy humans has changed our view of the gut phageome (Shkoporov et al., 2019). 
Formerly it was thought that the healthy gut phageome was dominated by temperate 
phages with a minority of virulent phages. However, now it is known that the converse 
is true. Having observed the geographical variation of crAss-like phages among 
individuals, how location, diet and ethnicity influence the individual composition of 
the virulent core should be explored. Gregory et al. observed significant differences 
in the dominant viral populations in Western and non-Western gut viromes, further 
suggesting that lifestyle and diet differences associated with geographical location can 
influence both phage and bacterial composition in the gut (Gregory et al., 2019). 
Additionally, in vitro and in vivo isolation and characterization of representatives of 
the lytic core will be essential in providing insights into phage-host interactions, how 
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virulent phages can persistent in the gut, and drive homeostasis. The biogeography of 
these phages, radially and longitudinally along the GIT also requires probing. 
Elucidation of the personal persistent virome will serve as an important window into 
the gut phageome and provide us with insights into ecology, composition and 
dynamics including the persistence of virulent phages. 
 
5. Conclusions 
In summary, we need to expand our understanding of the mechanisms phages 
use to drive the compositions of the gut microbiome. One of the most critical 
shortcomings of human gut phage research is the incomplete analysis of metagenomic 
datasets due to dependency on a poorly curated viral database. Furthermore, little 
progress has been made in the isolation and characterisation of novel gut phage-host 
pairs. In recent years, efforts are being made to overcome these bottlenecks. This 
requires the development of universal and easily reproducible methods that limit bias 
during viral enrichment, nucleic acid extraction, and sequencing library preparation. 
In silico analyses need to be performed using database-independent methods that 
allow for a complete de novo virome analysis using benchmarked criteria. There is 
also the need to develop a sequence-based taxonomic scheme to facilitate the rapid 
expansion of identified phage sequences due to modern sequencing technology. The 
current contradictions among different gut virome studies need to be rectified and 
clarified. Overall progression in metagenomic analyses of the gut phageome has been 
more rapid than in the isolation of gut phages, which is ultimately the key for 
expanding our scope of the mechanisms mediating phage-host relationships. If we are 
to better understand the driving force of phages, more in vitro and in vivo studies are 
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necessary. Recent findings have provided important insights, but they also highlight 













































Figure 1. Overview of phage lifecycles. (A) Lytic phages hijack host cell machinery 
to replicate, assemble and produce progeny which are released from the cytoplasm on 
host cell lysis to initiation further rounds of infection. This phage lifecycle is thought 
to be the most prevalent in the healthy human gut. (B) Lysogenic phages integrate 
their genome into the bacterial host genome with which they passively replicate until 
stress signals trigger their induction and switch to the lytic cycle. (C) Phages that 
follow a pseudolysogenic lifecycle also passively replicate with the host but their 
genome remains independent from that of the host and is maintained in the cytoplasm 
as an episome. (D). When phages are in a carrier state they can remain attached to the 
surface of a non-permissive host without infection. (E) During a chronic infection 
phages produce progeny similarly to that of lytic phages but without host cell lysis. 






















Figure 2. The phageome composition of a healthy human gut. (A). Virulent phages of 
the crAss-like phage family, other members of the Caudovirales order and the 
Microviridae family are among the most dominant and stable phages in the human gut 
forming the personal persistent virome (PPV). (B) Temperate phages and certain 
virulent phages are less abundant, less stable and more shared across individual 
viromes forming the transiently detected virome (TDV). Induction of specific 
















Figure 3. An overview of the factors that influence phage-host interactions in the 
human gut. (A). To overcome phage predation, bacteria possess an arsenal of defence 
mechanisms that target one or more stages of phage infection cycles. In retaliation 
phages have evolved an array of counter-defence mechanisms. This results in a cycle 
of infection, resistance and counter-resistance that leads to evolution and diversity in 
the human gut. (B) In the human gastrointestinal tract there is significant variation in 
biotic and abiotic factors both longitudinally and radially. This results in sectional 
variation in bacterial composition and spatial heterogeneity between phages and their 
hosts. Anatomical features of the gut such as mucus, crypts and villi create bacterial 
microhabitats which are inaccessible to phages allowing them to escape predation, 
gradually seed the lumen and maintain homeostasis. (C) Biotic and abiotic factors can 
also influence the metabolic state of the bacterial host. This can result in transient 
phenotypic changes mediated by mechanisms such as phase variation allowing 
adaptation to stress which includes phage infection. These phenotypic changes can 
result in an isogenic population of phage permissive and non-permissive hosts 







Figure 4. A generic overview of key experimental steps required in studying the 
human gut phageome from metagenomics, database-independent whole virome 
analyses, in silico identification of novel phages to in vitro isolation and in vivo 
characterisation. Linking bioinformatics and laboratory research provides important 
insights into phageome composition, novel phage detection and isolation with 
characterisation of biological properties and phage interactions with both the bacterial 
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• Screening of human faecal metagenomic samples reveals 249 crAss-like 
phage genomes 
• The crAss-like phages were classified into 4 subfamilies composed of 10 
candidate genera 
• A crAss-like phage was propagated in ex vivo human faecal fermentations 






CrAssphages represents the most abundant virus in the human gut microbiota, 
but the lack of available genome sequences for comparison has kept them enigmatic. 
Recently, sequence-based classification of distantly related crAss-like phages from 
multiple environments was reported, leading to a proposed familial level taxonomic 
group. Here, we assembled the metagenomic sequencing reads from 702 human faecal 
virome/phageome samples and analysed 99 complete circular crAss-like phage 
genomes and 150 contigs ≥70kb. In silico comparative genomics and taxonomic 
analysis enabled a classification scheme of crAss-like phages from human faecal 
microbiomes into four candidate subfamilies composed of ten candidate genera. 
Laboratory analysis was performed on faecal samples from an individual harbouring 
seven distinct crAss-like phages. We achieved crAss-like phage propagation in ex vivo 
human faecal fermentations and visualised short-tailed podoviruses by electron 
microscopy. Mass spectrometry of a crAss-like phage capsid protein could be linked 




In recent years, increasing numbers of bacteria, archaea, fungi, protists and 
viruses residing on and within the human body have been associated with various 
states of human health and disease, including diet, age, weight, inflammatory bowel 
disease (IBD), diabetes, and cognition (Claesson et al., 2012; Cryan and Dinan, 2014; 
Everard and Cani, 2013; Frank et al., 2011; Norman et al., 2015; Reyes et al., 2010; 
Tremaroli and Bäckhed, 2012). A relatively small number of eukaryotic viruses 
present in the gastrointestinal tract can target human cells; however, much larger and 
more complex populations of viruses that target bacteria (bacteriophages or phages) 
are also present. The role of phages in the gut has been a subject of increased interest 
as initial investigations revealed substantial differences in phage populations between 
healthy and diseased cohorts (Manrique et al., 2016, 2017; Mills et al., 2013; Norman 
et al., 2015; Reyes et al., 2015). It is likely that phages have an important role in 
shaping our gut microbiome, but their precise role remains poorly understood. 
In 2014, metagenomic studies of the viral fraction of the human gut microbiota 
identified a DNA phage, crAssphage, detectable in approximately 50% of individuals 
from specific human populations and reaching up to 90% of the total viral DNA load 
in faeces of certain individuals (Dutilh et al., 2014). Dutilh and colleagues noted that 
crAssphage had been overlooked in previous metagenomic studies as the vast majority 
of its genes do not match known sequences present in databases. Based on host co-
occurrence and CRISPR-spacer profiling, it was predicted that prototypical 
crAssphage infects bacteria of the genus Bacteroides or other members of the 
Bacteroidetes phylum, an abundant human gut bacterial group which is important for 
the digestion of complex non-dietary carbohydrates. 
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Originally crAssphage was published as an individual genome following 
cross-assembly of several metagenomic samples (Dutilh et al., 2014). Analysis by 
Manrique et al., of the healthy human gut phageome identified 4 circular 
crAssphage genomes and several related incomplete contigs (Manrique et al., 
2016). PCR amplification and sequencing of the crAssphage polymerase gene by 
Liang and colleagues similarly demonstrated diversity amongst crAssphage-
positive faecal samples (Liang et al., 2016). Recently, Cinek et al. described updated 
PCR primer sequences for the detection and evaluation of crAssphage diversity, 
while Stachler et al. developed primers targeting conserved genomic regions to 
evaluate the abundance of crAssphage as an indicator of human faecal pollution 
(Cinek et al., 2018; Stachler et al., 2017). Finally, an epidemiological survey of 
crAssphages conducted by Edwards, Dutilh and colleagues has suggested 
crAssphage is associated with humans and primates globally with significant 
diversity (Edwards et al., 2019). 
A recent study provided the first detailed sequence-based taxonomic 
categorisation of crAss-like phages, proposing a novel familial level taxonomic 
group that would include prototypical crAssphage itself (‘p-crAssphage’), as well 
as various related phages, from multiple environments (Yutin et al., 2018). Previous 
attempts to reconcile sequence-based and classical viral taxonomy have proposed 
that Podoviridae (viruses with a short-tail morphology) sharing >40% orthologous 
protein-coding genes should be grouped at the taxonomic rank of genus, while 
phages sharing only 20-40% orthologous protein-coding genes should be grouped 
at the higher taxonomic rank of subfamily (Lavigne et al., 2008). Other reports 
describe a phage genus as a cohesive group of viruses sharing >50% nucleotide 
sequence similarity (Adriaenssens and Brister, 2017). As crAssphages are not a 
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single entity, but rather a group of crAss-like phages that share similarity with the 
originally discovered p-crAssphage at various levels, a comparative analysis of 
crAss-like phage sequences is required to enable detailed taxonomic 
characterisation. 
In this study, we combine several in silico and in vitro approaches to further 
explore the diversity of crAss-like phages in the human gut, and better understand 





















2.3 Experimental procedures 
Written in the Cell Host and Microbe STAR★Methods format 
 
2.3.1 Experiment model and subject details 
CrAss-like phage rich faeces 
Ethics for the collection of faecal samples from consenting donor subject ID 
924, according to study protocol APC055, were approved by the Cork Research Ethics 
Committee. The samples were collected (without fixative or preservative) in the 
volunteer’s home and transported to the research facility at ambient temperature, 
avoiding exposure to heat. In general, all samples were processed into frozen standard 
inoculum immediately. The donor, denoted as subject ID 924, is a healthy female. 
Later metadata showed the subject suffered from gastritis and is vitamin B12 deficient. 
Recruitment of this individual was based on the consistent presence of crAss-like 
phages in faecal samples over a 12-month period. 
 
2.3.2 Methods Details 
Metagenomic datasets and contig assemblies 
Sequencing reads from publicly available metagenomic datasets were 
downloaded from NCBI Sequence Read Archive (SRA) database. All published and 
unpublished metagenomic datasets that yielded crAss-like phage contigs, the DNA 
preparation protocol, the sequencing technology, the assembly program, and 
information related to contig nomenclature, are briefly described in (Table S1). All 
reads were processed using Trimmomatic v0.32 (Bolger et al., 2014) to remove 
adaptor sequences and to trim reads when the Phred quality score dropped below 30 
for a 4bp sliding window. Trimmed reads were assembled using either SPAdes v3.6.2 
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(Bankevich et al., 2012) or metaSPAdes v3.10.0 (Nurk et al., 2017). Contigs from the 
assembly of 702 metagenomic samples were assigned a specific nomenclature, 
representing: [1] study/sample description, [2] SPAdes or metaSPAdes assembly, and 
[3] numerical rank of largest-to-smallest assembled contigs. The full list of contigs 
assembled in this study and available associated metadata are detailed in (Table S2). 
 
Detection and curation of crAss-like phages 
The detection of crAss-like phage contigs was performed as follows. The amino 
acid polymerase sequence of prototypical crAssphage (p-crAssphage; UGP_018, 
NC_024711.1) was queried using BLAST v2.2.28+ (Altschul et al., 1997) against a 
translated nucleotide database consisting of assembled metagenome contig sequences. 
The most conserved orthologous protein group detected in our initial putative crAss-
like phage screening included p-crAssphage protein UGP_092, which was annotated 
through the HHPred homology and structural prediction web server (Söding et al., 
2005; Zimmermann et al., 2017) as a phage terminase. This was then used as a second 
genetic signature of crAss-like phages and used in an additional BLAST search. All 
putative crAss-like phages selected for analysis met the following criteria: [1] a 
BLASTp hit against either p-crAssphage polymerase or terminase with an E-value less 
than 1E-05, [2] a BLAST query alignment length ≥350bp, and [3] a minimum contig 
length of 70kb (representing near-complete crAss-like phage contigs). 
 
Identification of crAss-like phage orthologous proteins and clusters 
The encoded proteins of crAss-like phages were predicted using Prodigal v2.6.3 
(Hyatt et al., 2010). Orthologous proteins shared between crAss-like phages were 
detected using OrthoMCL v2.0 using default parameters (Li et al., 2003). The 
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presence/absence of orthologous proteins between crAss-like phages was initially 
converted into a binary count matrix where the percentage of shared orthologous 
proteins was calculated. The optimum number of phage clusters was calculated using 
the percentage of shared homologous proteins using the NbClust v3.0 package for R. 
Hierarchical clustering was performed on the count matrix of percentage shared crAss-
like phage orthologous proteins using Ward's minimum variance method [‘Ward.D2’ 
algorithm in R (Ward, 1963)]. The resulting dendrogram was cut at k = 10 based on 
the estimation of the number of crAss-like phage clusters (Figure 1). 
As a verification of the 10 predicted crAss-like phage clusters, the original 
abundance matrix of crAss-like phage orthologous proteins was used to calculate 
Euclidean distances between sequences. These distance variations were calculated 
using the t-SNE machine learning algorithm [‘tsne’ v0.1-3 for R; (Maaten and Hinton, 
2008)] and plotted using ggplot v2.2.1 (Figure 2). 
 
Genomic comparisons of crAss-like phages 
Complete circular genomes were annotated automatically using VIGA 
(https://github.com/EGTortuero/viga, genetic code table 11 or 15) and then manually 
using HHPred suit (Zimmerman et al., 2017) against the following databases: 
PDB_mm_CIF70_28_July, Pfam-A_v31.0, NCBI_CD_v3.16, TIGRFAMs_v15.0 
(Table S3 for details). Genome comparison image was generated with Easyfig v2.2.2 
(Sullivan et al., 2011), using tBLASTx algorithm with the following parameters: e-
value cut-off 0.001, length filter 30 (Figure 3). 
Conserved protein sequences were aligned using MUSCLE v3.8.31 and 
approximately-maximum-likelihood phylogenetic trees were generated using 
FastTree v2.1.7 with default parameters (Figure S2). 
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Alignment of virome metagenomic reads to crAss-like contigs 
The quality filtered reads from 512 human faecal viromes (as subset of 702 
viromes selected based on availability of sufficient metadata) were then aligned to the 
set of 131 nonredundant crAss-like phage genomes (with <90% identity and/or <90% 
overlap between them) using Bowtie2 v2.3.0 (Langmead and Salzberg, 2012) using 
the end-to-end alignment mode. A count table of reads aligned to contigs was 
generated with Samtools v0.1.19, which was then imported into R v3.3.1 for statistical 
analysis. 
 
Recruitment of a crAssphage faecal donor and faecal fermentation 
Human faecal viromes from a number of ongoing studies sequenced using 
Illumina HiSeq and MiSeq platforms were screened for crAss-like phages by aligning 
the obtained sequencing reads against prototypical crAssphage NC_024711.1 using 
Bowtie2 v2.3.0. One individual (subject ID 924) was found to carry crAssphage 
consistently at levels exceeding 30% of the total number of reads over a one-year 
period. A frozen standard inoculum (FSI) sample was processed as described by 
(O’Donnell et al., 2016) with the following modification: the sample was resuspended 
in 1X phosphate buffered saline (37 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 2 
mM KH2PO4.), 0.05% (w/v) L-cysteine (Sigma Aldrich, Ireland) and (1 mg/L) 
resazurin  (Sigma Aldrich, Ireland). The crAssphage-rich FSI was inoculated into 400 
ml YCFA-GSCM broth in a 500 ml fermenter vessel at 5% (v/v). Fermentation media 
was prepared exactly as described by (Duncan et al., 2002) with the addition of glucose 
(2 g/L), soluble starch (2 g/L), cellobiose (2 g/L) and maltose (2 g/L). Fermentation 
was performed in batch format at approximately 37°C for 51 hours. Dissolved oxygen 
was sustained at <0.1% by constantly sparging the vessel with anaerobic gas mix (80% 
131 
 
(v/v) N2, 10% (v/v) CO2, 10% (v/v) H2) and stirring at 200 rpm. Both 2M NaOH and 
HCl solutions were used to maintain pH at ~7. Samples were collected at the following 
time points; 0, 4, 21, 28, 45 and 51 hours. Collected samples were centrifuged at 4,700 
rpm at +4°C for 10 minutes. The resulting supernatants were filtered once through a 
0.45 μM pore syringe filter and stored at +4°C. Resultant pellets were stored at -80°C. 
 
Extraction of viral nucleic acids and sequencing library preparation 
Total virome extractions were performed on 0.45 μM pore filtered fermentation 
supernatants. Solid NaCl and polyethylene glycol 8000 were added to the filtrates to 
give a final concentration of 0.5M and 10% (w/v), respectively. After overnight 
incubation at +4°C samples were centrifuged at 4,700 rpm and +4°C for 20 minutes. 
The pellets were then resuspended in 400μl of SM buffer (1M Tris-HCl pH 7.5, 5M 
NaCl, 1M MgSO4) and briefly vortexed with an equal volume of chloroform. This 
mixture was then centrifuged at 2,500g for 5 minutes using a standard desktop 
centrifuge. The resultant aqueous phase was then transferred into an Eppendorf to 
which 40μl DNase buffer (10mM CaCl2 and 50mM MgCl2) and 8U and 4U TURBO 
DNase (Ambion/ThermoFisher Scientfic) and RNase I (ThermoFisher Scientific) 
were added, respectively. This was incubated at 37°C for 1 hour followed by an 
enzyme inactivation step at 70°C for 10 minutes. This was followed by the addition of 
2μl proteinase K and 10% SDS and further incubation at 56°C for 20 minutes. Lastly, 
100μl phage lysis buffer (4.5 M guanidinium isothiocyanate, 44 mM sodium citrate 
pH 7.0, 0.88% sarkosyl, 0.72% 2-mercaptoethanol) was added to lyse the viral 
particles. The final incubation was carried out at 65°C for 10 minutes. The resulting 
lysates were lightly vortexed with an equal volume of phenol/chloroform/isoamyl 
alcohol 25:24:1 (Fisher Scientific) and were centrifuged at room temperature for 5 
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minutes at 8,000g. This was again repeated with the resulting aqueous phase. 
Following the second extraction, the aqueous phase was passed through a DNeasy 
Blood and Tissue Kit (Qiagen) for final viral nucleic acid purification. The wash steps 
were each repeated twice, and the final elution was carried out in 50μl elution buffer. 
Viral DNA quantification was carried out with the Qubit HS DNA Assay Kit 
(Invitrogen/ThermoFisher Scientific) in a Qubit 3.0 Flurometer (Life Technologies). 
The viral nucleic acids were then subjected to reverse transcription using SuperScript 
IV Reverse Transcriptase (RT) kit (Invitrogen/ThermoFisher Scientific). The protocol 
was carried out exactly as described in the manufacturer’s protocol for random 
hexamer primers. Following this, 1μl of the reversed transcribed viral DNA was 
subjected to GenomiPhi V2 (GE Healthcare) Multiple Displacement Amplification 
(MDA). Finally, MDA and non-MDA viral DNA was prepared for sequencing using 
TruSeq DNA Library Preparation Kit (Illumina, Ireland). All steps were performed as 
per the manufacturer’s instructions. Prepared libraries were sequenced on an Illumina 
HiSeq platform (Illumina, San Diego, California) with 2x300bp paired-end chemistry 
at GATC Biotech AG, Germany. Reads were filtered, trimmed and assembled into 
contigs as described above. A count matrix was created by aligning quality-filtered 
reads back to contigs using Bowtie2 and Samtools. 
 
P-crAssphage PCR detection 
Oligonucleotide primer pairs were designed based on the p-crAssphage DNA 
polymerase sequence UGP_018 (Dutilh et al., 2014) using PerlPrimer software 
(Marshall, 2004b). Primer sequences are as follows: pCrAss-DNAPol-Fwd5 5’-
GCCTATTGTTGCTCAAGCTATTGAA-3’ and pCrAss-DNAPol-Rev5 5’-
ACAACAGAACCAGCTGCCAT-3’. PCR products were cloned into pCR2.1-TOPO 
133 
 
TA vector (ThermoFisher Scientific) and obtained plasmids at known concentrations 
were used to establish calibration curves through serial ten-fold dilutions. This plasmid 
was denoted as pCR2.1::pCrAssDNApol5. Subsequently, qPCR were run in 15μl 
reaction volumes using SensiFAST SYBR No-ROX Master Mix (Bioline) and 
LightCycler 480 thermocycler with the following conditions: initial denaturation at 
95°C for 5 minutes, then 45 cycles of 94°C for 20 seconds, 55°C for 20 seconds and 
72°C for 20 seconds, with a final extension at 72°C for 7 minutes. All samples were 
run in triplicate and the standard error was determined following calculation of DNA 
concentration based on the above standard curve.  
 
Electron microscopy and detection of crAss-like phage proteins 
A virus-enriched fraction of the crAssphage positive faecal sample, collected 
from subject ID 924, was prepared for electron microscopy imaging as follows. A 1:20 
suspension (w/v) of faeces was prepared in SM buffer followed by vigorous vortexing 
until homogenised. The homogenised sample was chilled on ice for 5 minutes prior to 
centrifugation twice at 4,700 rpm for 10 minutes at +4°C. The resulting supernatant 
was then filtered twice through a 0.45 μM pore syringe filters. The filtrate was ultra-
centrifuged at 120,000g for 3 hours using a F65L-6x13.5 rotor (ThermoScientific). 
The resulting pellets were resuspended in 5 ml SM buffer. The viral suspensions were 
ultracentrifuged again by overlaying them onto a caesium chloride (CsCl) step 
gradient of 5M and 3M, followed by centrifugation at 105,000g for 2.5 hours. A band 
of viral particles visible under side illumination was collected and buffer-exchanged 
using 3 sequential rounds of 10-fold diluting and concentrating to the original volume 
by ultra-filtration using Amicon Centifugal Filter Units 10,000 MWCO (Merck). The 
purified fraction was then analysed by qPCR for the presence of crAssphage as 
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described above. Following this, 5μl aliquots of the viral fraction were applied to 
Formvar/Carbon 200 Mesh, Cu grids (Electron Microscopy Sciences) with subsequent 
removal of excess sample by blotting. Grids were then negatively contrasted with 
0.5% (w/v) uranyl acetate and examined at UCD Conway Imaging Core Facility 
(University College Dublin, Dublin, Ireland) by transmission electron microscope. 
The faecal viral fraction from subject ID 924 was further concentrated using Amicon 
Ultra-0.5 Centrifugal Filter Unit with 3 kDa MWCO membrane (Merck, Ireland). This 
concentrated fraction was loaded onto a premade Bolt 4-12% Bis-Tris Plus reducing 
SDS-PAGE gel (Invitrogen) and separated at 200 V for 30 minutes using 1X NuPAGE 
MOPS SDS Running Buffer. Six brightest bands with approximate molecular weights 
of 28, 35, 45, 55, 120 and 200 kDa were excised and subjected to MALDI-TOF/TOF 
(Bruker ultraflex III) protein identification following in-gel trypsinization, at 
Metabolomics & Proteomics Technology Facility (University of York, York, UK). 
 
16S rRNA gene library preparations 
Total DNA was extracted from the pellets formed following centrifugation of 
fermentation samples. This was carried out using the QIAamp Fast DNA Stool Mini 
Kit (Qiagen, Hilden, Germany). All steps were carried out as per the manufacturer’s 
protocol with the addition of a bead-beating step to aid total DNA extraction from the 
bacterial cells. Approximately 200mg of each pellet was placed in a 2ml screw-cap 
tube containing a mixture of one 3.5 mm glass bead, a 200μl scoop of 1mm zirconium 
beads and a 200μl scoop of 0.1mm zirconium beads (ThistleScientific) with 1ml of 
InhibitEX Buffer. Bead-beating was carried out three times for 30 seconds using the 
FastPrep-24 benchtop homogeniser (MP Biomedicals). Between each bead-beating 
the samples were cooled on ice for 30 seconds. The samples were then lysed at 95°C 
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for 5 minutes. All other steps were carried out as per the manufacturer’s protocol. 
Following extraction of total bacterial DNA, the hypervariable regions of V3 and V4 
16S ribosomal RNA genes were amplified from 15ng of the DNA using Phusion High-
Fidelity PCR Master Mix (ThermoFisher Scientific) and 0.2µM of each of the 
following primers, containing Illumina-compatible overhang adapter sequences: 
MiSeq341F: 5'-TCGTCGGCAG CGTCAGATGT GTATAAGAGA CAGCCTACGG 
GNGGCWGCAG-3' and MiSeq805R 5'-GTCTCGTGGG CTCGGAGATG 
TGTATAAGAG ACAGGACTAC HVGGGTATCT AATCC-3' (56) The PCR program 
was run as follows: 98°C for 30 seconds, 25 cycles of 98°C for 10 seconds, 55°C for 
15 seconds and 72°C for 20 seconds, with a final extension of 72°C for 5 minutes. The 
amplicons were then purified using Agencourt AMPure XP magnetic beads 
(Beckman-Coulter) followed by a second PCR to attach dual Illumina Nextera indices 
using the Nextera XT index kit v2 (Illumina). Purification was performed once again, 
and the libraries were quantified using a Qubit dsDNA HS Assay Kit. The libraries 
were then pooled in equimolar concentration and sent for sequencing on an Illumina 
MiSeq platform (Illumina, San Diego, California) at GATC Biotech AG, Germany. 
The quality of the raw reads was assessed with FastQC (v11.5) and initial quality 
filtering was performed using Trimmomatic v0.36. Filtered reads were imported into 
R (v3.4.3) for analysis with DADA2 v1.6.0. (Callahan et al., 2016) Further quality 
filtering and trimming (maxN of 0 and a maxEE of 2) was carried out on both the 
forward and reverse reads with only retention in cases of pairs being of sufficient high 
quality. Error correction was performed on forward and reverse reads separately and 
following this, reads were merged. The resulting unique Ribosomal Sequence Variants 
(RSVs) were subjected to further chimera filtering using USEACH v8.1 (55) with the 
Chimera-Slayer gold database v20110519. The retained, high quality, chimera-free, 
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RSVs were classified with the RDP-classifier in mothur v1.34.4 (Schloss et al., 2009) 
against the RDP database v11.4 (phylum to genus) and SPINGO (Allard et al., 2015) 
for species assignment. Plots were generated using the R package ggplot2 v2.2.1. 
 
2.3.3 Quantification and statistical analysis 
Alignment of virome metagenomic reads to crAss-like contigs 
The count table generated from Samtools v0.1.19 was then imported into R 
v3.3.1 for statistical analysis. The β-diversity of crAss-like viral populations in human 
cohorts was visualized using PCoA plot based on Spearman rank distances (D = 1 – ρ, 
where ρ is Spearman rank correlation coefficient of relative abundance of different 
crAss-like contigs between samples). Statistical analysis was performed using 
permutational multivariate analysis of variance (PERMANOVA) implemented in 
Vegan v2.4.3 package for R (Anderson, 2001) and non-parametric Kruskal-Wallis test. 
 
Faecal fermentations 
Statistical analysis was performed on the qPCR data acquired for the technical 
triplicates set-up for each fermentation time point. This was done to ensure minimal 
variation and error. The analysis was carried using GraphPad Prism v7.0 software 
using the standard error of the mean (SEM). Based on these bars we can have high 








2.3.4 Data and software availability 
The data and R scripts required to reproduce the analyses of this study have 
provided as supplementary material. https://doi.org/10.1016/j.chom.2018.10.002 
 
Data deposition: 
The 249 crAss-like phage contigs analysed in this study are provided as 





















2.4.1 Detection of crAss-like phage contigs  
Following the assembly of 702 human faecal virome/phageome metagenomic 
samples listed in (Table S1), contigs were screened for relatedness to the p-
crAssphage. Initially, the polymerase of p-crAssphage (UGP_018, NC_024711.1) was 
used for crAss-like phage detection due to its use in several studies as a genetic 
signature to determine diversity of crAss-like phages (García-Aljaro et al., 2017; 
Liang et al., 2018, 2016). However, we extended our criteria in order to include partial 
genomes (≥70kb) that may not have included the polymerase gene in the assembly. 
Therefore, after an initial detection of crAss-like phages using the polymerase 
sequence, we identified the most frequently detected crAss-like phage protein in our 
dataset as the terminase protein, encoded by p-crAssphage UGP_092. This terminase 
was subsequently used as a second genetic signature for identifying crAss-like phages. 
Initially, 239 contigs ≥70kb were detected with similarity to the p-crAssphage 
polymerase sequence. An additional 59 contigs ≥70kb were subsequently detected 
with relatedness to the p-crAssphage terminase sequence. Following an initial 
examination of these contigs, more stringent parameters were implemented. Only 
those contigs whose polymerase and/or terminase sequence(s) aligned across greater 
than 350bp were considered for further analysis as crAss-like phages. This reduced 
the total number of crAss-like phages to 256. In addition, as several assembled 
metagenomic samples were from the same person sequenced at multiple time points, 
redundant contigs were removed. When a contig aligned with 100% identity across 
the entire length or within a larger contig, the longer contig or that with the highest 
coverage was retained (see Methods section for a detailed description). This resulted 
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in a total of 244 crAss-like contigs, with 144 containing both a polymerase and 
terminase, 60 a polymerase only and 40 a terminase only (Figure S1). 
Contigs ≥70kb from the family level taxonomic analysis of crAss-like phages 
conducted by Yutin et al. (Yutin et al., 2018) were analysed for inclusion into this 
study. Whole genome comparisons highlighted some sequences predicted as related at 
the familial taxonomic rank shared no significant homology at the nucleotide level (E-
value 1E-05), including one of this study’s predicted 244 crAss-like phages. In 
addition, contig SRR073438_s_3, while sharing weak nucleotide homology to crAss-
like phages, was more similar to larger putative Caudovirales phages (~170kb) and 
was not predicted as a crAss-like phage. Therefore, a total of 249 contigs/genomes 
were analysed in this study as crAss-like phages. Metadata was available for the 
majority of the crAss-like phage originating faecal samples (see Table S2). CrAss-like 
phages were detected in healthy individuals across a wide age range (including infants 
1 year of age and individuals ≥65 years of age) and individuals suffering from Crohn’s 
disease, ulcerative colitis, HIV, cystic fibrosis, kwashiorkor and marasmus. 
 
2.4.2 Taxonomy of crAss-like phages 
 Previously, studies have used the percentage of shared homologous proteins as 
a means of defining phage taxonomic ranks (Lavigne et al., 2008). Therefore, clusters 
of phages sharing between 20-40% of their protein-coding genes were categorised as 
related at the subfamily level, while phages sharing >40% protein-coding genes were 
grouped at the genus level. A heatmap based on the percentages of shared orthologous 
proteins suggests that crAss-like phages form 4 candidate subfamilies. The four 
subfamilies were assigned the nomenclature Alphacrassvirinae (which contains p-
crAssphage), Betacrassvirinae (which contains IAS virus), Gammacrassvirinae and 
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Deltacrassvirinae (Figure 1). These subfamilies can be further subdivided into 10 
candidate genera, with I containing p-crAssphage and Candidate Genus VI containing 
the IAS virus. Metadata of all crAss-like phages analysed in this study, including their 
categorisation into the various taxonomic divisions, is available in (Table S2). 
An alternative approach for characterising the encoded proteome of crAss-like 
phages was performed by visualisation of genome clusters using the t-SNE machine 
learning algorithm with Euclidean distances of orthologous genes distribution between 
genomes as an input. Applying the previously determined 10 crAss-like phage 
candidate genera classifications to the t-SNE two-dimensional ordination 
demonstrated that some ellipses are tightly clustered (e.g. Candidate Genus II), 
suggesting uniformity. Other ellipses are larger relative to the number of sequences 
(e.g. Candidate Genus III), signifying heterogeneity (Figure 2A). In addition, no single 
cluster of crAss-like phages is exclusively associated with healthy or diseased 
individuals (R2 = 0.03 in Adonis/PERMANOVA, p = 0.006). 
Specific genera of crAss-like phages share similar G+C% nucleotide 
composition and may share related bacterial hosts, since phage G+C% content can be 
related to that of their hosts (Edwards et al., 2016; Lucks et al., 2008). Therefore, 
several groups of crAss-like phages with similar G+C% compositions, such as 
candidate genera I, IV, VII, IX and X, are likely to infect closely related bacterial taxa 
within the human microbiome (Figure 2B). Candidate Genus I is the most 
homogenous group of crAss-like phages containing p-crAssphage and 30 additional 
complete circular genomes and 32 linear contigs ≥70kb which all share a very similar 
G+C% nucleotide content (29.12 ± 0.14%). Candidate genera III and VI display the 




2.4.3 Genome structure of crAss-like phages 
A set of representative complete circular genomes of the ten genera of crAss-
like phages ranges in length from 91.3 to 104.5 kb with varying degrees of genomic 
synteny (Figure 3). A prominent feature of crAss-like phages is two clearly separated 
genome regions with opposite gene orientation, the smaller region encoding proteins 
involved in replication, the bigger region coding for proteins involved in transcription 
and virion assembly. CrAss-like phages encode large ORFs with sizes up to 18 kb 
(UGP_052 and UGP_053 in the genome of p-crAssphage), possibly coding for fused 
subunits of an RNA polymerase (Yutin et al., 2018). However, these large ORFs are 
only observed in Candidate Genus VII and VIII when a non-standard genetic code is 
used in ORF prediction (see Methods). All of the crAss-like phages of Candidate 
Genus I, II, and IV contain no tRNAs, while members of Candidate Genus VI had 
large sets of tRNA genes (up to 27; Table S2). Analysis of the crAss-like phage 
proteome suggests that four proteins are universally conserved across crAss-like phage 
subfamilies and have monophyletic evolutionary origin: major capsid protein (MCP, 
UGP_086), terminase (UGP_092), portal protein (UGP_091) and primase (UGP_025; 
Figures S2, Table S3). Phylogeny of crAss-like phages based on multiple alignment 
of these four proteins supports that based on percentage of shared proteins and clearly 
separates the four subfamilies. As clearly shown in Figure 3, blocks of genes 
responsible for tail morphogenesis are especially variable even between members of 
the same subfamily, both in the number of genes and sequence of the encoded protein 
products, highlighting potentially wide range of bacterial hosts infected by different 





2.4.4 Prevalence of crAss-like phages in human faecal virome samples 
To obtain insights into relative abundance in various human populations we 
aligned quality filtered reads, representing 512 human faecal samples from the same 
datasets as used for assembly of crAss-like genomes, to a database of 131 
nonredundant crAss-like phage genomic sequences (with <90% of homology and/or 
<90% overlap between them) representing all ten candidate genera. 
CrAss-like phage colonization rates varied from 51-59% in Malawian infants to 
98-100% of healthy individuals of various ages in the Western cohorts (Figure S3A). 
In total, 77% of all samples were positive for one or more crAss candidate genera. The 
relative phage abundance ranged from 0 to 95% of total reads per sample (Figure S3B) 
and depended significantly on the country of residence (p = 4.2E-09 in Kruskal-Wallis 
test) and age group of the donor (p = 1.1E-10). In ~8% of all virome samples, >50% 
of reads aligned to crAss-like phage genomes. The lowest overall crAss-like phage 
counts were seen in Irish and Malawian infants and in USA adults with IBD (Figure 
S3A). On a global scale, crAss-like candidate genera I, VIII, and IX seem to be the 
most prevalent with the highest mean percentage of reads aligned; 5%, 1.7% and 1.8%, 
respectively. 
The specific composition of crAss-like phages in faeces partly separated a cohort 
of healthy and malnourished infants living in rural areas of Malawi from the healthy 
and diseased urban Western cohorts (Figure S3C). PERMANOVA analysis suggested 
that crAss-like phage composition was mostly driven by place of residence (R2 = 0.24, 
p = 0.001) with condition and age group also having significant impact (R2 = 0.05 and 
0.01 respectively, p = 0.001). This observation is further supported by a clear 
difference in the distribution of specific crAss-like candidate genera across different 
populations (Figure 4). Specifically, Candidate Genus I, which includes p-crAssphage, 
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is by far the most prevalent type in Western population regardless of age. At the same 
time, the same genus was extremely scarce in Malawian cohort where Candidate 
Genus VIII and IX were the most common (p = 4.7E-02 and 4.4E-013, respectively). 
 
2.4.5 Faecal fermentations of a Candidate Genus I rich sample 
During an ongoing longitudinal study of faecal viromes in healthy adults we 
identified one individual (subject ID 924), in which p-crAssphage consistently 
contributed >30% of virome metagenomic reads over a 12-month period. Thus, this 
donor was selected in order to investigate if p-crAssphage could be propagated in a 
batch faecal fermentation system. Quantitative PCR (qPCR) detection of a conserved 
fragment of the p-crAssphage DNA polymerase gene in the viral nucleic acid fractions 
throughout the fermentation revealed that p-crAssphage was effectively propagated. 
P-crAssphage was found to increase in titre 89-fold 21 hours into the fermentation 
(Figure 5A). 
Interestingly, a shotgun metagenomic sequencing run, following multiple 
displacement amplification (MDA) of the viral enriched DNA from the fermentation 
supernatants, showed the presence of six other crAss-like phages in the study subject, 
in addition to a phage highly similar to p-crAssphage (Figure 5B; Table S2). Each of 
these crAss-like phage contigs were ≥70kb and grouped into five candidate genera 
(Figure 5B). Four of these contigs contributed to ≥1% of the reads per sample. The 
most abundant phage of subject ID 924 detected after sequencing this viral DNA 
preparation was crAss-like phage Fferm_ms_6 (linear, 90.4kb), a member of 
Candidate Genus I and is closely related to p-crAssphage. Contig Fferm_ms_2 (linear, 
88.8 kb) is the second most abundant in the sample and belongs to Candidate Genus 
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V. Five additional crAss-like phages were detected in the faeces of subject ID 924 
(Table S2). 
Analysis of the bacterial fraction of the microbiota in the fermentation vessel 
was performed using compositional 16S rRNA gene sequencing to investigate 
potential crAss-like phage hosts and to examine the hypothesis that their hosts are of 
the Bacteroides genus or Bacteroidetes phylum. The analysis showed a decrease in the 
relative abundance of Bacteroides up to time point 21 after which levels begin to 
recover. The converse was observed for p-crAssphage propagation for which titres 
increased up to time point 21 followed by a gradual decrease. Two Bacteroides species 
found to be abundant in the vessel included B. dorei and B. uniformis. However, 
attempts to isolate crAss-like phages on these strains did not yield plaques; therefore, 
we cannot definitively infer a host for p-crAssphage, but only confirm the presence of 
bacteria that other studies have suggested as putative hosts (Cinek et al., 2017; Reyes 
et al., 2013; Figure S4). 
 
2.4.6 Biological characterisation of crAss-like phages 
 Transmission electron microscopy (TEM) of a faecal filtrate rich in a Candidate 
Genus I crAss-like phage showed a significant presence of short-tailed or non-tailed 
viral particles with icosahedral or isometric heads (53% with a Podoviridae-like short 
tail morphology and 29% of Microviridae or a smaller type of Podoviridae), with 
lower levels of tailed phages with a Siphoviridae-like morphology (15%; Figure 6A). 
The large Podoviridae-like icosahedral capsids with short-tails could be further 
classified into two types: type I, with head diameters of ~76.5 nm and short tails; and 
type II, with a similar head size but head-tail collar structures and slightly longer tails 
(Figure 6B). Sequencing, without MDA, of CsCl purified fraction of the same faecal 
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material as used for the TEM showed that approximately 40% of reads aligned to 
crAss-like genomic contigs (Figure 6C), with the Candidate Genus V crAss-like phage 
being the most abundant. Based on the size of the 7 crAss-like genomic contigs 
assembled (88.8-104.6 kb; termed ‘Fferm’ contigs within (Table S2) it is predicted that 
the predominant podovirus morphology observed corresponds to the crAss-like 
phages. For comparison, Microviridae phages have genomes 4.4-6.1 kb and 
icosahedral capsids of approx. 15-30 nm in diameter (Roux et al., 2012; Zhong et al., 
2015). 
The same CsCl fraction of faeces that was subjected to metagenomic sequencing 
without MDA and TEM visualisation was also analysed by SDS-PAGE followed by 
identification of major bands using MALDI-TOF mass spectrometry. A major 
structural protein of crAss-like phage Fferm_ms_2 was detected from a band excised 
from the ~55kDa area on a SDS-PAGE gel (Figure 6D). The obtained peptide profile 
corresponded to a protein of 490 amino acids and 55.4 kDa, with analysis showing the 
protein as having 37% identity with UGP_086, predicted as the major capsid protein 
of p-crAssphage (Yutin et al., 2018). 
Finally, we attempted to independently establish the size of crAss-like phage 
virions by passing faecal filtrates through a series of filters with gradually decreasing 
pore sizes (Figure S5). Filtration through 0.1 μm pores (equivalent to 100 nm) resulted 
in partial retention of crAss-like phages while pores of 0.02 μm size completely 








The overall objective of this study was to gain an insight into one of the most 
enigmatic phages discovered to date, crAssphage. This phage is highly abundant in 
the human microbiome on a global scale; however, it remains poorly understood. One 
reason why crAssphage has remained such a mystery is due to the lack of available 
genome sequences for comparison. When crAssphage was assigned a specific 
nomenclature and uploaded to a public repository by Dutilh and colleagues (Dutilh et 
al., 2014), it became a template for other studies. 
P-crAssphage was the first identified representative of an expanding group of 
phages, associated with animal, soil and oceanic microbiomes (Dutilh et al., 2014; 
Yutin et al., 2018). While a previous study proposed a sequence-based classification 
of crAss-like phages at the familial level (Yutin et al., 2018), our in silico analysis 
focuses on human faecal-associated crAss-like phages. In this study, we present 244 
new crAss-like phages from various metagenomic studies. Comparative genomics 
demonstrates an extensive degree of diversity among these phages, including the 
identification of four crAss-like phage subfamilies. While the Alphacrassvirinae 
subfamily currently has the greatest number of sequences of the 4 subfamilies, future 
studies looking for additional homologues of Betacrassvirinae, Gammacrassvirinae 
and Deltacrassvirinae members will expand and refine these taxonomic ranks. In 
particular, future faecal virome/phageome studies of humans from diverse 
geographical locations will likely expand the repertoire of known human-associated 
crAss-like phages significantly, as the large interpersonal differences in the human 
virome are likely multiplied by variations of diet and environmental exposure. 
Assigning phage taxonomy, in the absence of a universal genetic marker such as 
16S rRNA, is a difficult and potentially erroneous process. While crAss-like phages 
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will likely form their own taxonomic family (Yutin et al., 2018), they possess a dsDNA 
genome and a Podoviridae-like short tailed virion. The categorisation of crAss-like 
phages by the percentage of shared proteins identified ten candidate genera, with 
crAss-like phages in each genus originating from the faeces of putatively healthy 
individuals and people suffering from various metabolic, infectious, diet and gut-
related disorders. 
Several crAss-like phage genera proposed in this study have distinct nucleotide 
G+C% compositions. The nucleotide composition of obligate parasites, such as 
phages, can evolve in close association with their host bacterium (Lucks et al., 2008; 
Mavrich and Hatfull, 2017; Pride et al., 2006; Roux et al., 2015). Following this logic, 
Candidate Genera III and VI with diverse G+C% compositions are either 
heterogeneous groups of crAss-like phages that require further sequences to refine 
their taxonomic structure, or they are potentially capable of infecting across a broad 
host range. However, not all phages have a G+C% composition which mirrors their 
host; therefore, these results must be treated cautiously until further investigated 
(Henry et al., 2015). 
Quantitative analysis of the crAss-like phage content in several cohorts revealed 
that in agreement with previous studies the vast majority of faecal viral metagenomic 
samples contained varied amounts of crAssphage DNA. P-crAssphage (Candidate 
Genus I) is by far most predominant type in Western populations, co-existing with 
other crAss-like phages in the majority of samples. By contrast, in the cohort of 
malnourished and healthy Malawian infants (Reyes et al., 2015; Smith et al., 2013), 
other candidate genera such as VI, VIII and IX are more abundant. It is well known 
that non-Western rural populations, which mostly consume high fibre, low fat and low 
animal protein diet are predominantly associated with high Prevotella/low Bacteroides 
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type of gut microbiota [known as enterotype II (Arumugam et al., 2011)], as opposed 
to Bacteroides/Clostridia-dominated microbiota (enterotype I) in urban populations 
consuming a western diet (Filippo et al., 2010; Gorvitovskaia et al., 2016). Indeed, our 
analysis of the Reyes et al. (2015) 16S rRNA gene sequencing data confirmed high 
prevalence of Prevotella in Malawian samples (Figure S6). Therefore, one can 
hypothesize that crAss-like phages of candidate genera VIII and IX might be 
associated with Prevotella or other members of the order Bacteroidales. 
The in vitro analysis of samples obtained from subject ID 924 was particularly 
intriguing. By mapping metagenomic sequencing reads against p-crAssphage, it was 
initially thought that this donor only carried the prototypical crAssphage at levels 
exceeding 30% of total viral reads for a one-year period. A subsequent mining for 
phages related to p-crAssphage using metagenomic sequencing at later time points, 
with and without multiple displacement amplification, resulted in six additional crAss-
like phages being simultaneously detected in this donor. It is possible many additional 
crAss-like phage genomes could be present within the metagenomic datasets that were 
examined in this study, but they were not included in our analysis because of the 
inclusion criteria chosen or even the choice of assembly program. 
In total, subject ID 924 consistently carried seven crAss-like phages, which 
resolved in our taxonomic analysis into five candidate genera. Three belonged to 
Candidate Genus VI, supporting the notion this is a heterogeneous group and not 
simply composed of broad host range infecting phages. It is possible that there are 
more than seven crAss-like phages within subject ID 924. However, it is most probable 
that only a single representative of each candidate crAss-like phage genus (with the 
exception of the heterogeneous Candidate Genus VI) could assemble correctly, with 
two or more highly identical phages amalgamating their single nucleotide 
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polymorphisms into a single consensus representative sequence. This is a known 
feature of the chosen assembly program, where microdiversity is lost at the expense 
of assembling longer contigs/low coverage contigs within complex samples (Vollmers 
et al., 2017). 
This study demonstrates the proliferation of crAss-like phages in a faecal 
fermenter, which represents the first evidence of a phage similar to p-crAssphage 
propagating under laboratory conditions. Furthermore, following our ability to 
propagate faecal crAss-like phages, we conducted the first transmission electron 
micrographs (TEMs) of these phages using faecal filtrate from sample ID 924 prepared 
prior to fermentation. The most abundant faecal viruses had short tails and were 
Podoviridae-like in structure. This agrees with the predictions made by Yutin et al., 
following their detailed genome annotation of two crAss-like phages (Yutin et al., 
2018). Interestingly, however, our TEMs suggest presence of two types of virions with 
short non-contractile tails (Figure 6B). Presumably, the more abundant type I virions 
with shorter tails may belong to members of Candidate Genus V, found as the most 
abundant crAss-like phage group sequenced in the same sample from subject ID 924 
(Figure 6C). But without isolating these phages in pure culture, it is not possible to 
accurately assign which tail structure corresponds to which specific crAss-like phage 
subfamily or genera. 
This work provides multiple levels of in vitro evidence confirming that crAss-
like phages have a short-tailed podovirus structure. Experimentally, this is shown 
using the same CsCl fraction purified from a crAssphage rich faecal sample of a 
healthy human donor. A qPCR performed on this fraction using Candidate Genus I 
specific primers showed that approximately 1 x 109 copies per microlitre were present. 
To examine the size of the crAss-like phage virions in vitro, faecal filtrates from the 
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same sample were passed through a number of filters with decreasing pore sizes 
(ranging from 450-20nm). It was found that p-crAssphage could no longer be detected 
after filtration through a pore size of 20nm but was partially retained by filter sizes of 
100nm. This supports the size prediction of crAss-like phage virions observed in 
TEMs. Sequencing, without MDA, of the same CsCl fraction that was visualised by 
TEM confirmed that almost 40% of the reads aligned to crAss-like phages, consistent 
with the percentage of short-tailed Podoviridae-like phage virions present in the 
sample. An examination of the protein content in the sample visualised by TEM 
detected the predominant major capsid protein of the Fferm_ms_2 crAss-like phage. 
The capsid protein was found to have similarity to other crAss-like phages of 
Candidate Genus V, as well as a moderate degree of similarity to p-crAssphage 
(Candidate Genus I). 
Identifying a means of propagating crAss-like phages is of particular importance 
in expanding our knowledge on crAss-like phages. However, the primers applied in 
the qPCR analyses of viral nucleic acids were not suitable for targeting crAss-like 
phages associated with the various subfamilies and candidate genera other than p-
crAssphage. With the availability of more crAss-like phage sequences, broad and 
narrow spectrum qPCR assays can be subsequently designed and applied to the 
analysis of these phages, which will be an important part of future work. 
It is clear that human gut-associated crAss-like phages are not a single entity, 
but rather a group of diverse viruses sharing genomic traits, which target diverse 
bacterial taxa of the human microbiome. Previously, a member of the Bacteroides 
genus was hypothesised as being the host for crAssphage (Dutilh et al., 2014). In a 
study prior to the discovery of crAssphage (Reyes et al., 2013), a 95.9kb contig 
corresponding to a putative virus φHSC05 was shown to be stably engrafted after 
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transplantation of human faecal virus fraction into germ-free mice colonized with an 
artificial defined community of 15 bacterial species. The retrospective analysis of 
contigs from that study conducted by ourselves showed that the φHSC05 contig was 
91.73% identical by its nucleotide sequence to p-crAssphage. The artificial bacterial 
community, among others, included: Bacteroides thetaiotaomicron (2 strains), B. 
caccae, B. ovatus, B. vulgatus, B. cellulosilyticus and B. uniformis. We suggest that 
one of these strains is more likely to have served as a host for this crAss-like phage 
propagation than the remaining eight strains of Gram-positive anaerobic bacteria. 
Since crAssphage had not been described at the time the article was published, this 
very interesting observation obviously could not have been made at that time. 
Recently, a crAss-like phage infecting B. intestinalis has been isolated in axenic 
culture (Shkoporov et al., 2018), allowing a preliminary investigation of its host range, 
replication strategy, virion morphology, and potential ecological impact on the human 
gastrointestinal microbiota. 
With more divergent sequences, we could assume that different members of the 
Bacteroides genus, or even Bacteroidetes phylum for example, may serve as hosts for 
different crAss-like phages. One host that has been hypothesised for prototypical 
crAss-like phages is B. dorei (Cinek et al., 2017). This was inferred following the 
analysis of a dataset generated from infants and toddlers with islet autoimmunity. It 
was shown that crAssphage was only present when B. dorei also was detected within 
the samples. This was not true for other Bacteroides members tested, including B. 
vulgatus which is highly related to B. dorei. This correlation is compelling; however, 
it should be noted that there was no confirmation that crAssphage has any role in 
causing bacteriome alterations that lead to islet autoimmunity. Interestingly, one of the 
key Bacteroides species detected from our faecal fermentation 16S rRNA analysis was 
152 
 
B. dorei. Although our results cannot confirm this as a possible host of a crAss-like 
phage, this phage-host pair as well as the Bacteroides discussed above merit further 
investigation. 
CrAss-like phages have also been defined as a part of the core human gut 
phageome (Manrique et al., 2016). This emphasises the importance of identifying 
hosts for diverse crAss-like phages belonging to different candidate genera proposed 
in this study. The ability to propagate crAss-like phages in vitro will prove a key step 
in gaining an insight into their biological significance including the possible role they 
play in shaping the bacterial composition of the human gut microbiome. This could be 
in a positive or negative manner, in the context of various disease states, such as 
inflammatory bowel disease, cancer, and obesity among others. Thus far, only a few 
studies have attempted to correlate crAss-like phages with a gastrointestinal disorder 
(Cinek et al., 2017; Liang et al., 2016; Norman et al., 2015). 
In conclusion, our results expand the repertoire of known crAss-like phages 
significantly, providing a path towards the identification of further crAss-like phages 
and their hosts. This will lead to a better understanding of their role, if any, in human 
health and disease. Our work also provides an interesting insight into the diversity of 
these human gut-associated phages in various populations. In addition, we also 
demonstrate that these enigmatic phages can be efficiently propagated in vitro in a 
mixed culture as well as providing the first TEMs of crAss-like phages, giving an 
insight into their morphology. CrAss-like phages appear to be universally present in 
human populations, including those with various disease states. Due to the specificity 
of phage-host interactions, the diversity of crAss-like phages suggests they infect 
multiple diverse bacteria of the human gastrointestinal microbiota. However, more 
studies will be required to determine the biological significance and role of crAss-like 
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phages in the human gut and determine if its presence positively or negatively impacts 
















Figure 1. Determination of crAssphage candidate subfamilies and genera based on the 
percentage of shared protein-encoding genes. (Upper) The 4 red lines cut the 
hierarchical clustering dendrogram of crAss-like phage contigs into the 4 proposed 
candidate subfamilies of crAss-like phages. The histogram insert (top-right) represents 
the calculated optimal number of crAss-like phage clusters. The 10 optimal crAss-like 
phage clusters represent the putative candidate genera and are assigned specific 
colours. (Lower) Heatmap showing the percentage of shared protein-coding genes 
between crAss-like phage genomes. CrAss-like phages with 20-40% shared protein 
encoding genes are considered related at the subfamily level while phages with >40% 
similarity are believed to be related at the genus level, consistent with the calculated 

























Figure 2. Two-dimensional ordination of crAss-like phages based on the abundance 
of their protein-encoded orthologous sequences was performed using t-SNE machine 
learning algorithm. (A) CrAss-like phages are coloured by candidate genus 
annotations and shape is determined by the health status of individuals carrying these 
crAss-like phages. (B) CrAss-like phages are coloured by the percentage G+C mol% 
nucleotide composition of their contig, while shape represents complete (circular) or 
partial (linear) genomes. (C) Ellipses highlighting the distribution of complete 
(circular) or near-complete (linear) crAss-like phage genomes. (D) Ellipses grouping 
the health status associated with the individual donating faecal samples which yielded 
crAss-like phage contigs. (E) Ellipses highlighting the geographical location of 



















Figure 3. Whole genome comparisons of crAss-like phages from the proposed 10 
candidate genera (including 10 complete circular genomes representative of each 
genus). Partial genomes of Fferm_ms_2 and Fferm_ms_6 of subject ID 924, which 
are prevalent during the in vitro characterisations of crAss-like phages, highlight the 
inter- and intra-relatedness of the different crAss-like genera. Circular genome maps 
were permuted in order to standardize for starting coordinate and gene order (gene 
product [gp] numbers indicate the first and the last gene on a map left to right). Protein 
coding sequences (CDS, arrows) are coloured by putative HHpred-predicted function. 
Numbers inside CDS arrows indicate gp numbers (see Table S3 for detailed 









Figure 4. Relative abundance of the ten candidate genera of crAss-like phages in six 
different human cohorts based on the fraction of metagenomic reads aligned. Bars 
represent median relative abundances, while values within boxes represent percentage 











Figure 5. Analysis of crAss-like phage dynamics in a faecal fermenter. (A) Evidence 
of a Candidate Genus I crAss-like phage propagation following in vitro fermentations 
(standard error, n=3). The level of propagation was determined by qPCR analysis of 
viral-enriched DNA, respectively, using primers specific to a segment of the p-
crAssphage DNA polymerase gene. (B) Six additional crAss-like phages, that group 
into five of the candidate genera, were identified following sequencing of the same 
viral-enriched DNA from the fermenter. The relative abundance of each of these 
crAss-like phages is skewed due to the biased amplification of other components of 







Figure 6. CrAss-like phage morphology was examined using a CsCl fraction purified 
from a crAss-like phage rich faecal filtrate of donor subject ID 924. (A) Analysis of 
the fraction through transmission electron microscopy (TEM) was performed, and is 
largely dominated by podoviruses (53%), microviruses (29%), siphoviruses (15%), 
and other phage morphologies (3%). (B) Further examination of the observed 
podovirus virions identifies two variants with differing tail morphologies, highlighted 
in panel (A) with a pink and orange arrow, respectively. Both variants having head 
diameters of ~76.5 nm. (C) Sequencing of the CsCl purified viral fraction, without 
multiple displacement amplification, showed that approximately 40% the reads 
aligned to crAss-like phages. (D) SDS-PAGE gel of the CsCl fraction, highlighting six 
bands which were excised and analysed by mass spectrometry. The major capsid 
protein of crAss-like phage Fferm_ms_2 was detected from the ~55 kDa band (the 









Figure S1. Work-flow overview for the detection of crAss-like phage 
contigs/genomes, related to Figure 1 and Star Methods sections ‘Metagenomic 
datasets and contig assemblies’ and ‘Detection and curation of crAss-like phages’. 
All contigs were extracted from human faecal associated samples. Two of the 244 















Figure S2. Phylogeny of the (A) MCP, (B) primase, (C) terminase and (D) portal 
proteins of crAss-like phages, related to Figure 3. Leaves of the phylogenetic NJ-tree 
represent the different candidate genera. The Alpha-, Beta-, Gamma- and 
Deltacrassvirinae subfamilies (α, β, γ, and δ) are grouped by ellipses (grey). 





















Figure S3. Prevalence of crAss-like phages in human faecal viromes, related to Figure 
2 and Figure 4. (A) Relative abundance of total crAss-like phage in several cohorts 
differing in age, health status and country of origin, based on the fraction of 
metagenomic reads aligned. Bars represent median relative abundances, while the 
values within boxes represent percentage of positive samples. (B) Relative abundance 
of total crAss-like phage metagenomic reads across cohorts varying by age, health 
status and country of origin, with reads grouped by the proposed crAss-like candidate 






















Figure S4. The relative abundance of 16S rRNA throughout the crAssphage-rich 
frozen standard inoculum initiated faecal fermentation, related to Figure 5. (A) The 
relative abundance of the major genera detected throughout the fermentation. 
Bacteroides (*), the genus hypothesised to be associated with p-crAssphage, can be 
seen to decrease between time points 0 and 4 of the fermentation after which levels 
gradually begin to increase again. (B) The relative abundance of total Bacteroides at 









Figure S5. Quantitative PCR analysis of crAssphage rich filtrates, related to Figure 6. 
Filtrates were obtained with different pore sizes from a crAssphage-rich faecal sample 














Figure S6. Comparison of 16S rRNA Prevotella abundances, related to Figure 4. 













Tables S1 -S4: 
Table S1. Studies Examined for the Presence of crAss-like Phages, Related to STAR 
Methods Section “Metagenomic Datasets and Contig Assemblies”. 
Table S2. Characteristics of crAss-like Contigs Assembled in This Study, Related to 
STAR Methods Section “Detection and Curation of crAss-like Phages”. 
Table S3. Annotation of crAss-like Phage Candidate Genus Representative Sequences, 
Related to Figure 3. 
Table S4. Core Proteome of crAss-like Phage Family, Related to STAR Methods 
Section “Genomic Comparisons of crAss-like Phage” and Figure S2. 
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Isolation and characterization of a Bacteroides xylanisolvens 
infecting crAss-like phage from the human gut, ΦcrAss002 
 

















Bacteriophages are a major component of the human gut microbiome. 
However, we know little about the role and composition of these diverse biological 
entities. The gut phageome comprises a complex phage community of thousands of 
individual strains, with a few highly abundant bacteriophages. CrAss-like phages, 
which infect bacteria of the order Bacteroidales, are the most abundant bacteriophage 
family in the human gut and make an important contribution to an individual’s core 
virome. Based on metagenomic data, crAss-like phages form a family, with four sub-
families and ten candidate genera. To date, only three representatives have been 
reported to have been isolated in culture; ΦcrAss001 and two closely related phages 
DAC15 and DAC17; all are members of the less abundant genus VI. The persistence 
at high levels of both crAss-like phage and their Bacteroidales hosts in the human gut 
has not been explained mechanistically and this phage-host relationship can only be 
properly studied with isolated phage-host pairs from as many genera as possible. 
Faeces from a healthy donor with high levels of crAss-like phage was used to 
initiate a faecal fermentation in a chemostat, with selected antibiotics chosen to inhibit 
rapidly growing bacteria and selectively enrich for Gram-negative Bacteroidales. This 
had the objective of promoting the simultaneous expansion of crAss-like phages on 
their native hosts. The levels of seven different crAss-like phages expanded during the 
fermentation, indicating that their hosts were also present in the fermenter.  The 
enriched supernatant was then tested against individual Bacteroidales strains isolated 
from the same faecal sample. This resulted in the isolation of a previously 
uncharacterised crAss-like phage of genus IV of the Alphacrassvirinae sub-family, 
ΦcrAss002, that infects the gut commensal Bacteroides xylanisolvens. ΦcrAss002 
does not form plaques or spots on lawns of sensitive cells, nor does it lyse liquid 
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cultures, even at high titres. In keeping with the co-abundance of phage and host in 
the human gut, ΦcrAss002 and Bacteroides xylanisolvens can also co-exist at high 
levels when co-cultured in laboratory media.  
We report the isolation and characterisation of ΦcrAss002, the first 
representative of the Alphacrassvirinae of the highly abundant crAss-like phage 
family. ΦcrAss002 cannot form plaques or spots on bacterial lawns but can co-exist 
with its’ host, Bacteroides xylanisolvens, at very high levels in liquid culture without 




















It is over a century since the discovery of bacteriophages (phages), viruses 
capable of infecting bacterial cells (Twort, 1915; d’Hérelle, 1917). Phages are almost 
certainly the most abundant biological entities on Earth with an estimated total count 
of 1031 virions in the biosphere, potentially outnumbering their bacterial hosts by a 
factor of 10 (Breitbart and Rohwer, 2005; Dion et al., 2020) . In recent years, interest 
in phage communities residing in the human gut (the gut phageome) has greatly 
increased due to the growing awareness of the role of gut microbiome in human health 
and a resurgence in interest in phage therapy (Shkoporov and Hill, 2019; Shkoporov 
et al., 2019). Recent, reports also suggest that the human gut phageome may play a 
role in human health and disease (Reyes et al., 2015; Norman et al., 2015; Monaco et 
al., 2016; Manrique et al., 2017; Zhao et al., 2017; Carding et al., 2017; Kieser et al., 
2018; Ma et al., 2018; Clooney et al., 2019). 
The viral (which is overwhelmingly phage) fraction of the human gut 
microbiome remains its most elusive component (Mirzaei and Maurice, 2017; Reyes 
et al., 2010). In human faeces, the viral load has been estimated at only 109 - 1010 virus-
like particles (VLPs) g-1, meaning that unlike in other environments where phage 
dominate, phage in the human gut are outnumbered by their bacterial hosts (Shkoporov 
and Hill, 2019). Advances in sequencing technology have allowed us to generate vast 
numbers of viral sequences, but the majority are poorly annotated and unclassified 
taxonomically due to the lack of homology with known viruses in current databases. 
These sequences have been termed viral “dark matter” and can constitute up to 90% 
of total virome reads (Aggarwala et al., 2017). Perhaps the best example are the crAss-
like phages, the most abundant phages in the human gut, but no representative had 
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ever been cultured and it was only identified by a database-independent approach in 
2014 (Dutilh et al., 2014). 
The prototypical crAssphage (p-crAssphage) is a 97 kb dsDNA phage of the 
Caudovirales order that was detected through cross-assembly (using crAss software) 
of human gut viral reads from metagenomic data. Intriguingly, this phage shared no 
homology with any other virus in databases at the time of its discovery, despite its 
extraordinary abundance (up to 90% of all phages in some individuals) (Dutilh et al., 
2014). Protein sequence-based analysis of the prototypical crAssphage (p-
crAssphage) demonstrated that this phage is the founder member of a family-level 
group of ‘crAss-like phages’ and was predicted to have a podovirus-like morphology 
(Yutin et al., 2018). We have proposed a taxonomic system for crAss-like phages from 
the human gut with four subfamilies (Alpha-, Beta-, Gamma- and Deltacrassvirinae) 
and ten candidate genera (I-X), with p-crAssphage belonging to genus I of the 
Alphacrassvirinae. We then confirmed the predicted podovirus-like morphology by 
transmission electron microscopy of a crAss-like phage rich faecal filtrate and 
followed this with the isolation in culture of the first representative member of the 
family, ΦcrAss001 (genus VI, subfamily Betacrassvirinae) (Guerin et al., 2018; 
Shkoporov et al., 2018a). 
Although crAss-like phages are largely gut associated, they have also been 
detected in other diverse samples such as animal litter, surface/ground water and 
termite gut (Stachler et al., 2017; Yutin et al., 2018). In humans, the relative abundance 
of this phage family in the gut can be as high as 90% of the total viral load in some 
individuals. The geographical spread of this phage family has also been confirmed 
with p-crAssphage for example, being largely absent from hunter-gatherer gut 
populations compared to industrialized populations (Cinek et al., 2018; Edwards et al., 
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2019; Guerin et al., 2018; Honap et al., 2020). This may be due to differences in dietary 
habits and bacteriome compositions. Our recent  results showed that 77% of healthy 
Western adults carry one or more representatives of this phage family, although at 
widely variable abundances (Guerin et al., 2018). Despite the fact that hundreds of of 
crAss-like phages genomes have been identified in silico, their bacterial hosts remain 
to be determined (Dutilh et al., 2014; Oude Munnink et al., 2014). The host phylum 
was hypothesised to be member of the phylum Bacteroidetes through co-abundance 
analysis, the presence of BACON-domain-containing proteins which are very 
characteristic of this phylum and partial matches in CRISPR-spacer sequences (Dutilh 
et al., 2014). ΦcrAss001 that infects Bacteroides intestinalis, became the first crAss-
like phage to be isolated in pure culture in 2018 (Shkoporov et al., 2018a).  
Here we present the isolation and characterisation of ΦcrAss002, that infects 
the gut commensal Bacteroides xylanisolvens. This is the first member from genus IV 
as well as the sub-family Alphacrassvirinae to be isolated. Initial attempts to isolate 
crAss-like phages using traditional methods, such as screening of crAss-rich faecal 
samples using plaque or spot assays, proved unsuccessful. ΦcrAss002 was isolated 
following ex vivo enrichment in a faecal fermentation using antibiotics to selectively 
promote the growth of Bacteroidales, followed by liquid culturing, metagenomic 
sequencing, in silico analyses and quantitative real-time PCR. Biological 
characterisation of ΦcrAss002 confirmed that this phage shares multiple traits with 







3.3 Experimental Procedure 
3.3.1 Donor recruitment and sample collection 
 A healthy female donor in her forties, denoted as subject ID: 924, was recruited 
for faecal sample donation in October 2017. The individual was previously identified 
as being a persistent carrier of crAss-like phages over a period of two years (Guerin et 
al., 2018; Shkoporov et al., 2019). Therefore, this subject was deemed as a donor of 
interest for the isolation of potential novel crAss-like phages in vitro. Sample 
collection was in accordance with the study protocol APC055 and ethics approved by 
Cork Research Ethics Committee. 
 
3.3.2 Faecal fermentation 
 On receipt, the sample was processed into frozen standard inoculum (FSI). 
This was done as described by (O’Donnell et al., 2016) with modifications as 
previously outlined (Guerin et al., 2018). Triplicate fermentations were run in batch 
format over 24 hours with conditions applied as by Guerin et al., (Guerin et al., 2018). 
Two fermenter vessels were set up in parallel, one with and one without the addition 
of antibiotics to the YCFA-GSCM broth post-autoclaving. Added antibiotics included 
7.5 μg/ml vancomycin and 100 μg/ml kanamycin. The former was chosen based on its  
ability to suppress a broad range of Gram-positive bacteria (Wilhelm, 1991) and the 
latter to limit faster growing facultative anaerobes. Samples were collected at 0, 4.5, 
17.5, 21 and 24 hours were directly processed after collection through centrifugation 
at 4,700 rpm for 10 minutes at +4°C. Following this, supernatants were passed through 
a 0.45μM pore polyethersulfone (PES) membrane filter and the resulting filtrates were 
stored at +4°C. The remaining bacterial rich pellets were stored at -80°C. 
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3.3.3 Extraction of viral nucleic acids and virome library preparation 
 VLPs were enriched and viral nucleic acids extracted from 10 ml of filtered 
fermentation supernatants using the protocol as previously described (Shkoporov et 
al., 2018b). One microlitre of the DNA was subjected to multiple displacement 
amplification (MDA) using Illustra GenomiPhi V2 kit (GE Healthcare) according to 
manufacturer’s instructions. This was performed in triplicate for each sample. Further 
steps were performed as described previously (Shkoporov et al., 2019). The prepared 
libraries were then sequenced on an Illumina HiSeq 4000 platform with 2 x 150 nt 
paired-end chemistry at GATC Biotech AG, Germany. 
The quality of the raw paired-end reads was analysed using FastQC v0.11.5. 
Trimming and filtered of the reads was performed with Trimmomatic v0.36. (Bolger 
et al., 2014). Parameters implemented were as follows: minimum length of 60, a 
sliding window size of 4 and a minimum Phread score of 33. The trimmed and filtered 
reads were then assembled into contigs using metaSPAdes v3.13.1 (Nurk et al., 2017). 
Contigs that correspond to crAss-like phages were then identified using BLASTn 
v2.2.28+ against a database of 249 crAss-like phages (Altschul et al., 1997; Guerin et 
al., 2018). A read count table was generated using Bowtie2 v2.3.0 (Langmead and 
Salzberg, 2012) and Samtools v0.1.19 to determine the relative abundance reads that 
resolve into crAss-like phage family genera. Virome diversity metrics for the 








3.3.4 Total DNA extraction and 16S rRNA gene sequencing library preparation  
 Total DNA was extracted from faecal pellets collected from centrifugation of 
fermentation samples. Extractions were performed using the QIAamp Fast Stool Mini 
Kit (Qiagen, Hilden, Germany). Approximately 200mg of each pellet was weighed 
into a 2ml screw-cap tube containing a combination of glass beads varying in size – 
one 3.5mm glass bead, ~200 μl pf 1m zirconium beads and ~200 μl of 0.1 mm (Thistle 
Scientific). Proceeding extraction and library preparation steps were performed as 
described by Shkoporov and colleagues (Shkoporov et al., 2018b) 
 The quality of the reads was analysed using FastQC v0.11.5. Initial quality 
filtering was performed with Trimmomatic v0.36. The filtered reads were imported 
into R v3.4.3 and were analysed for errors using DADA2 package (v1.6.0) (Callahan 
et al., 2016). Identified errors were corrected via further quality filtering and trimming 
resulting in unique Ribosomal Sequence Variants (RSVs). The RSVs were subjected 
to chimera filtering using USEARCH v8.1 with the ChimeraSlayer gold database 
v20110519. The remaining RSVs were classified using RDP database v11.4 via the 
RDP-classifier in mothur v1.34.4 (Schloss et al., 2009). Species assignment was also 
performed using SPINGO (Allard et al., 2015). The resultant RSVs were further 
analysed. This data was then used to determine the relative abundance of bacterial 
orders within the antibiotic and non-antibiotic containing vessels, which was 
visualised using the R package ggplot2 v2.2.1. The 16S diversity metrices for the 
antibiotic versus non-antibiotic containing vessels were also calculated using R 






3.3.5 Absolute composition and quantitative real-time PCR  
 The absolute composition of detected crAss-like phages strains throughout the 
fermentations was determined using quantitative real-time PCR (qPCR) with the 
standard curve method. Primers were designed to target a consensus region of the 
terminase gene for each genus detected in the fermenter. Where possible, genus 
specific primers were designed based on terminase gene alignments as annotated by 
Guerin and colleagues (Guerin et al., 2018). Due to the heterogeneity of candidate 
genus VI and the genetic code variations observed for candidate genus VII crAss-like 
phages, primers were designed with phage specificity. Primer sequences are listed in 
(Table 1). PCR products generated from these primers were cloned into pCR2.1-
TOPO TA vector (Thermo Fisher Scientific) to develop standards. Extracted plasmids 
were quantified using Qubit dsDNA BR Assay kit and diluted to 109 copies/μl based 
on molar mass of DNA. Ten-fold serial dilutions of the plasmids were used to build a 
standard calibration curve. Absolute quantification qPCR was performed with a 15 μl 
reaction volume using SensiFAST SYBR No-ROX mastermix (Bioline) in a 
LightCycler 480 thermocycler with the following conditions: initial denaturation at 
95°C for 5 minutes, then 45 cycles of 95°C for 20 seconds, 60°C for 20 seconds and 
72°C for 20 seconds. Resulting Ct-values were converted to copies/ml based on the 
generated calibration curves. Results were visualised using GraphPad Prism v8.0 
software. 
 
3.3.6 Screening for novel crAss-like phages from faecal fermentates 
 Bacteroidales were enriched for from the FSI preparation. Ten-fold serial 
dilutions of the FSI were prepared in fresh Fastidious Anaerobe Broth (FAB, Neogen) 
and 100 µl of each was spread plated on Fastidious Anaerobe Agar (FAA, Neogen), 
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YCFA-Agar, and Columbia Blood Agar (Oxoid) with 5% sheep blood supplemented 
with 25 μg/ml haemin and 100 μg/ml vitamin K. To each of these media 7.5 μg/ml 
vancomycin and 100 μg/ml kanamycin was added post autoclaving. The dilution 
plates were anaerobically incubated at 37°C for 48 hours and formed colonies were 
restreaked. Approximate species identification was performed by Sanger sequencing 
of the 16S rRNA region using the universal bacterial primers 1492R 5′-
GGTTACCTTGTTACGACTT-3′′ (Reysenbach et al., 2000) and Bact 8 F 5′-
AGAGTTTGATCCTGGCTCAG-3′ (Edwards et al., 1989). Samples were prepared 
as per the instruction for LightRun Tube service (GATC) analysed via BLASTn 
against the NCBI 16S ribosomal RNA sequences (Bacteria and Archaea) database. 
Phage-bacterium host pair screening was performed in biological triplicate by 
co-culturing. Overnight cultures were prepared from the purified Bacteroidales strains. 
Ten microlitres was sub-cultured into 400 μl of fresh FAB, with cofactors MgSO4 and 
CaCl2 at a final concentration of 1 mM, contained within deep well plates (Sigma-
Aldrich). The cultures were incubated anaerobically at 37°C until early logarithmic 
phase of growth. An OD600 = ~0.2 was measured approximately five hours post sub-
culturing. To the early log phase cultures, 100 μl of crAss-like phage rich fermentate 
filtered of bacterial cells was added and incubated anaerobically at 37°C for 24 hours. 
Without centrifugation or filtering, 10 μl of the phage-bacteria mix was directly sub-
cultured (1:50) into fresh FAB. Sub-culturing was repeated over three consecutive 
days. Total DNA was extracted using DNeasy Blood & Tissue Kit (Qiagen) and 
analysed for phage propagation on a specific host by qPCR analysis (Table 1).     
The detected phage-host pair, ΦcrAss002 and B. xylanisolvens APCS1/XY, 
was enriched using the above co-culturing method in 10 ml volumes. Following five 
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rounds of enrichment, viral nucleic acids were extracted from phage lysates using the 
protocol as described by (Shkoporov et al., 2018a). Library preparation for shotgun 
sequences was performed using the Accel-NGS 1S Plus DNA Library Kit (Swift 
Biosciences) according to the manufacturer’s protocol. After index PCR an additional 
bead clean-up was performed using a ratio of 1:1 DNA/AMPure beads. Sequencing 
was performed using a 2 x 150 nt paired end run on an Illumina HiSeq 4000 platform 
at GATC Biotech AG, Germany. 
 
3.3.7 Transmission electron microscopy  
Ultra-centrifugation was performed using a 60 ml volume of ΦcrAss002 
filtrate. The supernatant was concentrated for a total of 4 hours at 120,000g using a 
F65L-6x13.5 rotor (Thermo Scientific). The resulting pellets were resuspended in a 
final volume of 5ml SM buffer. The suspensions were then applied onto to a step 
gradient of 5M and 3M CsCl solutions, followed by centrifugation at 105,000g for 2.5 
hours at +4°C. The CsCl clean-up steps following this were previously described 
(Guerin et al., 2018). 
 Five microlitre aliquots of the concentrated viral fraction were applied to 
Formvar/Carbon 200 Mesh, Cu grids (Electron Microscopy Sciences), with 
subsequent removal of excess sample by blotting. Grids were then negatively 
contrasted with 0.5% (w/v) uranyl acetate and examined at UCD Conway Imaging 
Core Facility (University College Dublin, Ireland) by Tecnai G2 12 BioTWIN 




3.3.8 Shotgun sequencing of B. xylanisolvens APCS1/XY using Illumina and 
Oxford Nanopore platforms 
Genomic DNA was extracted from 10 ml of B. xylanisolvens APCS1/XY 
overnight culture using phenol/chloroform extraction with precipitation in 3M sodium 
acetate and cold absolute ethanol. Cultures were centrifuged at 5,000 g for 10 minutes 
and pellets were resuspended in 1 ml deionised water. The protocol was then 
performed as described by Sambrook et al. with the modifications implemented by 
Bardina et al (Bardina et al., 2016; Sambrook et al., 1989). Following precipitation, 
the DNA was resuspended in 50 μl Tris-EDTA buffer and incubated at 37°C to aid 
resuspension. 
A long read Oxford Nanopore library preparation was performed as described 
per the user manual for Rapid Barcoding Sequencing Kit (SQK-RPK004; Oxford 
Nanopore Technologies) with the following modifications: 800ng of each sample was 
used and final pellet resuspension was carried out using 20μl of nuclease-free water 
pre-warmed to 65°C followed by a 10 minute incubation at room temperature. Pooled 
samples were loaded into SpotON Flow Cell (Oxford Nanopore Technologies) and 
MinION sequenced for 48 hours (Oxford Nanopore Technologies). Short-read 
shotgun sequencing of the extracted DNA was performed as described above using 
Accel-NGS 1S Plus DNA Library Kit and Illumina HiSeq 4000 technology. Hybrid 
assembly of quality-filtered and trimmed Illumina and raw Nanopore reads was 
performed using SPAdes (v1.13.1) (Nurk et al., 2013; Antipov et al., 2016) to generate 
3 circular scaffolds with a sequencing depth of 43.0x,  corresponding to B. 
xylanisolvens APCS1/XY chromosome (6.4 Mbp) and two plasmids (5.6 and 4.1 kbp). 
The assembled and circularised scaffolds were annotated using to NCBI Prokaryotic 
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Genome Annotation Pipeline (PGAP). The GenBank file for the genome was 
visualised using GView (v1.7) (Petkau et al., 2010). 
Dynamic local recombination hotspots in the B. xylanisolvens APCS1/XY 
chromosome were detected by aligning Oxford Nanopore reads to the assembled 
scaffolds. Alignment was performed using BLASTn and only reads with length >1000 
nt were considered (n = 155,425). Individual local alignments of >90% identity and 
>200nt length were kept. All internal inversions or shifts in alignment coordinates 
versus reference genomic scaffold >200 nt were deemed as recombinations. 
Recombination hotspots were identified when >8 reads with inconsistent alignment 
were present per 1000bp window of genome length. 
 
3.3.9 In silico characterisation of ΦcrAss002 
Annotation of ΦcrAss002 genome was performed using the de novo viral 
genome annotator VIGA (González-Tortuero et al., 2018). The predicted protein 
coding sequences were further analysed with HHPred using the following databases: 
PDB_mm_CIF70_28_Dec, Pfam-A_v31.0, NCBI_CD_v3.16, TIGRFAMs_v15.0 
(Zimmermann et al., 2017). A genomic map of the ΦcrAss002 genome was then 
generated using GView (v1.7). To examine the DNA termini and packing mechanism 
employed by ΦcrAss002, the command line version of Phage Term v1.0.12 was used 
(Garneau et al., 2017). 
The ΦcrAss002 genome was examined against other crAss-like phages of candidate 
genus IV using BLASTn to examine relatedness (Guerin et al., 2018) . Average 
nucleotide identity (ANI) was determined using the default settings in PYANI 
(Leighton Pritchard et al., 2017). The output was exported into R environment to 
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generate a heatmap with Bioconducter Complex Heatmap (v1.20.0) and Circilize 
(v0.4.5) packages (Gentleman et al., 2004; Gu et al., 2014). A pairwise comparison of 
the genomes was performed to examine synteny using tBLASTx in Easyfig (v2.2.2) 
with a minimum alignment length of 50bp and 30 percent identity. Genome 
comparison were also performed investigate the synteny of ΦcrAss002 in comparison 
to ΦcrAss001 (GenBank MH675552.1). and p-crAssphage (GenBank NC_024711.1). 
 
3.3.10 Biological characterisation of ΦcrAss002 
Plaque assays were performed using 10-fold serial dilutions of ΦcrAss002 
lysate prepared in SM buffer with an overlay of 0.3% FAA agar (0.3% agar w/v), 
containing MgSO4 and CaCl2 at a final concentration of 1 mM. To 3 ml of molten 
overlay, 300 µl B. xylanisolvens APCS1/XY overnight culture was added and 50 µl of 
phage dilution. This mixture was vortexed and poured onto pre-prepared FAA base 
agar (1.5% agar w/v). Plates were incubated anaerobically at 37°C. Plaque formation 
was checked at 24 and 48 hours. Spot assays were performed as described for plaque 
assays but without addition of phage to the molten overlay agar. A 10µl drop of phage 
was directly applied to the solidified lawn of B. xylanisolvens APCS1/XY and dried 
prior to incubation. 
 Attempts to generate a one-step growth curve were performed by infecting an 
early logarithmic phase culture of B. xylanisolvens APCS1/XY with ΦcrAss002 at a 
multiplicity of infection (MOI) of 1. Following incubation at room temperature for 5 
mins, centrifugation was performed at 5000 rpm in a swing bucket rotor for 15 minutes 
at 20°C. The supernatant was removed, and the resultant pellet was resuspended with 
FAB. Anaerobic conditions were maintained at 37°C for 3 hours with 1 ml sample 
collection every 15 mins. Samples were centrifuged and filtered through 0.45 µM pore 
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syringe filters. Analysis was performed using qPCR as described above using 
CGIV_Fwd and CGIV_Rev primers (Table 1). 
The ability of ΦcrAss002 to infect another commercially available B. 
xylanisolvens strain, DSM 18836 (DSMZ), and the ΦcrAss001 host, B. intestinalis 
919/174, was examined by co-culture and the standard propagation method of 
centrifuging and filtering phage lysate between propagations and re-exposure to the 
host. Efficiency of lysogeny was performed using 100 µl of ΦcrAss002 at ~109 pfu/ml 
spread plated on FAA agar plates. One hundred microlitres of 10-fold serially diluted 
B. xylanisolvens APCS1/XY overnight culture was added to 3ml of molten 0.3% FAA 
soft agar with co-factors and was poured onto the phage seeded plates. Negative 
controls were prepared in the same manner but without the addition of phage to the 
plate. The plates were incubated anaerobically at 37°C for 48 hours. Efficiency of 
lysogeny was calculated as the percentage of colonies on the phage seeded plate versus 
counts for the equivalent negative control. Thirty resistant colonies were restreaked 
three times. Standard PCR was performed using ΦcrAss002 specific primers to test 
for potential lysogens. 
 
3.3.11 Co-cultivation of ΦcrAss002 and Bacteroides xylanisolvens APCS1/XY 
Co-cultivation of ΦcrAss002 and B. xylanisolvens APCS1/XY was performed 
to examine propagation dynamics over time in vitro via serial sub-culturing of phage 
and host. This was initiated using 10 ml of culture (OD600 = ~0.2) prepared from naïve 
B. xylanisolvens cells i.e. ~10 generations without exposure to ΦcrAss002 and 1ml of 
phage lysate at ~109 pfu/ml. Subsequent rounds of sub-culturing were performed by 
introducing the prior co-culture into fresh FAB at a ratio of 1:50. This was repeated 
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over 11 days and ΦcrAss002 titre quantification was performed via qPCR. The phage 
lysate generated from the final time point was then used to initiate another round of 
serial co-cultivation over 30 days. Having observed a propagation pattern, a third 
round of experimentation was initiated over 6 days. On day six, the co-culture was 
centrifuged for 15 mins at 5000 rpm in a swing bucket rotor at 4°C. The supernatant 
was filtered through 0.45 µM pore syringe filters. The resultant pellet was retained 
and t-streaked for three generations to purify the bacteria of phage. The absence of 
adsorbed or integrated ΦcrAss002 was confirmed via qPCR. Ten B. xylanisolvens 
colonies, that were recently exposed to ΦcrAss002 but were free of any remaining 
phage, were used to initiate a final cycle of co-cultivation. Absolute quantification of 
ΦcrAss002 titre was performed via qPCR (Table 1). Significant differences between 
the ΦcrAss002 titres sustained by the cultures was evaluated using one-way ANOVA 
followed by Tukey’s post hoc comparisons. Spot assays of ΦcrAss002 were performed 
with each of the clones to test for resistance or changes in spot opacity. 
 
3.3.12 Examination of ΦcrAss001 and ΦcrAss002 dynamics in a fermenter 
system with a defined bacterial consortium 
An unusual phage-host equilibrium has been observed both of the crAss-like 
phages isolated to date. The was further examined in a fermenter system with a defined 
community of commensal bacteria.  This defined community was compiled of six 
bacteria in addition to B. xylanisolvens APCS1/XY and B. intestinalis 919/174: E. coli 
LF82, E. faecalis OG1RF, Ruminococcus gnavus ATCC 29149, Faecalibacterium 
prausnitzii A2-165, Lactobacillus plantarum WCFS1, and Bifidobacterium longum 
subsp. longum ATCC 15707. Collectively these human gut derived bacteria are 
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referred to as a simplified human consortium (SIHUMI) (Eun et al., 2014). Our 
community excluded Bacteroides vulgatus ATCC 8482 to avoid issues with 
discrimination between the Bacteroides phage hosts. 
 Fermentations were performed in batch format for the first 24 hours to allow 
establishment of the bacterial community. Overnight cultures were grown to ~109 
cfu/ml and combined at a ratio of 1:1. The fermenter vessels, containing 200 ml of 
YCFA-GSCM broth, were then inoculated with 1ml of this mixture. After 24 hours 10 
ml of ΦcrAss001 (~109 pfu/ml) and 10 ml of ΦcrAss002 (~108 pfu/ml) were inoculated 
into one vessel. The other remained without phage in parallel to act as a control. For 
4 days, a continuous fermentation was performed with 400 ml of media exchanged in 
every 24 hours with equivalent waste removal. Samples were collected at the 
following time points: 0,6, 24, 48, and 72 hours post-phage inoculation and were 
frozen directly at -80oC. Fermentation runs were performed in triplicate using aliquots 
from the same phage lysate. Total DNA was extracted using the QIAamp Fast Stool 
Mini Kit (Qiagen, Hilden, Germany). All DNA samples were normalised prior to 
analyses by diluting to 5 ng/µl. Bacterial primers were designed targeting unique genes 
(Table 2) and were used to develop qPCR standards with the method described 
previously. Primers specific to the portal protein were used in ФcrAss001 qPCR 
analyses (Shkoporov et al., 2018a). Conditions for qPCR were as follows: initial 
denaturation at 95°C for 5 minutes, then 45 cycles of 95°C for 20 seconds, 62°C for 
20 seconds and 72°C for 20 seconds. For bacterial analyses an annealing temperature 
of 62°C was used and when analysing both phages, 60°C. Results were visualised 





3.4.1 Schematic overview of workflow  
 A faecal fermentation was initiated was initiated using faeces from an 
individual (subject ID 924) identified as a persistent carrier of multiple crAss-like 
phages. The fermentation was performed under anaerobic conditions with vancomycin 
and kanamycin added in an attempt to suppress the growth of Gram-positive and 
facultative anaerobic bacteria and favour the growth of strictly anaerobic Gram-
negative Bacteroidales order bacteria (Figure 1 depicts the workflow). 
 
3.4.2 Bacterial composition following antibiotic enrichment in faecal fermenters 
 Faecal fermentations were conducted in the presence or absence of antibiotics 
designed to enrich for members of the Order Bacteroidales. 16S rRNA gene analysis 
of the bacterial composition confirmed a significant increase in the relative abundance 
of Bacteroidales in the presence of antibiotics (Figure 2A). After 4.5 hours the 
fermenter was dominated by members of this order and remained so for the remainder 
of the run. Bacteroides and Parabacteroides dominated at the genus level with the 
former representing as much as 75% of 16S rRNA gene reads, and the latter up to 15-
20% of reads. The vessels without added antibiotics were largely dominated by Gram-
positive bacterial orders. There was a rapid expansion of Erysipelotrichales after 4.5 
hours but by 17.5 hours the relative abundance of this order decreased and Clostridales 
once again became the dominant order. Diversity indices further highlight the shift in 
the overall bacterial communities under selective conditions (Figure S1A).  
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3.4.3 Enrichment of crAss-like phages  
Shotgun metagenomic sequencing data, generated from viral enriched DNA 
extracted from three separate fermentation runs for each condition, was examined for 
the presence of crAss-like phages. Assembled viral contigs were analysed against a 
database of 249 crAss-like phagesvia BLASTn v2.2.28+ (Guerin et al., 2018). This 
database includes seven crAss-like phages previously detected in donor subject ID: 
924 six months prior to donating a sample for this study (Guerin et al., 2018). Six of 
the original seven crAss-like phages could be detected but one phage (originally 
denoted as Fferm_ms_1 of candidate genus II) was no longer detectable. However, a 
previously undetected crAss-like phage of candidate genus VII was now present, 
meaning that five different crAss-like phage genera were represented in the sample. 
The relative abundance of all the crAss-like phages represented 38% of the total viral 
reads generated from VLPs. The relative abundance of each genus was calculated as 
a percentage of the reads identified as crAss-like (Figure 2B). In the presence and 
absence of antibiotics the vessels were dominated by a phage of candidate genus I (p-
crAssphage). The relative abundance of a phage of candidate genus IV was found to 
increase under the selective conditions. In line with similar alterations in the 
bacteriome, we observed a reduction in virome alpha-diversity, species richness and 
evenness when antibiotics were included in the fermenter (Figure S1B). 
 qPCR directed at the conserved terminase or primase genes was performed to 
determine an approximate titre in copies/ml of the seven crAss-like phages (Figure 
2C). Primers were either genus specific (genera I, IV, and V) or phage strain specific 
(genera IV and VII) depending on the level of  homo- or heterogeneity of the terminase 
gene sequence in each genus (or primase in the case of candidate genus VII). For each 
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candidate genus, higher phage titres were detected in the presence of antibiotics, 
although to varying extents. Candidate genus I was 6-fold higher in titre in comparison 
to the control vessel by the end of the fermentation, candidate genus IV 17-fold, 
candidate genus V 8-fold, candidate genus VI phage A 10-fold, candidate genus VI 
phage B  24-fold, candidate genus VI phage C 14-fold and candidate genus VII 5-fold 
higher. The statistical significance of the differences between the highest titres attained 
for each phage under both conditions tested was examined by a two-tailed paired t-
test. This showed that a statistically significant titre difference occurred for three of 
the phages: candidate genus IV and candidate genus VI phage B (P-value ≤ 0.001) and 
candidate genus VI phage C (P-value ≤ 0.01). 
 
3.4.4 Screening the 924 faecal sample for potential bacterial hosts 
 The same crAss-rich faecal sample was plated on antibiotic agar selective for 
Bacteroidetes and 48 colonies were chosen based on variations in colony morphology. 
Sequencing of the 16S rRNA gene fragment assigned the 48 isolates to six species: 
Bacteroides uniformis, Bacteroides ovatus, Bacteroides dorei, Bacteroides fragilis, 
Bacteroides xylanisolvens and Parabacteroides. distasonis (Table 3). The crAss-like 
phage enriched fermenter filtrate was added to a pure culture of each of the 48 strainns 
and following incubation anaerobically at 37°C genus- or phage-specific qPCR was 
used to detect increases in individual phage strains. We detected propagation of a 
crAss-like phage of candidate genus IV on B. xylanisolvens APCS1/XY following 
three consecutive days of sub-culturing. Despite the efficient propagation of the phage 
during this and subsequent enrichment, the liquid culture failed to clear. When faecal 
filtrate prepared from subject ID:924 faeces prior to fermentation was spotted onto a 
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lawn of B. xylanisolvens APCS1/XY no zone of clearing or individual plaques were 
observed. 
 
3.4.5 Genome analysis of ΦcrAss002  
Shotgun sequencing of the phage propagated in pure culture confirmed the 
isolation of a novel crAss-like phage, designated ΦcrAss002, with a circular genome 
of 93,030 bp (NCBI GenBank MN917146) (Figure 3, Table 4). ΦcrAss002 genome 
has 81 protein-coding genes in two oppositely orientated gene modules (possibly two 
transcriptional units) but less than half could be assigned a function (Additional file 4: 
Table S2). No genes for lysogeny functions were identified, and we did not detect 
integrated copies of this or related phages in bacterial genomes (NCBI RefSeq). 
Module 1 spanning 45-93kb is largely dominated by functions associated with 
replication and nucleic acid metabolism, whereas module 2 spanning 0-45kb includes 
phage structural genes, as well as those encoding lysis and packaging functions. Two 
large genes (gp32 and gp33) located at the beginning of module 1 are predicted to 
encode RNA polymerase subunits. The ΦcrAss001 genome also has large genes in a 
similar location that were assigned the same function (Shkoporov et al., 2018a). The 
G+C content of the ΦcrAss002 genome is 31.92 mol%, approximately 10 mol% lower 
than the host G+C content of 42.24 mol%.  The tail components and the receptor 
binding proteins remain to be identified, but are likely to be associated with gp11, 13-
15, and/or 17-31. The DNA packaging mechanism of ΦcrAss002 was predicted to be 
headful packaging with terminase initiation occurring at a pac site and so the packaged 
genomes are circularly permuted with redundant termini. The average nucleotide 
identity (ANI) was determined between ΦcrAss002 and twenty other phage genomes 
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of candidate genus IV (Figure 4A). The metadata associated with these phages is listed 
in (Table 5). ΦcrAss002 is the phage designated fferm_ms_10 in the original sample 
collection. There are three obvious clades with >95% nucleotide similarity, 
recommended by The International Committee on Taxonomy of Viruses (ICTV) as 
the cut-off level for species (Adriaenssens and Brister, 2017). Therefore, amongst the 
crAss-like candidate genus IV phage sequences, there are potentially four species, 
with err844056 potentially forming its own species. Genome comparison of a subset 
of these phages, with different degrees of relatedness, revealed a high degree of 
genome synteny (Figure 4B). Phages are in descending order of decreasing ANI in 
relation to ΦcrAss002. Even the most distant representative shown here, φeld18-
t3_s_1, shares a genetic organisation highly syntenic to that of ΦcrAss002. 
The genomic synteny of ΦcrAss002, φcrAss001 and p-crAssphage 
(prototypical crAssphage generated only from in silico data) were also compared 
(Figure 4C). ΦcrAss002 shares no tBLASTx homology with φcrAss001 but there is 
much greater homology and synteny between ΦcrAss002 and p-crAssphage 
(candidate genus I), which could be expected as these phages both belong the 
Alphacrassvirinae sub-family. 
 
3.4.6 Biological characterisation of ΦcrAss002 
 Transmission electron microscopy confirmed that ΦcrAss002 has a Podovirus 
morphology with a capsid diameter of 77.0 ± 2.0 nm and tails of 18.1 ± 2.3 nm. Unlike 
crAss001, the tail structure is short and has no obvious appendages (Figure 5A). 
Plaque assays and spot assays were performed using enriched cultures of ΦcrAss002.  
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Plaques failed to form despite testing several media modifications and spots with 
concentrated phage suspensions were opaque and only barely visible. The clarity of 
spots was variable between independently generated overnight cultures of B. 
xylanisolvens APCS1/XY. Furthermore, the phage only propagated if co-cultured for 
a minimum of 3-5 days. 
To examine the growth dynamics of ΦcrAss002, the phage and host were 
serially propagated via daily sub-culturing over 11 days. The phage load was 
quantified daily in copies/ml using qPCR. The phage failed to propagate between day 
1 and day 3 during which a reduction in titre of about 4 to 6 logs occurred. This is 
largely consistent with a dilution effect on the inoculum. After day 3, the titre 
increased until it stabilised at approximately 108 copies/ml from day 5 onwards (Figure 
5B). The observed stability is consistent with the persistence of crAss-like phages 
observed in human gut viromes over time (Shkoporov et al., 2019). The commercially 
available strain, B. xylanisolvens DSM18836 failed to support replication of 
ΦcrAss002, as did the ΦcrAss001 host, B. intestinalis 919/174 (Figure 5C). When B. 
xylanisolvens APCS1/XY was plated on an agar plate coated with a high-density 
preparation of ΦcrAss002, 76% of bacterial cells gave rise to a colony. This suggests 
that a dominant fraction of the population does not support phage replication (perhaps 
due to phase variation). Ten of these colonies were triple streaked and tested for the 
presence of episomally replicating or integrated copies of ΦcrAss002.  PCR confirmed 
all clones were phage negative. When isolates were tested with the phage by spot 




3.4.7 Characterisation of the ΦcrAss002 host Bacteroides xylanisolvens 
APCS1/XY  
The genome of B. xylanisolvens APCS1/XY consists of a single circular 
chromosome (6,461,058 bp, GenBank CP042282) and two circular plasmids (pBXS1-
1, 5,595 bp, GenBank CP042281 and pBXS1-2, 4,148 bp, GenBank CP042283). A 
considerable number of elements were identified in the genome that could potentially 
drive phase variation of surface structures and contribute to phage 
resistance/sensitivity. These included multiple genes coding for site-specific tyrosine 
recombinases (9), tyrosine-type DNA invertases (4) and site-specific integrases (28) 
(Figure S2A). In certain cases, these genes were in proximity to genes encoding 
bacterial surface molecules that have been previously identified as being subjected to 
phase variation and affecting surface composition and phage sensitivity in Bacteroides 
(Porter et al., 2020). These bacterial features included nutrient uptake genes such as 
the products of the sus gene family, genes coding for TonB-dependent nutrient 
transporters or capsule polysaccharide biosynthesis genes (Sonnenburg et al., 2005; 
Nakayama-Imaohji et al., 2009; Horino et al., 2009; Porter et al., 2020). Examples of 
cell-surface associated genes co-localised with site-specific recombinases were 
observed at the following loci: FNQN58_01735-01770 (TonB gene family + tyrosine-
type recombinase/integrase), FNQN58_07900-07925 (TonB/Sus/Rag gene family + 
tyrosine-type recombinase/integrase), FNQN58_12195-12225 (lipopolysaccharide 
and capsule biosynthesis + tyrosine-type recombinase). In order to obtain preliminary 
evidence of phase variation in B. xylanisolvens APCS1/XY associated with dynamic 
recombinations in the genome, we performed analysis of individual Oxford Nanopore 
reads. Reads were aligned to the assembled chromosome scaffold and recombination 
hotspots, indicating potential phase-variable loci were identified (Figure S2B-D). 
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Interestingly, many of the recombination hotspots overlapped with or occur in 
proximity to genes that function as Sus or TonB family transporters or receptors, site-
specific integrases, restriction endonucleases or transposases. For example, a 
recombination hotspot that extends from genome position 6151000-6152000 bp 
overlaps a TonB-dependent receptor and occurs in proximity to RagB/SusD family 
nutrient uptake outer membrane protein encoding genes and site-specific integrase. 
Another example extends from 909000-910000 bp overlapping a site-specific 
integrase which occurs upstream of a capsule biosynthesis gene. The hotspot identified 
across genome position 916000-917000 bp overlaps a glycosyltranserase gene which 
is in proximity to lipopolysaccharide synthesis genes.    
Other features of interest noted in the B. xylanisolvens APCS1/XY genome 
were over 139 transposases associated with thirteen or more insertion sequence (IS) 
families, the presence of three xylanases characteristic of this bacterial species, over 
one hundred sus/tonB associated genes and three capsule polysaccharide biosynthesis 
operons. Annotation of plasmids pBXS1-1 and pBXS1-2 showed that both carry genes 
coding for toxin-antitoxin systems which may have a role in phage defences by 
mechansims such as abortive infection. Other roles of these systems include post-
segregational killing or persistent formation which allows transient physiological 
changes that increase tolerance to antibacterial substances such as antibiotics (Harms 
et al., 2018). Plasmid pBXS1-2 also carries a gene that encodes for vesicle formation. 
This may be linked to the outer membrane vesicle-like structures (OMVs) observed in 
micrographs from cross-sections of soft agar lawns prepared with cultures of B. 
xylanisolvens APCS1/XY, with and without ΦcrAss002 exposure (Figure S3). The 
formation of such vesicles from the outer membrane occurs naturally among Gram-
negative bacteria and they are thought to have multiple roles including secretion and 
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transport of soluble and insoluble molecules, DNA transfer, stress adaptation, 
virulence and phage defence (Kulp and Kuehn, 2010; Toyofuku et al., 2019). The 
precise role of the vesicles observed on the surface of B. xylanisolvens APCS1/XY 
cells remains to be elucidated.    
The genetic accessibility of B. xylanisolvens APCS1/XY was confirmed via 
conjugation of pSAM-Bt with donor S17-1 λpir. This is significant as it allows the 
potential development of random mutant libraries. This may lead to the isolation of B. 
xylanisolvens APCS1/XY variants that are more sensitive to ΦcrAss002. Ultimately, 
this genetic accessibility could prove a useful tool in the further characterisation of 
ΦcrAss002 and its hosts. 
 
3.4.8 Co-cultivation of ΦcrAss002 and Bacteroides xylanisolvens APCS1/XY 
 We have already described the phenomenon in which ΦcrAss002 fails to 
propagate for several days in the presence of its host, before accumulating to and 
maintaining high levels (Figure 5B). This suggests that either the phage or the host has 
undergone some adaptation within the first days of propagation. This was confirmed 
via serial sub-culturing over 30 days in which the same phenomenon was observed. 
Following recovery and stabilisation, the phage propagated at approximately 108 
copies/ml for 21 days (Figure 6A). Phage lysate collected at the end of the 30 days 
was then propagated on a naïve host (a bacterial culture which had not been in recent 
contact with the phage) and once again there was an initial drop in titre, consistent 
with a dilution effect, before recovery and maintenance at high titres. (Figure 6B). 
This suggests that phage variants have not been selected, and that bacterial host 
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adaptation may be responsible for the stable co-propagation. To examine this, ten 
individual colonies were selected from the bacterial pellet formed after centrifugation 
of the 6-day co-culture on naïve cells (grown in the presence of phage) and used as the 
starting material for another co-culture cycle. Three behaviours were observed.  Two 
clones immediately supported ΦcrAss002 propagation at high titres, whereas the 
phage titre dropped significantly in the presence of one clone (Figure 6C).   
The remaining seven clones gave an intermediate response. By day two, all 
cultures supported a high titre of ΦcrAss002 of ~109 copies/ml. On naïve cells, 4-5 
days of co-culturing is required to achieve similar titres. This suggests that the 
bacterial population is heterogenous in terms of its phage permissiveness and that 
counterintuitively the presence of the phage selects for phage sensitive host variants. 
When ΦcrAss002 was spotted on lawns the phage exposed clones, spot turbidity was 
reduced in varying amounts compared to spots on lawns of naïve cells. 
 
3.4.9 Impact of crAssphage on hosts in a defined community 
 A continuous fermentation model was initiated in triplicate with a defined 
bacterial community constructed from eight different species representing a simplified 
human microbiota consortium (SIHUMI) (Figure 7). Following inoculation at similar 
levels, a community structure formed within hours that remained stable for 72 hours 
(Figure 7A).  When ΦcrAss002 and ΦcrAss001 were added from time point 0, there 
was no impact on either the levels of their individual hosts, or on the community 
structure (Figure 7B). ΦcrAss002 levels decreased as observed previously consistent 
with a washout due to media replacement, before recovering within 72 hours (Figure 
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7C).  ΦcrAss001 achieved high levels within a few hours and were maintained at high 

























Further advances in understanding the biology of the human gut phageome will 
depend on the isolation, propagation and characterisation of individual phage-host 
pairs.  This is particularly true for the most abundant representatives of this viral 
community, the crAss-like phages. With the exception of ΦcrAss001 and two close 
relatives of this phage, DAC15 and DAC17, all other crAss-like genomes described 
to date are the result of composite assemblies and have never been propagated in pure 
culture in a laboratory (Dutilh et al., 2014; Norman et al., 2015; Manrique et al., 2016; 
Yutin et al., 2018; Guerin et al., 2018; Shkoporov et al., 2018a; McCann et al., 2018; 
Cervantes-Echeverría et al., 2018; Shkoporov et al., 2019; Edwards et al., 2019; 
Siranosian et al., 2020; Hryckowian et al., 2020). Biological characterisation of 
ΦcrAss001 revealed several intriguing traits. Although shown to be virulent and 
capable of forming plaques on agar plates, it fails to clear liquid cultures of its host 
where both phage and host can stably co-exist and propagate to high levels (Shkoporov 
et al., 2018a). CrAss-like phages also form part of the personal persistent virome 
(PPV), a consistently present, individual-specific core of mostly virulent phages in the 
viromes of healthy individuals (Clooney et al., 2019; Shkoporov et al., 2019). In 
addition, crAss-like phages have been demonstrated to engraft and persist in the 
microbiome of faecal microbiota transplantation recipients and can undergo vertical 
transmission between mother and infant (Draper et al., 2018; McCann et al., 2018; 
Siranosian et al., 2020). This suggests that ecological models yet to be characterised 
are at play in the human gut that allow this persistence. It may be that virulent phages 
employ a “piggyback-the-winner” strategy to take advantage of the success of well-
adapted bacterial hosts in the gut. Originally this model was described by Rohwer and 
colleagues proposing that in thriving bacterial populations with a low virus-to-microbe 
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ratio (VMR), phages can make a lytic to lysogenic lifestyle switch to “piggyback on” 
the success of their host and thus ensure their maintenance in the ecosystem (Knowles 
et al., 2016; Silveira and Rohwer, 2016). In the context of the human gut, similar 
strategies may be employed that do not necessarily involve lysogeny but allow virulent 
phages persist in the human gut. The human gut is thought to have a VMR of ~0.1:1, 
which is lower than the VMR predicted in other ecosystems (Shkoporov and Hill, 
2019). Virulent gut phages may have evolved less aggressive infection strategies to 
ensure efficient and sustained replication without host elimination thus ensuring their 
persistence in the gut. Elucidation of the mechanisms behind this persistence requires 
further investigation.   
Isolation of these dominant gut bacteriophages is a challenge given that they 
are likely to be specialists in terms of their host range, and the high levels of variation 
observed in their predicted receptor-binding proteins (Shkoporov et al., 2018a). 
Furthermore, many anaerobic gut bacteria are difficult to cultivate and variations in 
host sensitivity/resistance may make it difficult to identify phage host pairs by 
standard agar-based methods such as plaquing and spot assays. The isolation of further 
crAss-like phages will be important in helping us understand their interaction with 
their host(s) and how certain phages can persist in the human gut over such extensive 
time periods. 
The overall objective of this study was the isolation of novel phages from the 
gut of an individual previously identified as being rich in several different crAss-like 
phages. The antibiotic-driven crAss-like phage enrichment implemented in this study 
confirmed that suitable hosts for crAss-like phage propagation were present and viable 
in the faecal samples. This led to the isolation of ΦcrAss002, a novel member of the 
crAss-like phage family isolated in pure culture. ΦcrAss002 infects B. xylanisolvens, 
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a Gram-negative, strictly anaerobic, non-pathogenic, xylan-degrading bacterium, 
which was first isolated from human faeces in 2008 (Chassard et al., 2008; Ulsemer et 
al., 2012). Recently, B. xylanisolvens has been demonstrated to be capable of boosting 
production of natural TFα sugar antigen-specific IgM antibodies in healthy humans, 
an antibody response believed to be involved in cancer immune surveillance (Ulsemer 
et al., 2016). Due to the associated beneficial properties of this bacterial species, B. 
xylanisolvens DSM23964 is one of the few bacterial strains approved by the European 
Food Safety Authority for applications in a novel food; heat-treated milk products 
fermented with the strain in a non-viable form, under the Novel Food Regulation No 
258/97 (European Commission, 2015). 
ΦcrAss002 is a member of candidate genus IV of the Alphacrassvirinae sub-
family, according to our recently proposed taxonomic scheme for gut-associated 
crAss-like phages (Guerin et al., 2018). The first crAss-like phage isolated, 
ΦcrAss001, infects B. intestinalis and is a member of the more heterogenous candidate 
genus VI of the sub-family Betacrassvirinae (Shkoporov et al., 2018a). The isolation 
of two crAss-like phages which are from the same genus VI has been reported, DAC15 
and DAC17, that both infect Bacteroides thetaiotaomicron (Hryckowian et al., 2020). 
Detailed biological characterisation of these two phages, isolated from sewer-adjacent 
pond water collected in Bangladesh will provide further insights into this phage 
family. ΦcrAss002 is more closely related to p-crAssphage, the founder member of 
the family and most abundant bacteriophage in the Western populations, which also 
belongs to the Alphacrassvirinae sub-family (Figure 4C). The cultured crAss-like 
phages share a podovirus-like morphology but the tail structure of ΦcrAss001 appears 
to be more elaborate than that of ΦcrAss002 (Figure 5A) (Shkoporov et al., 2018a). 
ΦcrAss001 produces large plaques whereas ΦcrAss002 does not and even at high titre 
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only forms opaque zones of clearing when spotted in high concentration on a lawn of 
its host bacterium. Both phages also employ different mechanisms for DNA packaging 
(short direct terminal repeats in ΦcrAss001 versus pac-type headful packaging in 
ΦcrAss002). Despite their apparent differences, both phages share notable similarities 
(Table 6). Both phages infect Bacteroides hosts, appear to be specialists in host range 
and neither possess lysogeny associated genes nor are they able to form stable lysogens 
or pseudolysogens. Their genomes also differ in G + C content by about 10% mol in 
comparison to their host genomes. While ΦcrAss001 and ΦcrAss002 are virulent in 
nature, both fail to clear liquid cultures yet still reach high titres. Intriguingly, both can 
co-exist in high levels with their host over prolonged periods.  
It has become apparent that many virulent phages persist at high levels in 
concert with their bacterial hosts. This has been indicated by observations in multiple 
studies (Weiss et al., 2009; Maura et al., 2012a; Siringan et al., 2014; Shkoporov et 
al., 2018a; Lourenço et al., 2019). Overall, the “kill-the-winner” dynamics has not 
been observed in the human gut virome, at least at the level of resolution of genus or 
species taxonomic levels (Reyes et al., 2010; Minot et al., 2011; Reyes et al., 2013; 
Moreno-Gallego et al., 2019; Shkoporov et al., 2019). The observed persistence of the 
crAss-like phages is consistent with an in-depth longitudinal study of the virome 
which followed ten healthy individuals over a one-year period. The stable abundant 
component of a healthy virome largely consists of virulent phages (including crAss-
like phages) with a minority of temperate phages (Shkoporov et al., 2019). This study 
strongly supports the notion that phage communities employ strategies that allow 
stable co-existence with their hosts.  
Continuous co-culture of ΦcrAss002 revealed that propagation does not occur 
efficiently on initial host contact. Following a period in which no replication is 
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observed, phage titre recovers and stabilizes (Figure 6A, B). Counterintuitively, this 
suggests that growth in the presence of phage selects for a phage permissive population 
composition, whereas growth in the absence of phage selects for a phage resistant 
population structure.  When added to a simplified bacteria community grown in a 
chemostat host levels are unaffected by the presence and propagation of the phages 
(Figure 7B).  Similar findings were observed for phages infecting enteroaggregative 
O104:H4 Escherichia coli in a conventional mouse model. These phages, isolated 
from sewage, were able to propagate stably and continuously over a number of weeks 
in vivo. Interestingly, faecal bacterial counts for phage treated and non-phage treated 
mice remained the same despite phage propagation (Maura et al., 2012a). In the 
fermenter, no knock-on effects were observed for off-target community members. 
This is both supported and contradicted by other in vitro and in vivo studies (Lourenço 
et al., 2019; Cieplak et al., 2018; Hsu et al., 2019). The observed stability and 
persistence may be due “piggyback-the-winner” style dynamics which describes the 
way in which phages can adopt less disruptive infection strategies and “piggyback” 
on the success of their bacterial host in an ecosystem (Knowles et al., 2016; Silveira 
and Rohwer, 2016). This allows more efficient replication and permits co-existence 
with that cognate host that would not be achieved with aggressive lytic replication. In 
the context of the gut, this would be favourable as it guarantees persistence. It may 
also be that “Royal Family” ecological dynamics are at play which is the occurrence 
of “kill-the-winner” dynamics at a strain or sub-strain level thus resulting phage-host 
fluctuations going undetected at genus or species level (Breitbart et al., 2018).  This is 
supported by the observed “host-jumping” of phages at the strain level which requires 
as little as a single point mutation in the tail fiber gene (Sordi et al., 2017). This 
phenomenon most likely occurs due to the inability of the phage to access the original 
215 
 
host strain or as a result of a reduction in the cognate host strain counts due to 
variations in the gut environment. Interestingly, enrichment of non-synonymous 
mutations in the tail fibre gene of p-crAssphage have been observed with a greater 
incidence compared to other genes (Siranosian et al., 2020). Strain level variation can 
be difficult to identify as 16S rRNA gene sequencing does not detect below species 
level (Sutton and Hill, 2019). Long-read sequencing, with platforms such as Oxford 
Nanopore, which can generate reads that are representative of near complete genomes 
may aid strain-level analyses (Somerville et al., 2019; Warwick-Dugdale et al., 2019). 
Bioinformatic pipelines that allow strain-resolved metagenomics have also been 
described (Edwards et al., 2019; Segata, 2018). It is still unclear why B. xylanisovlens 
APCS1/XY seems to select for the presence of high titres of the phage while the 
bacterial count remains unaffected by its presence. Perhaps it is favourable to the host 
to prevent extinction of the phage. It may be that some ecological advantage is 
conveyed or that sub-strain level variation imposed by the presence of the phage is 
important in more complex situations than those examined in this study.  
Phase variation (PV) is one possible mechanism that could allow hosts and 
phages to co-exist stably. This allows the host to transiently switch between phage 
permissive and non-permissive phenotypes through the reversible inversion of 
promotor-containing DNA regions called invertons at loci such as those encoding cell 
surface features which can act as phage receptors (Jiang et al., 2019; Porter et al., 
2020). Bacterial hosts have been shown to use PV to their advantage by developing 
herd immunity on phage exposure via phenotypic switch control of predating phage 
viral load (Turkington et al., 2019). This is possible due to the constant presence of a 
transiently phage permissive sub-population with the other portion of the population 
in a non-permissive state. This permits phage propagation but limits the viral load so 
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that the host is never completely eliminated. A sub-population of each culture may 
revert to non-phage permissive at a certain threshold and thus control viral load. It has 
also been demonstrated in murine models that host permissiveness to phage infection 
is not uniform throughout the gut and is influenced by ecophysiology (Maura et al., 
2012b; Galtier et al., 2017). Recently, the significance of transient resistance conveyed 
by PV and how it can dictate phage-host interactions has become of interest (Jiang et 
al., 2019; Turkington et al., 2019; Porter et al., 2020). Examination of the B. 
xylanisovlens APCS1/XY genome revealed a large number of genes coding for outer 
membrane proteins and capsular polysaccharide biosynthesis enzymes, associated in 
many cases with potential invertons (GenBank CP042282, Figure S2) (Zaleski et al., 
2005; Nakayama-Imaohji et al., 2009; Zitomersky et al., 2011; Nakayama-Imaohji et 
al., 2016; Porter et al., 2020). One study demonstrated that PV invertons are 
particularly dominant among human gut Bacteroidetes with ~19 invertons per genome 
(Jiang et al., 2019). Another noteworthy characteristic of PV detected in vitro is the 
inability of the phage to clear liquid culture despite reaching a high titre (Porter et al., 
2020). This is consistent with behaviour observed for both ΦcrAss001 and ΦcrAss002 
(Shkoporov et al., 2018a). Furthermore, this may explain the observed variability of 
opacity in zones of clearing and co-culture titres using cultures produced on different 
days and originating from different single colonies of B. xylanisovlens APCS1/XY. 
In vivo studies with relevant conditions and transcriptomics could potentially 
expand our understanding of how B. xylanisolvens and ΦcrAss002 interact and co-
exist. The persistence of virulent gut phages and their bacterial hosts was examined in 
a murine model using the defined Oligo-Mouse-Microbiota (OMM) bacterial 
consortium with the addition of two E. coli strains (murine commensal strain Mt1B1 
and enteroaggregative strain 55989) with three virulent phages infecting the former 
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and one the latter (Lourenço et al., 2019; Brugiroux et al., 2016). Interestingly, it was 
found that the radial variation in the murine gut due to anatomical features and 
condition gradients allows for variable virulent phage-host accessibility. Phage 
replication appears to largely occur in the lumen whereas the mucosa crypts provide a 
site of refuge for part of the target bacterial population which gradually migrate into 
the lumen. Further supporting this was the identification of an increasing mucosa to 
lumen gradient of lytic phages Therefore, hosts are exposed to variable phage 
concentrations in the gut highlighting the significance of spatial heterogeneity 
(Lourenço et al., 2019). This is also supported by observations of non-uniform phage 
propagation and composition throughout the GIT (Galtier et al., 2017; Maura et al., 
2012b; Zhao et al., 2019). This work also suggests that arm-race dynamics and 
extension of host range do not have a role in persistence of virulent phages (Lourenço 
et al., 2019). With strain variation among gut bacterial species often linked with 
genetic changes associated with phage resistance, the rate of and occurrence of genetic 
versus transient phage resistance requires further analysis (Scanlan, 2017). Overall, 
the above study specifically provides valuable insights into how persistent propagation 
of virulent phages can occur in the human gut without host elimination. Spatial 
separation in parallel with strain level interactions and transient host resistance may 
have important roles in this persistence. 
 
Conclusions 
We report the isolation of ΦcrAss002 from the human gut following antibiotic driven 
enrichment of its host, B. xylanisolvens APCS1/XY, in a faecal fermenter. Biological 
and in silico characterization of ΦcrAss002 revealed a number of interesting traits 
including the inability to form plaques or clear liquid cultures of its host despite the 
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phage being lytic in nature and attaining high titres. Like ΦcrAss001, ΦcrAss002 can 
co-exist with its host over time without impacting host levels at the species level. In 
the context of the gut, we hypothesize that multiple phenomena are occurring in 
parallel to allow such persistence and co-existence including, “piggyback-the-winner” 
and “Royal Family” ecological dynamics, transient host phenotypic variations and 
spatial heterogeneity. The isolation of more crAss-like phages will be key to 
expanding our understanding of the most abundant phage family in the human gut. 
They infect one of the most abundant and important bacterial groups in the gut, 
Bacteroidales, and so these phages and their hosts provide an opportunity to study the 
dynamics involved in phage-bacterium interactions in microbial functionality within 
the gut. Understanding such interactions will be necessary if we are to comprehend 
























































   
   
   

















               
             
                 
               
             
                
                 
                  
                       
               
                  
                                 
                   
                        
  
   
   
   






































           





   














Figure 2. The effect of antibiotic selective enrichment in faecal fermenter on the 
abundance of bacterial orders and the parallel effect on different crAss-like phage 
abundances. (A) The mean (across three experimental runs) relative abundances of the 
key bacterial orders under both conditions tested. (only orders with relative abundance 
of 1% in any of the samples are shown). (B) The mean relative abundance of crAss-
like phage contigs per genus as a percentage of total crAss-like reads. The crAss-like 
phage contigs are coloured based on candidate genus. CrAss-like phages that resolves 
into five of the ten crAss-like family candidate genera were detected. (C) Absolute 
quantification of each crAss-like phage detected using qPCR with phage or genus 
specific primers targeting a segment of the terminase or primase gene. Error bars 









Figure 3. Circular genome map of the ΦcrAss002 genome. The innermost ring (blue; 
positive strand, green; negative strand) depicts G + C skew, the central ring (black) 
shows G + C content and the outer ring (red) highlights Illumina read coverage along 
the genome. The outermost circle shows coding genes (CDS) which are labelled on 
HHpred function predictions. CDS are coloured based on general function which 












Figure 4. In silico characterisation of ΦcrAss002. (A) To examine relatedness of 
ΦcrAss002 with twenty other phages of candidate genus IV identified in silico, a 
heatmap was generated based on average nucleotide identity (ANI). (B) Whole 
genome comparisons of ΦcrAss002 and a subset of related phages to highlight synteny 
and genome organisation. In decreasing order from the top are phages with higher to 
lower ANI/relatedness. Genes with predicted functions are colour coded based on 
generalised function. Areas of tBLASTx homology between the genomes is 
highlighted. (C) Whole genome comparison of ΦcrAss002 with ΦcrAss001 (sequence 
from pure isolate) and the prototypical crAssphage (sequence solely in silico) to 




















Figure 5. Biological characterisation of ΦcrAss002. (A) Transmission electron 
micrographs generated from ΦcrAss002 enriched lysate, stained with uranyl acetate. 
Micrographs show podovirus virions with a diameter of ~77 nm and a simple tail 
structure. Scale bars represent 100 nm. A micrograph of φcrAss001 included for 
comparative purposes. (B) In vitro propagation of ΦcrAss002 over 11 days to 
interaction with its host. Titre quantification was performed using qPCR. (C) 
Investigation of the ability of ΦcrAss002 to propagate on commercial B. xylanisolvens 
DSM18836 and B. intestinalis 919/174 via liquid propagation over five days. Error 

















Figure 6. Continuous co-culture of ΦcrAss002 and Bacteroides xylanisolvens 
APCS1/XY. (A) Serial co-culturing of ΦcrAss002 over 30 days. (B) Serial 
propagation of the phage on naïve host cells (absent of phage exposure for ~10 
generations). (C) Equivalent experiment using ten B. xylanisolvens cultures with 
recent phage exposure.  ΦcrAss002 titre is shown in copies/ml, determined by absolute 
qPCR.  Statistical analysis was performed by the one-way ANOVA (P < 0.001) with 
Tukeys as post-test comparing titres. Statistical significance of the difference between 
the lowest titre and the highest titre sustained shown (P < 0.001, ***). Arrows indicate 
the approximate titre ΦcrAss002 at the initiation of each propagation cycle.  Error bars 

















Figure 7. The impact of ΦcrAss001 and ΦcrAss002 on host counts in a defined 
bacterial community. Continuous fermentations were performed in parallel with and 
without phage addition. Respective hosts were included; B. xylanisolvens 
(ΦcrAss002) and B. intestinalis (ΦcrAss001. Absolute quantification, by qPCR, was 
performed on total DNA. (A) Absolute quantification of the bacterial community 
structure without phage addition. (B) Equivalent graph showing the community 
structure in the presence of the phages. (C) The titre and propagation dynamic of 
ΦcrAss002. (D) Equivalent graph for ΦcrAss001.  Error bars represent standard 









Supplementary Figure 1. Diversity index of fermentates generated with and without 
selective conditions. (A) 16S diversity index. In the presence of antibiotics alpha-
diversity, evenness and richness are decreased. (B) Virome diversity index. Under 
selective enrichment there is a reduction for each index in parallel with bacteriome 















Supplementary Figure 2. Multiple site-specific recombinase-encoding genes and 
evidence of dynamic recombinations in the genome of B. xylanisolvens APCS1/XY. 
(A) Circular map of genome (the innermost circle [green and purple], GC skew; circle 
two [black], relative G+C content; circles three and four [red and dark blue], open 
reading frames identified on the positive and negative DNA strands respectively; 
circle five [orange], tRNA and rRNA genes. circle six, genes annotated as Sus-like 
surface-associated glycan utilisation proteins [green] and TonB-dependent nutrient 
receptor [light blue]; circle seven [black], genes annotated as invertases, integrases 
and recombinases). To the right of the genome map, circular maps of the two 
associated circular plasmids are shown; pBXS1-1 and pBXS1-2. Annotated features are 
coloured and labelled; (B) Distribution of length of Oxford Nanopore sequencing reads 
used for dynamic genome recombination analysis; (C) Distribution of percentage 
identity in Oxford Nanopore reads aligned using BLASTn to the chromosome 
scaffold; (D) Frequency of detected recombinations at a single read level (reads of at 
least 1000nt, with individual alignments of >90% identity and >200nt length; all 
inversions or shifts in coordinates >200 nt were deemed as recombinations) versus 
coordinates in the chromosome scaffold (histogram bin size = 1000bp); recombination 
hotspots were identified when >8 reads with inconsistent alignment were present per 















Supplementary Figure 3.  Transmission electron micrographs showing vesicle-like 
structures on the surface of B. xylanisolvens APCS1/XY cells. Micrographs were 
prepared from cross-sections of soft agar collected lawns of B. xylanisolvens 





Table 1. Primer sequences specific to each crAss-like phage detected following 
sequencing of subject ID: 924 faeces post fermentation. 




































































































CG = candidate genus; Fwd = forward primer; Rev = reverse primer 
 
 
Table 2. Primers specific to the SIHUMI bacterial community, ΦcrAss001 host B. 
intestinalis 919/174, and ΦcrAss002 host B. xylanisolvens APCS1/XY. 













































Table 3.  
Bacterial isolates identified following Sanger sequencing. The isolates were enriched 
from subject ID: 924 faeces with the aid of antibiotic selective enrichment to promote 
Bacteroidales growth. FAA; Fastidious anaerobic agar, YCFA; yeast extract, casitone, 














FAA       
FFA S1 968 99 100 B.uniformis  FAA 
FFA S2 1186 99 99 B.uniformis  FAA 
FAA S3 1120 99 100 B.uniformis  FAA 
FFA S4 1105 99 100 B.uniformis  FAA 
FFA S5 1122 99 100 B.ovatus  FAA 
FAA S6  >1000 99 100 B.dorei  FAA 
FFA S7 1279 99 99 B.uniformis  FAA 
FAA S8 1115 98 99 P.distasonis  FAA 
FAA B1 673 95 100 P.distasonis  FAA 
FAA B2 977 97 99 B.uniformis  FAA 
FAA B3 1071 95 96 P.distasonis  FAA 
FAA B4 947 97 99 P.distasonis  FAA 
FAA B5 1000 98 99 P.distasonis  FAA 
FAA B6 1138 97 100 P.distasonis  FAA 
FAA B7 1057 99 97 P.distasonis  FAA 
FAA B8 1111 98 100 P.distasonis  FAA 
        
YCFA       
YCFA S1 776 99 100 B.uniformis  YCFA 
YCFA S2 1101 99 99 B.uniformis  YCFA 
YCFA S3 1171 91 100 B.uniformis  YCFA 
YCFA S4 1109 99 99 B.uniformis  YCFA 
YCFA S5 965 99 100 B.uniformis  YCFA 
YCFA S6 1087 99 98 B.uniformis  YCFA 
YCFA S7 1195 99 100 B.uniformis  YCFA 
YCFA S8 1107 99 100 B.uniformis  YCFA 
YCFA B1 901 98 100 B.uniformis  YCFA 
YCFA B2 658 99 99 B.dorei  YCFA 
YCFA B3 1081 99 100 B.uniformis  YCFA 
YCFA B4 906 99 99 P.distasonis  YCFA 
YCFA B5 895 99 100 B.uniformis  YCFA 
YCFA B6 698 99 100 B.uniformis  YCFA 
YCFA B7 742 99 100 B.uniformis  YCFA 
YCFA B8 884 99 100 B.uniformis  YCFA 
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CBA 
      
CBA S1 800 99 100 B.xylanisolvens  
CBA (horse blood 
& vitK) 
CBA S2 936 96 100 P.distasonis  
CBA (horse blood 
& vitK) 
CBA S3 1000 99 100 B.uniformis  
CBA (horse blood 
& vitK) 
CBA S4 701 99 100 P.distasonis  
CBA (horse blood 
& vitK) 
CBA S5 917 99 100 B.uniformis  
CBA (horse blood 
& vitK) 
CBA S6 938 98 99 P.distasonis  
CBA (horse blood 
& vitK) 
CBA S7 574 99 100 B.uniformis  
CBA (horse blood 
& vitK) 
CBA S8 790 99 100 B.uniformis  
CBA (horse blood 
& vitK) 
CBA B1 893 99 100 B.uniformis  
CBA (horse blood 
& vitK) 
CBA B2 >1000 99 99 B.fragilis  
CBA (horse blood 
& vitK) 
CBA B3 647 93 99 B.dorei  
CBA (horse blood 
& vitK) 
CBA B4 351 94 100 P.distasonis  
CBA (horse blood 
& vitK) 
CBA B5 173 90 98 B.dorei  
CBA (horse blood 
& vitK) 
CBA B6 394 81 100 B.dorei  
CBA (horse blood 
& vitK) 
CBA B7 922 99 100 B.dorei  
CBA (horse blood 
& vitK) 
CBA B8 481 82 100 B.dorei  









Hit  Probability  E-value  Function 
LOC_1_1 213 Unknown Unknown Unknown Unknown 
LOC_1_2 181 cd13833 89.55 1.3 
HU_IHF_like/DNA-binding protein HU-
beta/Topoisomerase II subunit 
LOC_1_3 239 Unknown Unknown Unknown Unknown 
LOC_1_4 332 5ZYU_A 99.78 5.40E-20 
Mitochondrial genome maintenance 
exonuclease X2, CRISPR-associated 
exonuclease Csa1 
LOC_1_5 204 Unknown Unknown Unknown Unknown 
LOC_1_6 111 PF00430.18 78.76 26 ATP synthase 
LOC_1_7 121 N/+C8:K8A Unknown Unknown Unknown 
LOC_1_8 765 3CPE_A 100 1.80E-33 Terminase (large subunit) 
LOC_1_9 88 PF10043.9 98.82 4.30E-10 
Predicted periplasmic 
lipoprotein (DUF2279)/VanZ like 
family/Unknown function (DUF2585) 
LOC_1_10 810 PF16510.5 100 7.00E-41 Portal protein 
LOC_1_11 436 Unknown Unknown Unknown Unknown 
LOC_1_12 491 PF17236.2 99.84 3.80E-23 Major Capsid Protein 
LOC_1_13 384 Unknown Unknown Unknown Unknown 
LOC_1_14 217 2BSQ_G 56.01 74 Trafficking protein 
LOC_1_15 293 Unknown Unknown Unknown Unknown 
LOC_1_16 196 PF10960.8 65.59 90 Holin (BhIA) 
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LOC_1_17 72 Unknown Unknown Unknown Unknown 
LOC_1_18 322 Unknown Unknown Unknown Unknown 
LOC_1_19 1153 3ZK4_B 100 2.60E-37 Phosphatase (purple acid) 
LOC_1_20 2622 5JDA_A 98.36 1.20E-06 Transferase/Internalin-J; leucine rich repeat 
LOC_1_21 106 Unknown Unknown Unknown Unknown 
LOC_1_22 1197 3VTM_A 67.45 34 Iron-regulated surface determinant protein 
LOC_1_23 103 Unknown Unknown Unknown Unknown 
LOC_1_24 57 Unknown Unknown Unknown Unknown 
LOC_1_25 118 Unknown Unknown Unknown Unknown 
LOC_1_26 230 Unknown Unknown Unknown Unknown 
LOC_1_27 323 Unknown Unknown Unknown Unknown 
LOC_1_28 243 Unknown Unknown Unknown Unknown 
LOC_1_29 1287 Unknown Unknown Unknown Unknown 
LOC_1_30 557 Unknown Unknown Unknown Unknown 
LOC_1_31 922 Unknown Unknown Unknown Unknown 
LOC_1_32 2020 4QHJ_A 90.48 2.1 Peptidase 
LOC_1_33 4245 5IJO_Y 44.14 300 Nuclear pore complex 
LOC_1_34 71 Unknown Unknown Unknown Unknown 
LOC_1_35 61 Unknown Unknown Unknown Unknown 
LOC_1_36 38 Unknown Unknown Unknown Unknown 
LOC_1_37 98 Unknown Unknown Unknown Unknown 
LOC_1_38 150 PF13876.6 100 1.90E-32 Phage gp49_66 
LOC_1_39 218 3C2T_A 100 1.30E-32 Deoxyuridine triphosphatase (E.C.3.6.1.23) 
LOC_1_40 64 Unknown Unknown Unknown Unknown 
LOC_1_41 81 Unknown Unknown Unknown Unknown 
LOC_1_42 50 PF13719.6 98.39 1.70E-09 Zinc finger 
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LOC_1_43 362 TIGR03299 100 2.10E-57 Phage/plasmid-like protein/Unknown 
LOC_1_44 35 cd14416 94.73 0.04 
UBA-like domain found in nascent 
polypeptide-associated complex 
LOC_1_45 257 PF05565.11 99.9 1.00E-25 
Siphovirus Gp157/Mu Gam like 
protein/Host-nuclease inhibitor protein 
LOC_1_46 60 Unknown Unknown Unknown Unknown 
LOC_1_47 89 Unknown Unknown Unknown Unknown 
LOC_1_48 101 Unknown Unknown Unknown Unknown 
LOC_1_49 58 Unknown Unknown Unknown Unknown 
LOC_1_50 99 Unknown Unknown Unknown Unknown 
LOC_1_51 111 1U3E_M 99.89 1.10E-25 HNH endonuclease 
LOC_1_52 92 Unknown Unknown Unknown Unknown 
LOC_1_53 117 Unknown Unknown Unknown Unknown 
LOC_1_54 421 6GDR_A 100 1.10E-38 DNA ligase 
LOC_1_55 160 Unknown Unknown Unknown Unknown 
LOC_1_56 179 Unknown Unknown Unknown Unknown 
LOC_1_57 377 TIGR01391 100 7.40E-33 DNA primase 
LOC_1_58 203 1U3E_M 100 4.30E-32 
Zinc-binding loop region of homing 
endonuclease/ HNH endonuclease 
LOC_1_59 347 Unknown Unknown Unknown Unknown 
LOC_1_60 251 Unknown Unknown Unknown Unknown 
LOC_1_61 185 1U3E_M 100 4.90E-32 HNH catalytic motif/HNH endonuclease 
LOC_1_62 306 TIGR01913 99.43 8.60E-15 
Recombination protein Bet/RecT 
recombinase family 
LOC_1_63 488 2FWR_C 100 6.50E-34 
DNA repair protein/UnknownTP-dependent 
DNA helicase/DNA phosphorothioation 
system restriction enzyme 
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LOC_1_64 77 Unknown Unknown Unknown Unknown 
LOC_1_65 79 3DOA_A 77.42 7.7 Fibrinogen binding protein 
LOC_1_66 753 2GV9_B 100 2.00E-61 DNA polymerase 
LOC_1_67 485 3UPU_B 100 2.60E-36 ATP-dependent DNA helicase 
LOC_1_68 121 Unknown Unknown Unknown Unknown 
LOC_1_69 83 Unknown Unknown Unknown Unknown 
LOC_1_70 103 5JBH_Y 96.41 3.30E-04 30S ribosomal protein/Zinc ribbon domain 
LOC_1_71 48 Unknown Unknown Unknown Unknown 
LOC_1_72 113 Unknown Unknown Unknown Unknown 
LOC_1_73 176 4H9Q_C 75.51 21 DNA binding protein 
LOC_1_74 127 Unknown Unknown Unknown Unknown 
LOC_1_75 50 Unknown Unknown Unknown Unknown 
LOC_1_76 314 6GAJ_C 95.48 0.027 
Outer capsid protein sigma-1 (cell 
attachment protein) 
LOC_1_77 60 3DUZ_A 35.09 45 Major envelope glycoprotein; 
LOC_1_78 67 Unknown Unknown Unknown Unknown 
LOC_1_79 59 PF06698.11 87.36 2.3 Leucine zipper 
LOC_1_80 230 Unknown Unknown Unknown Unknown 













Best Hit Max Score Query Cover E-value % Identity Accession 
LOC_1_15 293 
Putative tail sheath 
protein [CrAssphage 
sp.] 
134 96% 1.00E-33 34.83% AXF52196.1 





318 66% 3.00E-89 33.33% WP_087318698.1 
LOC_1_26 230 
Putative Integration host 
factor IHF   
234 97% 2.00E-74 49.57% YP_009052530.1 
LOC_1_28 243 
Putative tail tubular 
protein [CrAssphage 
sp.] 




P22_gp10 homolog  





106 13% 3.00E-20 68.42% AXQ62688.1 
LOC_1_32 2020 
Putative RNAP catalytic 
subunit  
219 34% 5.00E-53 30.13% AXF52200.1 
LOC_1_33 4245 
Putative RNAP catalytic 
subunit  
441 71% 1.00E-119 29.18% YP_009052522.2 
LOC_1_59 347 
Putative ssb single 
stranded DNA-binding 
protein  




Table 5.  Metadata associated with ΦcrAss002 and related phages of candidate 










srr4295172_ms_6 96564 31.92 Linear Healthy USA 
srr4295173_ms_15 96117 31.94 Linear Healthy USA 
err844065_ms_3 95257 32.14 Linear IBD USA 
err844021_ms_1 94809 32.02 Linear Healthy USA 
eld181-t3_s_1 97503 32.02 Linear Elderly Ireland 
cs_ms_45 71412 32.49 Linear Healthy Ireland 
err844056_ms_3 97150 32.14 Circular IBD USA 
hvcf_d5_ms_4 92723 32.09 Circular Healthy Ireland 
err844044_ms_2 96498 31.96 Linear Healthy USA 
err844065_ms_4 94590 31.92 Linear IBD USA 
cdzn01024782 93052 32 Linear Healthy Canada 
srr073436_s_2 95598 32.14 Circular Healthy USA 
err844016_ms_2 95883 32.29 Linear Healthy USA 
ΦcrAss002 93030 31.92 Circular Healthy Ireland 
fferm_ms_10 101844 32.09 Linear Healthy Ireland 
srr4295175_ms_5 96082 32.07 Circular Healthy USA 
hvcf_e12_ms_1 94697 32.3 Linear Healthy Ireland 
err843931_ms_1 94475 32.19 Circular IBD USA 














Table 6. Summary of ΦcrAss001 and ΦcrAss002 characteristics 
  ΦcrAss001 ΦcrAss002 
    
Isolation source  Faeces Faeces 
 
Genome size 






Preferred propagation method 
 





Clearing of culture 
 
























   











Lysogenic associated genes 
 
           No No 
tRNA genes 
           25 None 
DNA packaging 
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Isolation and characterization of a novel Parabacteroides 
distasonis bacteriophage isolated from the human gut   
 
 




















The human gut microbiome is thought to play a significant role in health and 
disease. The virome, predominantly composed of bacteriophages, has received 
significantly less attention in comparison to the bacteriome. This is largely due to the 
challenges associated with the isolation and characterization of novel gut 
bacteriophages, and bioinformatic challenges that include the lack of a universal 
bacteriophage marker gene and the absence of homologs in viral databases. Here we 
describe the isolation of a novel virulent siphovirus infecting Parabacteroides 
distasonis; ΦPDS1. Key to the isolation of this phage was the antibiotic driven 
selective enrichment of the bacterial host in a faecal fermenter that permitted parallel 
phage expansion. We also present the in silico and biological characterization of this 
phage. To date there have been no detailed reports of Parabacteroides distasonis 
siphoviruses or the genomes of such phages deposited in the NCBI Taxonomy 
database. Multiple studies have shown that perturbations of this gut commensal can 
be linked to various disease states, making this novel phage-host pair and their 











4.2 Introduction  
Bacteriophages (phages), were discovered a century ago by Twort and 
d’Herelle (Twort, 1915; d’Hérelle, 1917). In recent years, these bacteria infecting 
viruses have become the subject of renewed attention in light of their potential role in 
the microbiome. Phages form the largest component of the human gut virome, also 
referred to as the gut phageome. These viruses could have important implications for 
health by shaping the composition of the microbiome through interactions with the gut 
bacterial community or indirectly by interactions with the human host immune system 
(Norman et al., 2015; Manrique et al., 2016; Nguyen et al., 2017; Belleghem et al., 
2017; Gogokhia et al., 2019). Alterations in phageome composition have also been 
associated with multiple disease states (Reyes et al., 2015; Tetz and Tetz, 2018; Kieser 
et al., 2018; Ma et al., 2018; Zhao et al., 2019; Zuo et al., 2019; Khan Mirzaei et al., 
2020). For example, in IBD patients there is shift from predominantly virulent phages 
in health towards induction of temperate phages (Clooney et al., 2019). However, little 
is known about the mechanisms by which phages might support homeostasis or help 
to resist perturbations of the gut microbiome. 
Despite this revived interest in phages, the gut phageome remains largely 
unknown. Modern sequencing technology and viral metagenomics have played an 
important part in improving our insight into the composition of the phageome. 
However, bottlenecks associated with these methods include the absence of a universal 
marker gene and the lack of sequence homology with phages on currently available 
public databases the use of which can result in an incomplete analysis (Chibani et al., 
2019; Roux et al., 2015; Shkoporov and Hill, 2019; Sutton and Hill, 2019). Most phage 
contigs or genomes cannot be assigned with any certainty to a specific taxonomic 




uncharacterized viral sequences have been termed the “viral dark matter” (Aggarwala 
et al., 2017). The isolation of novel gut phages can be hindered due to difficulty in 
culturing associated hosts, traditional screening methods involving plaquing can result 
in novel phage-host pairs being overlooked, mimicking gut conditions is difficult and 
bacterial host factors, such as genetic resistance and transient resistance due to phase 
variation can further heighten this challenge (Hyman, 2019; Porter et al., 2020).  
The isolation of further human gut phage-host pairs permits the elucidation of 
novel biological properties and dynamics. Bacteroidales form the most abundant 
bacterial order in a healthy human gut, with Bacteroides and Parabacteroides being 
two of the most important genera (García-Bayona and Comstock, 2019). CRISPR-
spacer sequence analyses suggests that a significant proportion of persistent virulent 
phages in the human virome infect hosts of the Bacteroidales order (Shkoporov et al., 
2019).  Bacteroidales infecting crAss-like phages, the most abundant phage family in 
the human gut, provide one of the most notable examples of how the isolation and 
characterisation of a phage originally detected in silico was key in gaining insight into 
biological properties (Dutilh et al., 2014; Shkoporov et al., 2018a).  
Here we conducted an antibiotic enrichment of a faecal bacterial community 
in a fermenter system to promote the growth of Bacteroidales and parallel expansion 
of associated phages. We report the isolation a novel Parabacteroides distasonis 
phage; ΦPDS1. This phage is the first lytic P. distasonis infecting siphovirus to be 
biologically characterised and to have its genome deposited on NCBI Taxonomy. 
Isolation of novel gut phages in pure culture that interact with abundant members of 
the microbiome will play an important role in improving our understanding of phage-
host interactions. Given that P. distasonis has been linked to human disease and health, 




4.3 Experimental procedures 
4.3.1 Donor recruitment and faecal fermentation 
A healthy individual, denoted as subject ID:924, was recruited for faecal 
sample donation. Collection of samples from this individual was in accordance with 
the study protocol APC055 and ethics approved by Cork Research Ethics Committee. 
On receipt, the sample was processed immediately into frozen standard inoculum 
(FSI). This was done exactly as described by (O’Donnell et al., 2016) with a few minor 
modifications as outlined by (Guerin et al., 2018). The FSI was aliquoted into three 
volumes so the fermentations could be performed in triplicate. The prepared FSI is the 
same that was used to initiate a faecal fermentation investigating crAss-like phages 
(refer to chapter 3, methods 3.3.1). The fermentation was run in batch format over 24 
hours with conditions as applied by (Guerin et al., 2018). This was implemented as in 
(chapter 3, methods 3.3.2).  Two fermenter vessels were set up in parallel, one with 
and one without the addition of antibiotics to the YCFA-GSCM broth post-
autoclaving. The antibiotics used were 7.5 μg/ml vancomycin and 100 μg/ml 
kanamycin chosen to selectively promote the growth of Bacteroidales via the 
elimination of gram-positive bacteria as well as facultative anaerobes. Samples were 
collected at 0, 4.5, 17.5, 21 and 24 hours. The samples were directly processed after 
collection through centrifugation at 4,700 rpm at +4°C for 10 minutes. Following this, 
supernatants were passed through a 0.45μM pore polyethersulfone (PES) membrane 







4.3.2 Extraction of virus-like particles and sequencing of fermenter virome 
The extraction of virus-like particles (VLPs) from 10 ml of collected filtered 
fermentates, virome library preparation from VLPs, processing of the resultant viral 
reads via trimming and filtering followed by assembly into contigs was done exactly 
as described previously (Chapter 3; methods 3.3.3.). 
 
4.3.3 Extraction of total DNA and 16S rRNA gene library preparation 
Total DNA was extracted from faecal pellets generated following 
centrifugation of samples collected from the fermenter. The extractions were 
performed using the QIAamp Fast Stool Mini Kit (Qiagen, Hilden, Germany). The 
extraction protocol as well as 16S rRNA gene library preparation of the extracted DNA 
was implemented as described previously (Chapter 3; methods 3.3.4.). 
 
4.3.4 Novel phage-host pair screening 
Selective enrichment of anaerobic Bacteroidales species using Fastidious 
Anaerobe Agar (FAA), Columbia Blood Agar (CBA) and YCFA-Agar containing 
vancomycin and kanamycin, colony purification and identification via Sanger 
sequencing of the 16S rRNA region was performed as described previously (Chapter 
3; methods 3.3.6.). To ensure the absence of aerobes, incubation of isolated colonies 
was performed aerobically and anaerobically. Following identification of the bacterial 
species, 48 pure cultures were used in the phage-host pair screening. Unlike the 
screening method implemented in the search for novel crAss-like phage-host pairs 




process such as via primer development to target sequences detected in the fermenter. 
The screening implemented here was more traditional via spot assays. 
Overnight cultures of the Bacteroidales were prepared in 10 ml of Fastidious 
Anaerobe Broth (FAB, Neogen). From each of these cultures, 300 µl was added to 
0.3% FAA agar overlay (0.3% agar w/v), with MgSO4 and CaCl2 added to give final 
concentration of 1 mM. This was followed by pouring of the mixture onto pre-
prepared FAA base agar (1.5% agar w/v) after gentle vortexing. After drying of the 
overlay, 5 µl of the filtered fermentates collected from the antibiotic containing and 
antibiotic absent vessels at time point 21 were spotted onto the lawns of each culture 
and dried. In addition to this, the original faecal filtrate prepared from subject ID:924 
faeces without enrichment was spotted on the lawns. The plates were incubated 
anaerobically at 37°C for 48 hours. Formed spots were picked using an inoculation 
loop, placed into 100 µl of SM buffer, vortexed and incubated at room temperature for 
5 hours. Following this the resuspended spots were spun in a desktop centrifuge at 
maximum speed for 10 minutes. The resultant supernatant was filtered through a 
0.45μM pore polyethersulfone (PES) membrane filter. Spot assays were then repeated 
using each lysate on lawns of the culture it originally spotted on. Plaque assays were 
also performed using 3 ml of 0.3% FAA agar (0.3% agar w/v), with the addition of 
MgSO4 and CaCl2 at a final concentration of 1 mM. Ten-fold serial dilutions of the 
lysates were prepared in SM buffer. To the molten agar, 300 µl of each overnight 
culture was added and 50 µl of phage dilution. Following this, spot picking and spot 
assays were repeated a third time. It was observed that spots formed consistently on 
all the cultures identified as Parabacteroides distasonis, determined by Sanger 




produced the least turbid zones of clearing were chosen for phage enrichment. These 
cultures were designated as FAA-B5, FAA-B8, FAA-S8 and CBA-S2 (Table 1). 
 
4.3.5 Novel phage enrichment and shotgun sequencing 
Six rounds of phage enrichment were performed with the P. distasonis cultures 
to increase titre of the detected phage.  Phage filtrates was added to P. distasonis 
cultures at OD600 = ~0.2 which was achieved approximately 5 to 6 hours post sub-
culturing of 100μl of overnight culture in 10ml of fresh FAB (plus MgSO4 and CaCl2 
added to give final concentration of 1 mM) with anaerobic incubation at 37°C. Once 
the culture was at the desired optical density, 1ml of phage lysate was added at an 
unknown titre to each culture and incubated anaerobically overnight at 37°C. The 
lysates were then centrifuged at 4,700rpm and passed once through a 0.45μM 
membrane syringe filter. Filtrates were then stored at +4°C. Each round of propagation 
was performed following the same procedure. To ensure maintenance of phage 
throughout the serial propagations, spot assays were performed as described above. 
On completion of the enrichment spot and plaque assays were repeated to check for 
improved clarity of zones clearing. 
Nucleic acids were extracted from 10 ml of filtered phage lysate collected on 
the final round of enrichment. Solid NaCl and PEG-8000 were added to the lysates 
give a final concentration of 0.5M and 10% w/v. Following this, the powders were 
completely dissolved, and the samples were placed at +4°C for overnight incubation. 
The following VLP purification and DNA extraction steps proceeding this were 
performed as described by (Shkoporov et al., 2018b).. The DNA was then directly 




Preparation Kit (Illumina) without preliminary multiple displacement amplification 
(MDA). Normalisation was performed as per the manufacturer’s protocol using the 
bead-based method. The prepared libraries were sequenced using 2 x 300 bp paired-
end chemistry on an Illumina MiSeq platform (Illumina, San Diego, California) at 
GATC Biotech AG, Germany. The quality of the raw reads was analysed using 
FastQC v0.11.5. Removal of Nextera adaptors was performed Trimmomatic v0.36. 
(Bolger et al., 2014). Parameters implemented were as follows: minimum length of 
60, a sliding window size of 4 and a minimum Phread score of 33. The trimmed and 
filtered reads were then assembled into contigs using SPAdes (v1.13.1) (Antipov et 
al., 2016; Nurk et al., 2017). 
 
4.3.6 In silico analyses and characterisation of ΦPDS1 
Sequencing revealed that the novel phage, denoted as ΦPDS1, resolves into 
the Siphovirus family of the Caudovirales order. Prediction of protein coding genes 
and preliminary annotation of the ΦPDS1 genome was performed using de novo viral 
genome annotator VIGA (González-Tortuero et al., 2018).  The predicted protein 
coding sequences then underwent manual functional analyses using HHPred to 
generate more detailed annotations. HHPred annotations were performed with the 
following databases: PDB_mm_CIF70_3_Aug, Pfam-A_v32.0, NCBI_CD_v3.16, 
TIGRFAMs_v15.0 (Zimmermann et al., 2017).  A genomic map of the ΦPDS1 
genome was then generated using GView (v1.7) with annotations incorporated 
(Petkau et al., 2010). 
To analyse the incidence of ΦPDS1 in the gut phageome of different human 




multiple human virome studies using BLASTn v2.2.28+ (Altschul et al., 1997).  Hits 
used for further analyses met the following inclusion criteria: [1] a contig length of 
≥40kb and [2] an E-value of < 1E-05.  Metadata of the sixteen detected phages was 
examined to investigate possible cohort associations. 
To investigate the relatedness of the sixteen in silico detected phages and 
ΦPDS1, average nucleotide identity (ANI) was determined using the default settings 
in PYANI (Leighton Pritchard et al., 2017).  The ANI output was exported into R 
environment and used to generate a complex heatmap with Bioconducter Complex 
Heatmap (v1.20.0) and Circlize (v0.4.5) packages (Gentleman et al., 2004; Gu et al., 
2014, 2016). The topology of the contigs was determined and the sixteen ΦPDS1-like 
phage genomes were annotated using VIGA (González-Tortuero et al., 2018). A 
highly similar, an intermediately related and a more distantly related phage of ΦPDS1 
were chosen as representatives for a whole genome pairwise comparison to examine 
synteny using Easyfig (v2.2.2) by inputting the resultant GenBank files from VIGA. 
The EasyFig image was generated using BLASTn with a minimum length of 50bp and 
percentage identity of 30bp. In addition to this, the occurrence of ΦPDS1 associated 
CRISPR-spacers in bacterial genomes was analysed using an in-house database. This 
was also carried out for the sixteen ΦPDS1-like phages identified in silico to examine 
if they also infect P. distasonis or other bacterial hosts. 
 
4.3.7 Transmission electron microscopy  
Ultra-centrifugation was performed using a 50 ml pool of ΦPDS1 lysate. The 
lysate was concentrated for a total of 3 hours at 120,000g using a F65L-6x13.5 rotor 




followed by removal of the supernatant. The remaining 25 ml was added to the 
resultant pellets without resuspension and a second round of ultra-centrifugation was 
then performed. Finally, the pellets were resuspended in a final volume of 5ml SM 
buffer. The suspensions were then applied onto to a step gradient of 5M and 3M CsCl 
solutions and centrifuged at 105,000g for 2.5 hours at +4°C.  The steps following this 
were performed as described by Guerin et al. (Guerin et al., 2018). Five microlitre 
aliquots of the concentrated viral fraction were applied to Formvar/Carbon 200 Mesh, 
Cu grids (Electron Microscopy Sciences) with subsequent removal of excess sample 
by blotting. Grids were then negatively contrasted with 0.5% (w/v) uranyl acetate and 
examined at UCD Conway Imaging Core Facility (University College Dublin, Dublin, 
Ireland) by Tecnai G2 12 BioTWIN transmission electron microscope 
 
4.3.8 Quantitative real-time PCR: primer and standard development 
Following sequencing and annotation of ΦPDS1, the phage portal protein 
(gene gp_48) was chosen as a suitable target for qPCR primer and standard 
development. Primers were designed using PERL Primer software and CLC Sequence 
Viewer 8.0. The following primers;  Fwd 5'GGAACAACGGGACGATTG-3' and Rev 
5'-CAATCACGGACGCAATAGG-3' to produce a product of 193bp using standard 
PCR with the following conditions: initial denaturation at 95°C for 5 minutes, then 35 
cycles of 95°C for 20 seconds, 60°C for 20 seconds 72°C for 20 seconds and 72°C for 
1 minute. To develop standards for qPCR calibration curves, the products generated 
from the above primers were cloned into pCR2.1-TOPO TA vector (Thermo Fisher 
Scientific). Extracted plasmids were quantified using Qubit dsDNA BR Assay kit and 




plasmids were used to build a standard calibration curve. Following this, the absolute 
composition of ΦPDS1in the faecal fermenters was performed via qPCR of the viral 
nucleic extracted from the filtered fermentates. This was performed in a 15 μl reaction 
volume using SensiFAST SYBR No-ROX mastermix (Bioline) in a LightCycler 480 
thermocycler with the following conditions: initial denaturation at 95°C for 5 minutes, 
then 45 cycles of 95°C for 20 seconds, 60°C for 20 seconds and 72°C for 20 seconds. 
Resulting Ct-values were converted to copies/ml based on the generated calibration 
curves. The relative abundance of ΦPDS1 was also calculated. This was expressed as 
the percentage of total viral reads that align to the ΦPDS1 genome. Results were 
visualised using package ggplot2 v2.2.  
 
4.3.9 Biological characterisation of ΦPDS1 
A one-step growth curve was performed in triplicate to determine the latent 
period and burst size of ΦPDS1. An early logarithmic phase culture of P. distasonis 
APCS2/PD was infected with ΦPDS1 with a multiplicity of infection (MOI) of ~1. 
This was followed by incubation at room temperature for 5 mins and centrifugation at 
5000 rpm in a swing bucket rotor for 15 minutes at 20°C. The supernatant was 
removed, and the resultant pellet was resuspended with FAB. The phage-host pair 
were maintained at 37°C under anaerobic conditions for 3 hours with 1 ml sample 
collection every 15 mins. Samples were centrifuged and filtered through 0.45 µM pore 
syringe filters. Analysis was performed using absolute qPCR with the standard curve 
method as described above. 
Efficiency of lysogeny was performed by spreading 100 µl of ΦPDS1 lysate 




fold serial dilutions of P. distasonis APCS2/PD was poured onto the ΦPDS1 spread 
plates. Negative controls were prepared in the same manner but without the addition 
of phage to the base plate. The plates were incubated anaerobically at 37°C for 48 
hours. Efficiency of lysogeny was calculated as the percentage of colonies on the 
phage seeded plates versus counts for the equivalent negative control. Colony 
morphology was observed, and sixteen colonies were picked and restreaked four 
times. Standard PCR was performed using primers specific to ΦPDS1 as described 
above to check for the potential integration of the phage into the host genome. Spot 
assays were performed on clones after restreaking to check for host resistance after 
phage exposure. 
Co-culturing of ΦPDS1 P. distasonis APCS2/PD was performed by serial sub-
culturing over ten days in triplicate. This was initiated using 1ml of ΦPDS1 lysate at 
1010 copies/ml that was introduced into 10 ml of P. distasonis APCS2/PD culture in 
FAB at OD600 = 0.2. Subsequent rounds of sub-culturing were performed by 
introducing the prior co-culture into 10 ml fresh FAB at a ratio of 1:50. ΦPDS1 titre 
was quantified using qPCR. The bacterial pellet collected following generation of the 
final phage lysate collected on day ten was serially streaked three times and tested for 
resistance against ΦPDS1 by spot assay. The resultant colonies were also examined 
for presence of episomally replicating or integrated copies of the phage by standard 
PCR. 
The ability of the ΦPDS1 to infect other commercially available P. distasonis 
strains DSM 29491 and DSM 20701 (ATCC 8503) and Odoribacter splanchnicus 
DSM 20712, following CRISPR-spacer analysis results, was investigated via liquid 




Propagation of ΦPDS1 on P. distasonis APCS2/PD was performed in parallel as a 
control. Propagation was determined by examining titre increase using absolute qPCR. 
 
4.3.10 Shotgun sequencing of P. distasonis APCS2/PD using Illumina and Oxford 
Nanopore platforms 
For the generation of long and short read sequences for hybrid assembly, 
genomic DNA was extracted from 10 ml of P. distasonis APCS2/PD overnight culture 
using phenol/chloroform with precipitation in 3M sodium acetate and cold absolute 
ethanol (Sambrook et al., 1989; Bardina et al., 2016). DNA was quantified using using 
Qubit BR DNA Assay Kit in a Qubit 3.0 Flurometer. All proceeding steps were 
performed as described previously (Chapter 3; methods 3.3.8.) including library 
preparation, sequencing, read processing and assembly. Following assembly using 
SPAdes (v1.13.1), nine scaffolds greater than 1kb were generated (Nurk et al., 2013; 
Antipov et al., 2016). Scaffolds were then manually curated, joined and circularised 
using CLC Sequence Viewer. The assembled and circularised genome and associated 
plasmids were submitted to NCBI Prokaryotic Genome Annotation Pipeline. The 
GenBank file for the genome was visualised using GView (v1.7) with a style sheet 
optimised to highlight a number of potentially phase variable associated genes (Petkau 









4.4.1 Schematic overview 
A graphical overview of the protocol implemented to screen of novel 
Bacteroidales phages is presented in Figure 1. A healthy donor was recruited for faecal 
sample donation and a frozen standard inoculum (FSI) was prepared immediately. 
Triplicate fermentations were performed using two vessels in parallel, one of which 
contained vancomycin and kanamycin.  In conjunction with this, individual 
Bacteroidales were enriched and purified from the FSI on various media containing 
the same antibiotics. To screen for novel phage-host pairs, the phage enriched 
fermentate filtered of bacterial cells was screened against the isolated Bacteroidales 
species using spot on lawn assays.   
 
4.4.2 Bacterial composition following antibiotic enrichment 
16S rRNA gene sequencing of total DNA extracted from bacterial pellets, 
collected following centrifugation of faecal fermentates, revealed a significant 
difference in the composition and relative abundance of bacterial genera with and 
without selective enrichment (Figure 2). At T0 hours, both vessels are dominated by 
genera that resolve into the following orders: Clostridales (~50%), Bacteroidales 
(~30%) and Selenomonadales (12.5%). By T4.5 hours, the composition of the 
bacterial genera changes significantly under antibiotic enrichment with Bacteroidales 
associated genera beginning to dominate whereas the control vessel is dominated by 
gram-positive Catenibacterium. By T24 hours, the relative abundance of Bacteroides 
and Parabacteroides constitutes up to 90% of the total 16S rRNA gene reads under 




in the control vessel. These findings are consistent with the detected bacterial species 
isolated from the same faecal sample following plating on agar containing the same 
antibiotics.  The majority of the isolates are of the Bacteroides genus as well as a 
significant enrichment of the species Parabacteroides distasonis (Table 1). In the 
absence of antibiotics mostly gram-positive bacteria were recovered. This confirms 
that vancomycin and kanamycin were able to promote selective enrichment of 
Bacteroidales species. The phage-rich faecal fermentate collected from the antibiotic 
containing vessel formed more readily visible spots when screening for phage-host 
pairs, confirming that phages were also enriched using this approach (Figure S1). 
 
4.4.3 Genome analysis of ΦPDS1 and Parabacteroides distasonis APCS2/PD 
When the phage-rich faecal fermentate was spotted on lawns of the isolated 
Bacteroidales species it was observed that clearing consistently occurred on lawns of 
P. distasonis. This phage was subsequently enriched on its host and shotgun 
sequencing confirmed the isolation of a novel siphovirus. The reads generated 
assembled into a circularised genome of 44,691 bp with a read coverage of 347 
(GenBank MN929097) (Figure 3). Shotgun sequencing of the host, named 
Parabacteroides distasonis APCS2/PD (Figure S2), revealed that it has a genome size 
of 5,345,521 bp (deposited in the NCBI database under the following GenBank 
CP042285, BioProject PRJNA556872) with one associated plasmid, pPDS2-1 
(GenBank CP042284). The G + C content of the phage is 45.28 G + C mol% and its 
host genome is 45.30 G + C mol%. It has been reported that phages generally tend to 
have a G + C content slightly lower than that of their host although this is not true in 




Preliminary annotation of the ΦPDS1 genome identified 61 protein coding 
genes (CDS), half of which could be assigned functional annotations using HHpred 
(Figure 3, Table 2). These included three head structural proteins, five tail associated 
proteins, five DNA replication genes, two terminase genes and one gene for lysis. The 
right-hand side of the genome was dominated by structural genes and the left-hand 
side genes encoding functions associated with DNA replication and maintenance. A 
lysogenic gene module was not identified which is typically is composed of a serine 
or tyrosine integrase, a repressor of the lytic-cycle and excisionase (Luo et al., 2017; 
Shkoporov and Hill, 2019). These modules are also often in the opposite orientation 
to proximal gene modules and again this was not observed. One capsular 
polysaccharide synthesis gene, over one hundred sus/tonB associated genes and more 
than ten tyrosine recombinase genes were identified, characteristic of phase variable 
gene expression. 
 
4.4.4 Abundance of ΦPDS1 in faecal fermentates 
The relative and absolute abundance of ΦPDS1 was determined for both 
condition variables examined during the fermentations. It is evident that the selective 
enrichment of the host greatly aided the propagation and expansion of this phage 
which in turn facilitated its isolation (Figure S2). Relative abundance of the phage in 
relation to the total viral reads sequenced showed that ΦPDS1 contributed to ~13-14% 
of reads sequenced from the later time point samples collected from the antibiotic 
vessel (Figure 4A). Absolute quantification using qPCR with the standard curve 





4.4.5 Genome analysis of ΦPDS1  
Comparison of ΦPDS1 against an in-house database of human viral sequences 
generated from faeces identified sixteen phages with significant similarity (Figure 
5A). The G + C content of these phages ranged from 43.19 - 45.76 mol%, size 42,181 
- 46,687 bp and average nucleotide identity (ANI) 81 - 98%. The detected phages 
originate from four independent studies; Enteric Virome IBD (Norman et al., 2015), 
Longitudinal Virome Study (Shkoporov et al., 2019), Cystic Fibrosis Sibling (NCBI 
BioProject: PRJNA498332) and Cystic Fibrosis (unpublished). These phages do not 
correlate with any disease state or other metadata (Table 3). Despite slight variations 
in ANI, overall genome organisation and genetic synteny among these phages is 
largely conserved, even for phage Sib2_ms_18 which is the most distantly related to 
ΦPDS1 (Figure 5B). 
 The presence of CRISPR-spacers targeting ΦPDS1 were found in P. distasonis 
and in Odoribacter splanchnicus (Figure 5C). CRISPR-spacer analysis for the sixteen 
identified ΦPDS1-like phages found that the two phages most related to ΦPDS1, 
LS_917t11 and ERR944031, also had CRISPR-spacer hits for P. distasonis (Figure 
5C). CRISPR-spacer hits associated with the fourteen other phages were detected in 
O. splanchnicus and P. distasonis with the phage least related to ΦPDS1, Sib2_ms_18, 
found to have a CRISPR-spacer hit in Bacteroides fragilis.   
 
4.4.6 Biological characterisation of ΦPDS1 
Transmission electron micrographs of ΦPDS1-rich lysate show that this phage 
has a characteristic siphovirus morphology with a long, non-contractile tail (Figure 




observed for other siphoviruses. The capsid diameter is approximately 53 ± 2.0 nm 
and tail length 150 ± 10.0 nm. Zones of clearing on host lawns produced by high titres 
of the phage are readily visible, but clearing is incomplete (Figure 6B). The phage also 
produces plaques on its sensitive host, but they are pin prick in size making 
visualisation and enumeration difficult. ΦPDS1 one-step growth curve was performed 
in triplicate with a MOI of ~1 (Figure 6C). It was found that the phage has a latent 
period of approximately 90 minutes with a relatively small burst size of ~14 to 20 
virions per infected cell.  
Continuous co-culture of ΦPDS1 showed that after 24 hours the phage titre 
recovered to ~1 x 1010 copies/ml following initial reductions consistent with dilution 
associated with sub-culturing (Figure 6D). By day two, the titre reduces to ~4 x 108 
copies/ml and remains at this approximate titre for subsequent rounds of sub-culturing. 
This suggests that the presence of the phage selects for an increase in non-phage 
permissive host variants but as the phage continues to propagate without becoming 
extinct, a permissive sub-population of the host culture must co-exist to sustain the 
high titres observed. The bacterial pellet collected at the end of the experiment was 
serially streaked three times. PCR confirmed that all colonies were negative for 
ΦPDS1 integration or maintenance episomally. Ten clones were tested for phage 
resistance by spot assay. It was found that zones of clearing had varying increases in 
turbidity compared to zones of clearing on naïve host lawns. 
We examined the ability of the ΦPDS1 to propagate on two strain bank P. 
distasonis strains, DSM 29491 and DSM 20701, and an O. splanchnicus strain, DSM 
20712, chosen following findings from CRISPR-spacer analyses (Figure 6E). The 
phage failed to propagate on the tested strains despite efficient propagation on P. 




An efficiency of lysogeny style experiment (plating the host on agar seeded 
with high titres of phage) found that ~15% of P. distasonis APCS2/PD cells are 
resistant on initial exposure to ΦPDS1. This is consistent with lack of clearing of broth 
cultures and hazy zones of clearing on host lawns. In the absence of the phage, the 
host appeared to form two colony morphologies: large round creamy colonies and 
smaller granular colonies. A greater count of the former morphology type was present 
on the phage seeded plate, suggesting that possible phenotypic alterations have a role 
to play in morphology changes and the observed resistance. When ΦPDS1 was screen 
against lawns of the phage exposed clones, the zones of clearing had greater turbidity 
compared to the zones those formed on lawns of naïve P. distasonis APCS2/PD: 10% 
















In recent years many studies have revealed interesting insights into the human 
gut phageome. However, the majority of phages continue to exist only as sequence 
“dark matter” and phages which have been characterised in silico provide little insight 
into their biological properties.  Isolating and characterising these phages is key in 
advancing our understanding of phage-host interactions in the human gut. The human 
gut virome is largely composed of dsDNA phages of the Caudovirales order and 
ssDNA phages of the Microviridae family (Creasy et al., 2018; Lim et al., 2015; Minot 
et al., 2013; Shkoporov et al., 2019). The bacterial hosts of the majority of these phages 
are unknown. With the goal of isolating novel human gut phages and potentially gain 
insight into phage-host interactions, this study focused on Bacteroidales due to the 
importance of this bacterial order in the human gut. 
CRISPR-spacer analyses of virulent gut phages predicted that they are 
particularly associated with hosts of the Clostridales and Bacteroidales orders, 
including Bacteroides and Parabacteroides (Shkoporov et al., 2019). The majority of 
Bacteroidales species belong to the Bacteroides and Parabacteroides genera 
(Zitomersky et al., 2011). These form two important and abundant genera in the human 
gut and are associated with both health and disease (García-Bayona and Comstock, 
2019). There have been multiple reports of Bacteroides infecting phages (Booth et al., 
1979; Kai et al., 1985; Tartera and Jofre, 1987; Klieve et al., 1991; Puig and Gironés, 
1999; Hawkins et al., 2008; Ogilvie et al., 2012; Gilbert et al., 2017; Shkoporov et al., 
2018a; Benler et al., 2018; Porter et al., 2020; Hryckowian et al., 2020). However, few 
studies have examined Parabacteroides infecting phages. Currently, there are only 
two Parabacteroides associated prophage genomes deposited on NCBI Taxonomy; 




distasonis and the latter P. merdae and both are ssDNA phages of the Microviridae 
family. These phages were first detected in Sphagnum-dominated peat viromes 
(Quaiser et al., 2015). An additional seven Parabacteroides prophages of the 
Microviridae family were detected in the gut of Ciona robusta, a marine vertebrate 
(Creasy et al., 2018). This highlights how little is known about human gut 
Parabacteroides phages.  
The selective enrichment implemented in this study successfully selected for 
the growth of Bacteroidales (Figure 2). This led to the isolation of a novel lytic 
Parabacteroides distasonis phage of the Siphoviridae family, ΦPDS1. There are two 
brief reports of apparent virulent phages associated with Parabacteroides distasonis, 
formerly known as Bacteroides distasonis, however neither of this phages were 
characterized (Eggerth and Gagnon, 1933; Sabiston and Cohl, 1969; Booth et al., 
1979). Therefore, ΦPDS1 is the first P. distasonis targeting siphovirus to be isolated 
and characterised.  
P. distasonis is a Gram-negative, obligate anaerobe with rod-shaped 
morphology that is largely human gut associated (Sakamoto and Benno, 2006). These 
bacteria have been reported as important commensals with anti-inflammatory roles in 
the gut, alleviation of metabolic disorders and obesity (Kverka et al., 2011; Koh et al., 
2018; Wang et al., 2019). Reduced abundance of the Parabacteroides genus has also 
been observed in the faeces of patients suffering from inflammatory bowel disease 
(IBD) and multiple sclerosis patients (Lewis et al., 2015; Cekanaviciute et al., 2017; 
Olbjørn et al., 2019). However, multiple studies have also linked P. distasonis to 
disease states suggesting that it may be an opportunistic pathogen. It was found to be 
the most abundant bacterial species in faecal samples collected from individuals 




(Dziarski et al., 2016; Lopetuso et al., 2018).  Furthermore, P. distasonis was isolated 
in abundance from a lesion removed from the ileum of a CD patient (Yang et al., 
2019). This bacterial species was also shown to exacerbate symptoms in an 
amyotrophic lateral sclerosis mouse model (Blacher et al., 2019). Considering the 
health and disease implications associated with this bacterial species, P. distasonis and 
ΦPDS1 prove to be a phage-host pair of interest.  
Annotation of the ΦPDS1 genome revealed that nearly half of the genes remain 
unidentified (Figure 3). However, of the genes successfully annotated, some were 
associated with functions of interest including a quorum sensing (QS) regulated 
transcription factor associated with virulence (gp_26). Several QS response regulator 
homologs have been detected in sequenced phage genomes deposited on NCBI 
(Hargreaves et al., 2014). Furthermore, gene gp_34 encodes radical SAM enzymes 
which are involved in synthesis and metabolism of many cell compounds. They are 
also involved in pathways that lead to synthesis of  key players associated with quorum 
sensing; autoinducers (Parveen and Cornell, 2011).  QS is a phenomenon used by 
bacteria that allows population density dependent controlled expression of specific 
genes through cell-to-cell communication for processes such as virulence and biofilm 
formation (Whitehead et al., 2001; Turovskiy et al., 2007; Ng and Bassler, 2009; 
Papenfort and Bassler, 2016). There are several examples of phages hijacking this 
process. One such example includes a Vibrio cholerae infecting phage, VP882, which 
encodes a QS receptor homologous to that of the host. As a result, the phage can “listen 
in” on its hosts and monitor population densities thus allowing an informed 
lytic/lysogenic lifestyle switch. In high host cell density, lysis occurs resulting in 
optimal propagation (Silpe and Bassler, 2019). It has also been demonstrated in a lytic 




defences to aid infection (Hendrix et al., 2019). In addition, ΦPDS1 encodes a single-
stranded binding protein (SSB) which suggests that it does not depend on a host SSB 
for replication (Tang et al., 2013). Genes gp_25 and gp_31 both encode both encode 
Nin family recombinases, also known as orf and rap. These are associated with lytic 
growth (Tarkowski et al., 2002; Paepe et al., 2014). An auxillary metabolic gene, 
MazG, is encoded by gp_39. Such genes are of host origin and allow phages to alter 
host metabolic processes to their advantage. They have been mostly detected in marine 
phages and are associated with both lytic and temperate lifestyles (Breitbart et al., 
2018; Warwick-Dugdale et al., 2019).  MazG has been linked to maintenance of phage 
propagation in starved host cells by aiding metabolism (Bryan et al., 2008; Kang et 
al., 2013).  
Analysis of ΦPDS1 against an in-house human phage database identified 
sixteen ΦPDS1 related phages (Figure 5A). CRISPR-spacer analyses suggest that 
these phages have evolved to infect one of two members of the Bacteroidales order: 
Parabacteroides distasonis or Odoribacter splanchnicus. As ΦPDS1 CRISPR- 
spacers were detected in P. distasonis ATCC 8503 (DSM 20701) and O.  splanchnicus 
DSM 20712, these specific strains were ordered from DSMZ in addition to the only 
other P. distasonis strain available from culture collections, P. distasonis DSM 2949. 
None of these strains could support propagation of ΦPDS1 (Figure 6E). This suggests 
that ΦPDS1 is highly strain specific in its infection strategy and has specialised to 
propagate on the P. distasonis APCS2/PD on which it was isolated. Interestingly, 
when these findings are considered in parallel with whole genome comparisons, we 
can predict that the receptor binding protein is encoded by gene gp_60 (Figure 5B). 
ΦPDS1 and its closest relative, LS_917t11, both have top CRISPR-spacers hits in P. 




intermediate relative, LS_922til, had CRISPR-spacers detected in Odoribacter 
splanchnicus and a more distant relative, Sib2_ms_18, had spacer hits for B. fragilis. 
Both share no similarity with ΦPDS1 at gene gp_60 despite intermediate to high 
nucleotide similarity at the majority of other genes.  
ΦPDS1 fails to clear liquid cultures of its host despite efficient propagation 
and zones of clearing remain slightly hazy. The phage is also unable to form stable 
lysogens and its genome has no detectable integrase, strongly indicating that the phage 
is lytic. Although, with infrequent plaque formation pseudolysogeny may be possible 
but unlikely (Siringan et al., 2014). The phage can also stably co-exist with its host 
during serial co-culturing despite initially selecting for an increase in resistant host 
variants as indicated by the titre decrease on day two of the co-culture cycle (Figure 
6D). Following this initial titre decrease, the phage continues to stably propagate for 
days with titres maintained at ~6 x 108 pfu/ml and without clearing of the host culture. 
This could be indicative of host population heterogeneity in terms of phage 
permissivity. This may also explain the variation in turbidity for zones of clearing and 
phage kinetics observed for different P. distasonis APCS2/PD cultures. The inability 
of an apparently lytic phage to clear liquid culture of its host at high titres was 
previously observed for a B. intestinalis phage, ΦcrAss001, and B. thetaiotaomicron 
phages (Shkoporov et al., 2018a; Porter et al., 2020).  In the case of the latter, phase-
variable expression of host capsule polysaccharide loci and surface features created 
transient phenotypic heterogeneity within an isogenic population. This heterogeneity 
resulted in a mixture of phage permissive and non-permissive host variants thus 
allowing both phage and host to co-exist (Porter et al., 2020). This highlights the 
importance of bacterial host factors in influencing phage-host interactions. Phase-




Comstock, 2008; Fletcher et al., 2007). Potential phase-variable mediators such as 
invertases, integrases and serine/tyrosine recombinases were observed in the P. 
distasonis APCS2/PD genome (Figure S2).  Invertible promotor regions are 
characteristic of Bacteroidales species residing in the human gut and are not generally 
conserved among Bacteroidales occupying other niches (Coyne and Comstock, 2008; 
Jiang et al., 2019). Transcriptomics may provide important insights into the role of 
these features. The mechanisms that mediate the interaction between ΦPDS1 and P. 
distasonis APCS2/PD merit further investigation and this phage-host pair should be 
examined in in vivo models with naturally relevant conditions.  
In conclusion, we report the isolation, biological and in silico characterization 
of ΦPDS1. This phage is the first lytic siphovirus isolated from the human gut that 
infects P. distasonis to be characterised in detail. ΦPDS1 is also the first phage genome 
of this type to be deposited on NCBI Taxonomy. Considering the health and disease 
associations of P. distasonis, further characterisation of this phage-host pair could 
provide interesting insights into phage-host interactions in the human gut, particularly 











4.6 Figures  
 
Figure 1. Schematic overview of the key experimental steps implemented to screen 







Figure 2. The relative abundance of the bacterial genera detected with and without 
antibiotic driven selective enrichment of Bacteroidales throughout the faecal 










Figure 3. Circular genome map of novel ΦPDS1. Genome size is 44,691bp. The 
innermost ring (blue; positive strand, green; negative strand) depicts G + C skew, the 
central ring (black) shows G + C content. The outermost circle shows protein coding 
genes (CDS) which are labelled with HHpred predicted function. CDS are coloured 
based on general function which corresponds to the legend. Where function could not 






























Figure 4. The influence of host selective enrichment on the abundance of ΦPDS1 
throughout faecal fermentation (A) The relative abundance of ΦPDS1 with and 
without antibiotic enrichment of host, represented as the percentage of total viral reads 
aligning to the phage. (B) Absolute quantification of ΦPDS1 by qPCR targeting a 
segment of the phage portal protein. Titre determined in copies/ml using the standard 
curve method. Both results highlight that the selective conditions greatly aided ΦPDS1 
propagation as a result of host expansion. Error bars represent standard deviation (n = 
3). Statistical significance of titre difference was determined using the paired T-test 





























                                           
                                                                                                                                                                               
                                                                        
                                                                    
                                                                      
                                                                      
                                                                    
                                                                      
                                                                      
                                                                      
                                                                        
                                                                        
                                                                        
                                                                    
                                                                        
                                                             
                                                               
                                            
         
                                                                
                                                                            
                                                                   
                                                
                                                                                                                                                                                       
                                                                       
                                                                                 
                                                                             
                                                                           
                                                                           
                                                                                 
                                                                      
                                                                               
                                                                               
                                                                                 
                                                                       
                                                                       
                                                                       
                                                                       
                                                                             





Figure 5. In silico analysis of ΦPDS1 and related phages. BLASTn of the ΦPDS1 
genome against a database generated from multiple human gut virome studies 
identified sixteen closely related phage contigs. (A) Average nucleotide identity of the 
phages was determined to gain insight into relatedness. The closest relative of ΦPDS1 
was identified as LS_917t11 and the most distant Sib2_ms_118. (B) Whole genome 
comparison of ΦPDS1 against a highly, intermediately and more distantly related 
phage to examine synteny and conservation of genome organisation. (C) Analysis of 
ΦPDS1 and the sixteen related phages for the presence of CRISPR-spacer regions in 
bacterial genomes. The top 10 bacterial genome hits with ΦPDS1 CRISPR-spacers are 



























Figure 6. Biological characterisation of ΦPDS1 (A.) Transmission electron 
micrograph of ΦPDS1 generated from enriched lysate, stained with uranyl acetate 
showing that ΦPDS1 has a siphovirus morphology. The capsid diameter is 
approximately 53 ± 2.0 nm and tail length 150 ± 10.0 nm. (B) Spot morphology with 
incomplete clearing. (C) ΦPDS1 one-step growth curve. Sampling was performed 
every 15 mins over 3 hours. Latent period is 90 mins and burst size of ~14-20 virions 
per infected cell. (D) The titre of ΦPDS1 following continuous co-culture on host P. 
distasonis APCS2/PD over 10 days. (E)   Liquid propagation of ΦPDS1 on two 
commercial P. distasonis strains (DSM 29491 and DSM 20701) and O. splanchnicus 
(DSM 20712) was examined over five days with host P. distasonis APCS2/PD used 
as a control. Titres determined in copies/ml by qPCR. Arrows on y-axis indicate phage 



















Supplementary figure 1. Spot assay of φPDS1 on lawn of P. distasonis APCS2/PD. 
Samples examined originate from the same subject ID:924 faecal sample and were 
tested as follows: (A) Faecal filtrate prepared directly from subject ID:924 faeces. (B) 
Phage rich fermentate collected at time point 21 hours. Selective enrichment to 
promote the growth of Bacteroidales was not performed in the case of A + B (C) Phage 
rich fermentate collected at time point 21 hours following selective enrichment. These 













Supplementary figure 2. Circular map of ΦPDS1 host P. distasonis APCS2/PD 
genome 5.35 Mbp in size. The innermost circle (green and purple) depicts GC skew 
and circle two (black), G + C content. Circle 3 and 4 (red and dark blue), opening 
reading frames identified on the positive and negative DNA strands. Circle 5 (orange), 
tRNA and rRNA genes. Circle 6, genes annotated as sus gene family associated 
(green) and TonB dependent receptor (light blue). Circle 7 (black), genes annotated as 



















Table 1. Species identified from Sanger sequencing of bacteria enriched from subject 
ID: 924 faecal sample following selective enrichment. FAA; Fastidious anaerobic 
















    
  
FFA S1 968 99 100 B.uniformis  FAA 
FFA S2 1186 99 99 B.uniformis  FAA 
FAA S3 1120 99 100 B.uniformis  FAA 
FFA S4 1105 99 100 B.uniformis  FAA 
FFA S5 1122 99 100 B.ovatus  FAA 
FAA S6  >1000 99 100 B.dorei  FAA 
FFA S7 1279 99 99 B.uniformis  FAA 
FAA S8 1115 98 99 P.distasonis  FAA 
FAA B1 673 95 100 P.distasonis  FAA 
FAA B2 977 97 99 B.uniformis  FAA 
FAA B3 1071 95 96 P.distasonis  FAA 
FAA B4 947 97 99 P.distasonis  FAA 
FAA B5 1000 98 99 P.distasonis  FAA 
FAA B6 1138 97 100 P.distasonis  FAA 
FAA B7 1057 99 97 P.distasonis  FAA 
FAA B8 1111 98 100 P.distasonis  FAA 
  
    
  
YCFA 
    
  
YCFA S1 776 99 100 B.uniformis  YCFA 
YCFA S2 1101 99 99 B.uniformis  YCFA 
YCFA S3 1171 91 100 B.uniformis  YCFA 
YCFA S4 1109 99 99 B.uniformis  YCFA 
YCFA S5 965 99 100 B.uniformis  YCFA 
YCFA S6 1087 99 98 B.uniformis  YCFA 
YCFA S7 1195 99 100 B.uniformis  YCFA 
YCFA S8 1107 99 100 B.uniformis  YCFA 
YCFA B1 901 98 100 B.uniformis  YCFA 
YCFA B2 658 99 99 B.dorei  YCFA 
YCFA B3 1081 99 100 B.uniformis  YCFA 
YCFA B4 906 99 99 P.distasonis  YCFA 
YCFA B5 895 99 100 B.uniformis  YCFA 
YCFA B6 698 99 100 B.uniformis  YCFA 
YCFA B7 742 99 100 B.uniformis  YCFA 





    
  
CBA 
    
  
CBA S1 800 99 100 B.xylanisolvens  CBA (horse 
blood & vitK) 
CBA S2 936 96 100 P.distasonis  CBA (horse 
blood & vitK) 
CBA S3 1000 99 100 B.uniformis  CBA (horse 
blood & vitK) 
CBA S4 701 99 100 P.distasonis  CBA (horse 
blood & vitK) 
CBA S5 917 99 100 B.uniformis  CBA (horse 
blood & vitK) 
CBA S6 938 98 99 P.distasonis  CBA (horse 
blood & vitK) 
CBA S7 574 99 100 B.uniformis  CBA (horse 
blood & vitK) 
CBA S8 790 99 100 B.uniformis  CBA (horse 
blood & vitK) 
CBA B1 893 99 100 B.uniformis  CBA (horse 
blood & vitK) 
CBA B2 >1000 99 99 B.fragilis  CBA (horse 
blood & vitK) 
CBA B3 647 93 99 B.dorei  CBA (horse 
blood & vitK) 
CBA B4 351 94 100 P.distasonis  CBA (horse 
blood & vitK) 
CBA B5 173 90 98 B.dorei  CBA (horse 
blood & vitK) 
CBA B6 394 81 100 B.dorei  CBA (horse 
blood & vitK) 
CBA B7 922 99 100 B.dorei  CBA (horse 
blood & vitK) 
CBA B8 481 82 100 B.dorei  CBA (horse 








Table 2: HHpred determined functional annotation of ΦPDS1 genome 
LOC/CDS Name Protein Length (aa) Hit Probability E-value Function 
gp_1 45 - - - - 
gp_2 171 2EAX_B 99.84 1.20E-22 Peptidoglycan recognition protein 
gp_3 128 - - - - 
gp_4 204 - - - - 
gp_5 105 - - - 
Ribosomal large subunit pseudouridine 
synthase B (Determined by VIGA and 
BLASTp) 
gp_6 92 - - - - 
gp_7 68 PF12989.7 99.94 8.70E-31 Domain of - function (DUF3873) 
gp_8 123 - - - - 
gp_9 172 - - - - 
gp_10 162 - - - - 
gp_11 206 - - - - 
gp_12 80 2EWT_A 99.29 5.20E-13 
Helix-turn-helix transcriptional 
regulator 
gp_13 70 - - - - 
gp_14 447 PF12684.7 98.96 2.20E-10 
PDDEXK-like domain/CRISPR-
associated exonuclease Csa1 
gp_15 242 - - - - 
gp_16 274 4PT7_A 98.62 4.40E-09 Replication initiator A family protein 
gp_17 318 - - - - 
gp_18 184 1HJR_B 99.82 2.10E-21 Holliday junction resolvase, RuvC 




gp_20 63 - - - - 
gp_21 67 - - - - 
gp_22 60 - - - - 
gp_23 481 5XEI_A 99.68 8.30E-16 
Condensin - chromosome 
partition/DNA repair protein RecN 
gp_24 382 TIGR02757 100 8.40E-75 
Protein of - function/ N- 
glycosylase/DNA lysase 
gp_25 143 1PC6_A 99.83 4.00E-22 Protein ninB/Nuclease 
gp_26 68 PF12843.7 99.02 4.00E-12 
Putative quorum-sensing regulated 
virulence factor TF (QSregVF) 
gp_27 272 5M1S_D 99.71 4.80E-18 DNA Polymerase 
gp_28 152 1D3Y_A 95.97 8.30E-04 DNA topoisomerase 
gp_29 143 cd00223 97.57 1.30E-06 
Topoisomerase-primase nucleotidyl 
transferase/hydrolase 
gp_30 219 - - - - 
gp_31 150 PF05766.12 99.04 2.40E-12 
NinG recombination protein/HNH 
Endonuclease 
gp_32 117 - - - - 
gp_33 137 3LGJ_A 99.93 1.80E-26 Single-strand binding protein 
gp_34 278 TIGR04471 99.92 3.60E-28 Radical SAM enzyme 
gp_35 168 2DP9_A 99.58 1.80E-16 ASC-1 homology domain 
gp_36 84 - - - - 
gp_37 98 5CYB_A 92.9 0.12 Lipocalin lipoprotein 
gp_38 119 - - - - 
gp_39 345 3CRA_B 99.51 1.10E-16 
Nucleoside triphosphate 
pyrophosphohydrolase, MazG 




gp_41 56 - - - - 
gp_42 45 - - - - 
gp_43 227 PF07638.11 95.23 0.031 RNA polymerase sigma factor 
gp_44 72 - - - - 
gp_45 337 4BIJ_C 99.93 6.70E-27 Terminase large subunit 
gp_46 148 TIGR01630 99.67 7.10E-18 Terminase large subunit 
gp_47 216 - - - 
Putative tail protein (Determined by 
VIGA) 
gp_48 575 PF13264.6 99.42 2.00E-14 Portal protein 
gp_49 172 TIGR02794 95.33 6.60E-02 
TolA inner membrane protein (TonB 
paralog) 
gp_50 316 - - - 
Putative capsid associated protein 
(Determined by VIGA) 
gp_51 370 3J7W_D 93.08 5 Major capsid protein 
gp_52 440 - - - - 
gp_53 149 PF05069.13 96.49 1.90E-03 Phage virion morphogenesis protein 
gp_54 189 - - - - 
gp_55 85 PF07098.11 98.11 2.10E-07 Protein of - function (DUF1360) 
gp_56 257 - - - - 
gp_57 1164 - - - 
Tail tape meausre protein (Determined 
by VIGA and BLASTp) 
gp_58 836 - - - - 
gp_59 291 - - - 
Putative tail fibre protein (Determined 
by VIGA and BLASTp) 
gp_60 1151 - - - - 




Table 3. Metadata associated with ΦPDS1 and sixteen related phages identified in silico. 
 Study Health Status Gender Age Location/Nationality 




Cystic Fibrosis Unknown Unknown Irish 
ERR844031_ms_2 Norman Healthy F 51 Chicago, IL 
LS_917t11 Longitudinal Healthy F 40 Irish 
ERR844049_ms_5 Norman Healthy F 48 Boston, MA 
ERR844071_ms_9 Norman Healthy M 57 Cambridge, MA 
ERR844057_ms_4 Norman UC F 32 Chicago, IL 
ERR844021_ms_2 Norman Healthy F 24 Chicago, IL 
ERR843922_ms_4 Norman Healthy M 45 Cambridge, MA 
ERR844077_ms_8 Norman CD M <30 Cambridge, MA 
HvCF_a8_ms_3 Cystic Fibrosis Cystic Fibrosis M Unknown Irish 
LS_923t2l Longitudinal Healthy M 54 English 
PDS1 Longitudinal Healthy F 43 Irish 
LS_923t9 Longitudinal Healthy M 54 English 
LS_925t10 Longitudinal Healthy F 45 Irish 
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Thesis summary and future work 
Phages form an important and abundant component of the human gut. It has 
become apparent that their interactions with bacteria within the complex gut 
ecosystem have important implications for homeostasis and disease. In the past few 
decades, significant progress has been made towards improving our understanding of 
the bacterial residents of our gut, however, our knowledge on the role played by 
phages is significantly lacking in comparison. Essential to expanding this is the in vitro 
and in vivo isolation and characterisation of novel gut phages and their hosts.  
Chapter I provides a review of our current understanding of the human gut 
phageome. Current methodologies and hurdles in the context of both bioinformatic 
and laboratory analyses and possible solutions to these issues are discussed. A case 
study examining the crAss-like phage family highlights the importance of novel phage 
discovery, mining and isolation in expanding our insights into the gut phageome. In 
addition, the merits of phage research are discussed. 
Chapter II examines the diversity of crAssphage variants, the most abundant 
phage type in the human gut. This was performed through bioinformatic analyses of 
human faecal phageome datasets leading to the development of a taxonomic 
classification scheme for the crAss-like phage family. The crAss-like phages were 
detected in the analysed datasets using the prototypical crAssphage DNA polymerase 
and terminase proteins as genetic signatures. The crAss-like phages were then 
clustered based on percentage of shared orthologous proteins. This led to the de novo 
assembly of 244 crAss-like phages. A total of 249 crAss-like phages were resolved 




example of ex vivo propagation of prototypical crAssphage in a fermenter which was 
inoculated with faeces from a donor that persistently carried crAssphage at high 
abundances. Sequencing revealed the presence of six additional crAss-like phages in 
the fermenter that resolved into five of the new genera as defined in this study. It is 
likely that further lineages of this family will be identified in years to come. 
Chapter III focuses on the in vitro isolation of crAss-like phages and associated 
Bacteroidales hosts using the same faecal donor as recruited in chapter II. Antibiotic 
enrichment was successfully implemented in driving the expansion of Bacteroidales 
and parallel crAss-like phage propagation in a faecal fermenter. The crAss-rich 
fermentate was sequenced confirming this expansion and revealed the presence of 
seven crAss-like phages. Primers were developed to target these phages with the goal 
of detecting their expansion on a specific host in vitro by qPCR. The crAss-rich 
fermentate was co-cultured with individual Bacteroidales cultures isolated from the 
crAssphage-rich faeces. Propagation of a candidate genus IV crAss-like phage, 
ΦcrAss002, was detected on Bacteroides xylanisolvens by qPCR. Interestingly, this 
phage did not form plaques nor lyse liquid cultures of its host despite attaining high 
titres. Therefore, focusing on solely traditional properties may have hindered the 
detection of this phage. 
Chapter IV applies the same approach for phage-host pair enrichment with a 
particular focus on isolating novel Bacteroidales phages due to the importance of this 
bacterial order in the human gut. However, here a more traditional screening approach 
was implemented using host lysis by spot assays as an indication of phage-host 
pairing. Successive enrichment and sequencing revealed the detection a of novel 




could form visible but incomplete zones of clearing on lawns of its host and 
periodically formed pinprick plaques, it also failed to lyse host cultures at high titres. 
Both phage isolates do not possess lysogeny modules or are not maintained 
within in their hosts but yet they are able to co-exist with their host over time despite 
being virulent in nature. This is consistent with the observed persistence of the virulent 
phage core in the healthy human gut. With qPCR showing both can efficiently 
propagate without lysing host cultures, this could be indicative of phenotypic 
heterogeneity within the host population that may possibly be mediated by phase 
variation.  Future work would focus on gaining a better insight into the dynamics that 
allow these phage-host interactions to occur, using transcriptomics and more complex 
ex vivo or in vivo models to further extend the above findings. This may help provide 
important insights into mechanisms that allow the co-existence of virulent phages and 
theirs hosts. This thesis also shows the importance of methodology in the screening 
and isolation of novel phage-host pairs and highlights the value of incorporating both 
traditional and non-traditional approaches. This can also be greatly aided by 
metagenomics which allows a more targeted experimental design. With further 
isolation of phages from the human gut and examination of the dynamics involved in 
bacterial host interactions, it is hoped that we will better understand how they 
influence our microbiome and health and in turn how we can manipulate them for 
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